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Abstract 
Non-viral gene delivery into mammalian cells is widely used in bio-processing for the 
production of recombinant proteins as well as considered for clinical trials in gene therapy 
and vaccination. DNA can be delivered through various non-viral methods including 
polymers, lipids, peptides and entrapment within nanoparticles. Non-viral gene delivery often 
entails nucleic acids that are bound to a polymer or polycation to form a complex referred to 
as polyplexes. Various factors may affect the efficiency of polyplex uptake in mammalian 
cells. One factor is DNA topology, which is important from a regulatory perspective whereby 
FDA guidelines require the majority of plasmid DNA (pDNA) (>80%) to be in its 
supercoiled (SC) form. Therefore the motivation of this study was to investigate the impact of 
DNA topology on non-viral gene delivery. 
In this study pDNA (6.8kb) was complexed with poly-L-lysine (PLL) (MW, 9600) to form 
PLL/DNA polyplexes. pDNA of three topologies; SC, open circular (OC) and linear-pDNA 
were complexed with PLL. Biophysical analyses which included size, surface charge, DNA 
binding and nuclease resistance assays revealed topology dependent results. For example SC-
pDNA polyplexes were smaller (<140nm); more efficiently packaged and displayed greater 
nuclease resistance than OC- and linear-pDNA polyplexes. DNA release from PLL was 
analysed although such experiments were not a time course study, rather a confirmatory assay 
to identify PLL-bound DNA. 
Polyplex uptake in Chinese hamster ovary (CHO), HeLa and dendritic cells (DCs) were 
studied. Uptake was monitored by fluorescent confocal microscopy, flow cytometry and 
reporter gene expression assays. Regardless of cell type, complexes containing SC-pDNA 
displayed greater reporter gene expression than OC- and linear-pDNA polyplexes. In regards 
to CHO cells confocal image analysis revealed SC-pDNA polyplexes associated most 
  
efficiently with host cell nuclei. SC-pDNA polyplexes were smaller and nuclease resistant 
than its counterparts which may facilitate uptake. Endocytic mechanisms of uptake were 
analysed in CHO cells. This is important as knowledge of polyplex uptake pathways could be 
exploited for future gene delivery studies.   
Polyplex nuclear import was studied in regards to importin-7 (Imp7). Imp7 is key nuclear 
import receptor identified in previous studies, which was a preselected candidate. Gene 
expression studies along with qualitative and quantitative confocal microscopy analyses 
indicated possible exploitation of Imp7. However live cell imaging experiments showed co-
localisation between DNA and nuclei fluorescence in Imp7 KD cells which suggests other 
routes of nuclear import may be employed.  
Polyplex uptake in DCs was also studied as these are key sentinels of the immune system. 
SC-pDNA polyplexes displayed the most efficient uptake and gene expression profiles in 
DCs. Gene expression and ability to induce DC phenotypic changes was dependent on dosage 
and DNA topology. Therefore this study stresses the importance of DNA topology which 
impacts on the bio-processing of non-viral gene delivery products.         
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1: Introduction 
Genetic immunisation refers to the introduction of an engineered gene which encodes an 
antigen to immunise the host towards the respective encoded antigen (Tang et al, 1992). This 
is different to gene therapy which is defined as the employment of genetic material to treat a 
disease (Brown, 2004). Therefore genetic immunisation differs by aiming to trigger a specific 
immune response. Advantages include the bypassing of various purification steps and being 
economically viable. Consequently genetic immunisation methods are being explored in 
relation to the treatment of infectious diseases and cancer (Jones, 2008).    
One specific strategy for genetic immunisation is the targeted delivery of genes to antigen 
presenting cells (APCs). This is done with the aim of inducing specific innate and adaptive 
immune responses that would otherwise be bypassed by conventional treatments. However 
delivery of genes to such specialised cells is dependent on many factors including; the nature 
of the gene vector, size of the delivery vehicle, the potential safety hazards posed by 
introducing a foreign vector within host cells and DNA cargo amongst others.  
1.1 The importance of plasmid DNA technology 
The introduction of plasmid DNA (pDNA) encoding antigenic sequences within host cells is 
an exciting venture which has generated great interest (Cooke et al, 2004; Dhama et al, 
2008). Plasmids are circular forms of DNA which are frequently located within bacteria and 
replicate in an autonomous manner (Brown, 2001). There are many benefits offered by 
pDNA genetic immunisation. Plasmid DNA encoding the protein antigen of interest bypasses 
isolation and purification of pure proteins conventionally used as antigens. Expression of the 
encoded antigen can trigger an immune response to the protein antigen. This avoids the use of 
viral vectors and solvents that can potentially lead to insertional mutagenesis (Cooke et al, 
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2004). Additionally unlike conventional treatments pDNA is relatively simple to produce, 
manufacture can be scaled up, economically viable, stable and can be transported with no 
major issues unlike current vaccines which have hindered their impact upon global diseases 
(Dhama et al, 2008). In fact a cocktail of pDNA genes encoding various antigens can be 
administered to bolster immunity towards a range of diseases (Dhama et al, 2008). Such 
desirable characteristics has seen pDNA vaccines elevated to clinical trials (phase II) for 
diseases such as AIDS, rabies, and tuberculosis amongst others (Dhama et al, 2008; Cooke et 
al, 2004).  
1.1.1 Characteristics of plasmids  
Plasmids are sufficiently designed so as to allow optimal expression of the encoded antigen 
of interest which brings about the desired attributes mentioned previously. Plasmids 
employed for gene delivery consist of a eukaryotic promoter required to drive transcription 
and expression of the encoded gene (Babiuk et al, 2006; Brandsma, 2006). A poly-A tail in 
conjunction with an enhancer are present in order to allow sufficient translational expression 
(Brandsma, 2006; Liu, 2003). Importantly pDNA are designed to consist of antibiotic 
resistant genes (pre-requisite for such procedures) in order to allow distinction from non-
transformed bacterial cells. To allow uptake to be monitored pDNA usually encode reporter 
genes whose expression within the target cell indicates successful uptake (Brandsma, 2006; 
Dhama et al, 2008). Reporter genes often include green fluorescent protein (GFP) or lacZ, a 
gene that encodes for β-galactosidase that can be detected via enzymatic assays. A bacterial 
replication site (Ori site) allows the propagation of plasmids, enabling such structures to 
replicate autonomously thereby increasing the intracellular concentration of the expressed 
gene. Plasmids also consist of sequences that are recognised by endonucleases which cleave 
the nucleic acid which allow insertion of a desired sequence for a target protein for instance.  
Chapter 1 Introduction 
 
4 
 
1.1.2 Plasmid DNA topology 
Plasmid DNA (pDNA) can exist in a variety of topological conformations which have 
important implications upon its application in biotechnology and biochemical engineering.  
1.1.2.1 SC-pDNA 
Plasmids usually confer to a natural supercoiled (SC) form in which the nucleic acid strands 
are coiled and twisted to form a dense intact structure (Figure 1.1). SC-plasmid DNA (SC-
pDNA) can also display less compact forms whereby the unpaired nucleotide regions exist. 
Such forms may arise as a result of plasmid preparation and termed supercoiled denatured 
(Brown, 2001). 
1.1.2.2 OC-pDNA 
If the polynucleotide strands are nicked, the nucleic acid exhibits a more relaxed shape 
referred to as open circular (OC) (Brown, 2001; Cherng et al, 1999). OC-pDNA adopts 
conformations intermediate between those of SC and linear (see below) forms of pDNA. 
Interestingly OC-pDNA have been reported to exhibit similar sizes to those of SC-pDNA 
when bound to the polymer; poly((2-dimethylamino)ethyl methacrylate) (Cherng et al, 1999). 
1.1.2.3 Linear-pDNA 
Plasmids can also be cut at specific nucleotide sites through the recognition of nucleases 
which cleave both strands resulting in a linearized conformation; linear-pDNA. Linear-pDNA 
display more open and accessible conformations which may favour gene expression, but may 
also be prone to aggregation and exposure to nuclease attack (Anada et al, 2005).  
The topological form of plasmids has important consequences for use in biotechnology. 
Conventional DNA uptake studies employ SC-pDNA which exhibiting a condensed shape 
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has been assumed to facilitate cellular uptake (Hsu and Uludag, 2008). The FDA (U.S Food 
and Drug Administration) requires that at least 80% of plasmid bulk product content for DNA 
vaccination should be in the SC conformation (Guidance for Industry: Considerations for 
Plasmid DNA Vaccines for Infectious Disease Indications – FDA, 2007). Few studies have 
analysed and systematically compared DNA of differing topologies in regards to gene 
delivery and ultimately vaccination, and so is a key area for consideration. Figure 1.1 
displays the three major pDNA topologies.   
Production of OC- and linear-pDNA can be confirmed by agarose gel electrophoresis. The 
different pDNA conformations display different sizes which can allow distinction by gel 
electrophoresis as mobility through the gel occurs on the basis of size. The condensed SC 
form is the smallest which facilitates migration through the gel, hence faster electrophoretic 
mobility. The linear form containing a double strand cut is larger and migrates slower, 
followed by OC-pDNA which migrates the slowest (Figure 1.1b).  
 
 
 
 
 
 
 
 
 
Figure 1.1: The three major topological forms of pDNA. Diagramatic representation of supercoiled 
(SC), open circular (OC) and linear-pDNA (A). Different pDNA conformations can be detected by agarose 
gel electrophoresis. This is due to different pDNA conformations displaying different electrophoretic 
mobilities. Electrophoretic diagram is cited from Remaut et al, (2006) (B).  
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1.2 Methodology of pDNA processing 
Strategies for delivering new medicines can be brought about via non-viral methods such as 
recombinant pDNA in Escherichia coli (E. coli). As of 2011 naked pDNA or pDNA 
formulations constituted 18.7% of gene therapy clinical trials, demonstrating the growing 
importance of non-viral gene delivery strategies (The Journal of Gene Medicine Clinical Trial 
site, 2011). Bioprocess engineering of pDNA vaccines and the importance of upstream and 
downstream processing on productivity was reported previously (Hoare et al, 2005). Levy et 
al, (2000) stated the importance of pDNA processing and how maintenance of pDNA in its 
SC conformation is important for the attainment of pharmaceutical grade pDNA. A typical 
process diagram summarising the key aspects of pDNA processing is shown in Figure 1.2. 
Although the SC conformation is important for pharmaceutical grade DNA, other plasmid 
conformations such as linear-pDNA is important as it has a more open structure than the SC 
form which favours access for transcription factors to enable gene expression to occur. 
Furthermore very few studies have systematically compared plasmids of different DNA 
topologies in regards to biophysical characterisation, mammalian cell uptake and potential 
nuclear import.  
1.2.1 Upstream processing of pDNA 
Escherichia coli (E. coli) has often been employed as a vehicle to allow expression and 
propagation of pDNA. This is brought about by fermentation of cells (Figure 1.2). This is a 
key step in upstream processing in order to enhance the E. coli population and increase the 
quantity and quality of recombinant pDNA (Carnes et al, 2006; Ferreira et al, 2000; Lehajani 
et al, 1996: Yau et al, 2008). Studies have also stressed the need for the removal of 
contaminants. For example Shamlou (2003) identified increased genomic DNA (gDNA) 
impurities post fermentation, stressing the need to improve pDNA processing. In regards to 
clinical applications, FDA guidelines (2007) recommended that pDNA pharmaceutical 
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products should not exceed 100pg gDNA per dose. Studies have shown how factors such as 
host strain selection and DNA topology can affect pDNA processing and the amount of 
impurities (O’Kenedy   et al, 2003; Yau et al, 2008; Carnes et al, 2006). For example host 
strain selection in upstream processing is important as certain strains have a greater specific 
growth rate than others. This has resulted in increased plasmid yields for certain strains than 
others which aids in bioreactor optimisation (Yau et al, 2008).   
 
 
 
 
 
Figure 1.2: Schematic of process options. Schematic representation of pDNA processing stemming from 
upstream fermentation through to cell harvest, lysis filtration, ultrafiltration (UF) and further downstream 
chromatography steps prior to product formulation. 
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1.2.2 Downstream processing of pDNA  
Downstream purification procedures are important in order to yield large amounts of stable 
pDNA (Stadler et al, 2004; Ferreira et al, 2000). These incorporate a variety of techniques to 
purify and increase the yield of therapeutically viable pDNA (Figure 1.2). 
1.2.2.1 Lysis 
Following fermentation downstream processing involves cleavage of cells (Ferreira et al, 
2000). This is necessary for the secretion of cellular impurities including gDNA, RNA, and 
pDNA, which ultimately increases pDNA yields (Horn et al, 1995). Secretion is brought 
about by alkaline lysis, whereby cells previously suspended in neutral pH are then treated 
with alkaline detergent which lyses cells. Although this technique employs RNase to degrade 
impurities and is efficient on bench scale, such a method is unsuitable for large scale pDNA 
recovery due to the employment of RNase, which is considerably expensive (Ferreira et al, 
2000). However even after alkaline lysis studies have reported that lysates often consisted of 
only 3% pDNA (Stadler et al, 2004). Alternative methods also include ultrafiltration 
(Theodossiou et al, 1997; Varley et al, 1999) and nucleases to remove gDNA and RNA 
contaminants (Monteiro et al, 1999; Chakrabarti et al, 1992). 
1.2.2.2 Clarification and precipitation  
Alkaline lysis results in a pDNA lysate containing cellular impurities which constitute a 
white flocculate. Removal of flocculate is important and is referred to as clarification and 
precipitation of pDNA (Hoare et al, 2005). Following alkaline lysis centrifugation is 
employed for removal of cellular impurities of the flocculate. Whilst this is suitable for small 
scale processing, it is not ideal for large scale recovery of pDNA (Blom et al, 2010). 
Filtration methods are often employed for flocculate removal, although filter clogging is an 
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issue which reduces yield. Sensitive and efficient removal of flocculate, so as to reduce 
release of any impurities have been discussed ranging from specific filter aids (Theodossiou 
et al, 1999), to the use of a pressure vessel used to separate flocculate from lysate 
(Przybylowski et al, 2007). A recent report discussed the use of an improved scalable method 
of alkaline lysis clarification. This involved the addition of ammonium hydrogen carbonate to 
the lysate which resulted in separation from the lysate (Blom et al, 2010). The benefits of this 
technique are that it is economically efficient as less time is spent on filtration. Therefore the 
need for specialised filters is reduced. When 5g E. coli was processed, 91% SC-pDNA 
content was recovered, although this decreased to <80% when scaled up to 940g highlighting 
the sensitivity of clarification pDNA recovery (Blom et al, 2010).                 
1.2.2.3 Ultrafiltration  
Ultrafiltration (UF) is a form of membrane filtration in which hydrostatic pressure filters low 
molecular weight lysates through a permeable polymer membrane (van Reis and Zydney, 
2007). UF often proceeds clarification steps and has been shown to be an effective tool in 
pDNA purification. Studies using UF found adsorption of lysates and led to <80% impurity 
removal (Kendall et al, 2002). Transmission through membrane pores is dependent on size 
and elongation characteristics of plasmids, which has allowed separation of different pDNA 
isoforms. SC-pDNA is smaller and is able to elongate and stretch allowing passage through 
membrane pores when induced with high filtration velocity (Latulippe and Zydney, 2011). 
However pressurised filtration can cause shearing and can jeopardise pDNA isoforms, 
thereby limiting pDNA yield.      
1.2.2.4 Chromatographic purification  
Chromatography is generally regarded as one of the most effective purification procedures 
for the attainment of pDNA suitable for therapeutic purposes (Stadler et al, 2004). The 
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advantage of such procedures is that chromatographic techniques exploit physiochemical 
attributes of pDNA which can potentially lead to primary eluents consisting of up to >80% 
pDNA (Stadler et al, 2004). However there are limitations to various chromatographic 
techniques (Table 1.1). For example ion exchange chromatography, which separates on the 
basis of charge, has been reported to retain RNA impurities (Sousa et al, 2008). This is a 
major limitation that can decrease pDNA yields. Other limitations include damage to pDNA 
which can alter conformation (Ferreira et al, 1999). However a recent study reported 
increased removal of cellular impurities through the use of boronate glass pore beads which 
were able to adsorb E. coli impurities such as RNA, LPS and cellular proteins (Gomes et al, 
2010). Although improved pDNA yields have been reported, shearing and damage to pDNA 
throughout the processing procedure has reduced yields, highlighting the sensitivity and 
difficulty in attaining therapeutic viable pDNA. For example despite membrane filtration 
being an efficient tool in downstream pDNA purification, plasmids are susceptible to 
shearing and damage to the pDNA backbone (van Reis and Zydney, 2007). This emphasises 
the importance of pDNA yield for DNA vaccine production and attainment of pDNA in the 
correct topological form. 
1.2.2.5 Formulation  
Following purification pDNA products must undergo 0.22µm sterile filtration and meet 
various minimum requirements (Prather et al, 2003). According to Sagar et al, (2003), final 
pDNA product should consist approximately <1% total protein and <1% gDNA impurities. 
Although these parameters vary between regulatory bodies pDNA yield is still relatively low, 
which stresses the importance of optimal upstream and downstream pDNA processing to 
remove cellular impurities and enhance pDNA retention.    
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1.3 pDNA complexes and its use in non-viral gene delivery 
Non-viral gene delivery into mammalian cells is widely used in the biotechnology industry 
for the production of recombinant proteins requiring post translational modifications as well 
as considered for clinical trials in gene therapy vaccination. Gene transfer through such 
means often entails delivery of nucleic acids that are bound to a cationic polymer 
(polycations) resulting in pDNA/polymer products, often referred to as polyplexes (Elouahabi 
and Ruysschaert 2005). In terms of cell therapy non-viral gene delivery has recently been 
found to treat spinal cord regeneration. DNA polyplexes transfected into endogenous cells 
have been identified to lead to the production of therapeutic molecules that stimulate long 
term tissue regeneration (Yao et al, 2012). There are numerous polycations which have been 
found to operate by binding and condensing pDNA which facilitates mammalian cell uptake 
(Tsai et al, 1999; Lee and Huang, 1996). Such polycations have been shown to condense 
pDNA into confined structures of approximately 100-200nm. These include that of 
polyethylenimine (PEI), poly-L-lysine (PLL), poly(amidoamine) (PAAs) and dendrimers 
amongst others (Ko et al, 2009; Zhang et al, 2009; Hartmann et al, 2008; Tsai et al, 1999; 
Dutta et al, 2008).  
1.3.1 Transient transfection   
Transient transfection refers to the process of introducing foreign nucleic acids into host cells, 
often with the aim of expressing a desired protein product (Liu et al, 2008). The term 
‘transient  transfection’  is  often  used  to  describe  non-viral gene delivery methods, for which it 
is often applied (Derouazi et al, 2004). In such cases the DNA is bound to a positively 
charged vector and gains cellular access via endocytosis (mechanism of cellular entry through 
membrane compartmentalisation). Transient transfection often leads to the short term 
expression of the reporter gene of interest, whereby the foreign DNA does not integrate 
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within the host chromosomal DNA. In terms of research, transient transfection is a widely 
used technique to safely and effectively deliver nucleic acids in a variety of cell types. It 
offers advantages including being a relatively simple and effective procedure, and has been 
applied in industry to maximise the production of recombinant proteins (Liu et al, 2008).          
1.3.2 Reverse transfection 
Transient transfection is often carried out on adherent cell lines to which the addition of the 
nucleic acid to a set of immobilised cells within culture media occurs. However many other 
cells, particularly key primary and immunological target cells are in suspension. Therefore to 
transfect suspended cells an alternative technique is required. Reverse transfection (RT) 
involves non-viral gene delivery through the immobilisation of DNA polyplexes to a cell 
adhesive surface, to which suspended cells are added (Bengali et al, 2009). RT offers many 
benefits over the conventional adherent cell transfection (bolus) technique as direct exposure 
of cells promotes internalisation and limits aggregation (Bailey et al, 2002; Shea et al, 1999). 
A study by Bengali et al, (2009), compared the conventional bolus and RT procedures, and 
did not find major variables. The amount of polyplexes that were cell associated was not 
significantly different. In addition the majority of polyplexes were often located in the media 
(bolus) or surface (RT), highlighting the limitations of transient transfection as a whole.            
1.3.3 Labelling of DNA and polycation 
To understand the mechanism of polyplex transfection and confirm uptake (defined as the 
intake of materials by a cell or tissue leading to its permanent or temporary retention) 
labelling as a means of tracking is essential. It is also crucial to consider whether labelling 
(either direct or indirectly) can affect the physiochemical properties of DNA polyplexes.   
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1.3.3.1 DNA labelling 
Tracking the fate of transfected nucleic acids often involves labelling of some degree. This 
involves transfecting a plasmid encoding a reporter gene, in which the process depends on 
nuclear entry and gene expression, or staining procedures (or both). Nucleic acids can be 
fluorescently labelled both direct and indirectly allowing one to monitor the progress of 
uptake. Various methods of labelling are available which have been employed in the 
literature, and the key techniques will be reviewed in this present section.   
1.3.3.1.1 Direct labelling 
Labelling of nucleic acids allows one to follow the progress of uptake and identify the 
immediate fate of the DNA post transfection. Nucleic acids are often stained or tagged 
directly with fluorescent markers which can be traced by fluorescent confocal microscopy or 
flow cytometry. Direct labelling of nucleic acids is a relatively simple procedure which can 
be brought about by fluorescent intercalating dyes (Perry et al, 2008). An example of such 
fluorophores is the family of Dimeric Cyanine Nucleic Acid stains (Invitrogen) which are 
potent DNA intercalating agents. Advantages of such dyes are that they exhibit a high affinity 
for DNA with limited background fluorescence for unbound fluorophores (Perry et al, 2008). 
Additionally when bound to DNA such dyes are extremely stable and only fluorescence when 
interwoven between nucleic acid strands (Krishnamoorthy et al, 2002). Confirmation of 
successful staining can be deduced by fluorescence spectroscopy assays. Various studies have 
utilised such dyes to directly label DNA, particularly when analysing polyplex gene delivery 
(Krishnamoorthy et al, 2002; Srinivasan et al, 2009). One example is that of Perry et al, 
(2008) who employed an intercalating fluorescent stain and successfully monitored uptake of 
polyplexes within mammalian cells. The specific ability of the respective dye to intercalate 
(and fluoresce) between the DNA strands enabled characteristic analysis of the labelled 
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polycation/DNA complex, whereby direct labelling did not jeopardise key physiochemical 
attributes (size and surface charge).            
1.3.3.1.2 Indirect labelling   
Indirect labelling of transfected pDNA polyplexes has been successfully employed. For 
example DNA can be biotinylated and probed with a fluorescent avidin antibody. This 
provides a useful and sensitive detection system. Indirect labelling to monitor transfected 
pDNA polyplexes was reported by Wojda et al, (1999) whereby target biotinylation and 
streptavidin probing enabled PEI polyplexes to be followed by confocal microscopy. 
However a disadvantage of this particular labelling procedure is that it requires one to 
confirm that the target is successfully biotinylated. In the case of DNA this requires a 
Southern blot to confirm labelling was achieved (if any), which is laborious and a time 
consuming method prior to transfection.      
1.3.3.2 Polycation labelling 
Monitoring the cellular destiny of the nucleic acid through either direct or indirect labelling is 
essential, but it is equally important to investigate the fate of the polycation vector through 
fluorescent labelling. This is important in order to monitor and trace the path of the 
transfected polycation and whether it shares the same the fate as the nucleic acid or 
undergoes a different uptake mechanism. Godbey et al, (1999) previously reported successful 
fluorescent labelling of the polycation; PEI (polyethylenimine). These polycations consist of 
branched structures containing primary amine groups, which allow binding of fluorescent 
dyes via an ester linkage. For instance FITC-succinimidyl esters have been applied to bind 
and efficiently label such polycations with a reduction in background fluorescence. Such 
labelling has allowed research into the fate of transfected polyplexes (Godbey et al, 1999).       
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1.3.3.3 Cell labelling  
Labelling of cells (either live or fixed) is important in terms of observing the transport of 
polyplexes through different cellular compartments. Labelling is often brought about via 
fluorescent tagging or staining. For example recent studies have labelled cells by fluorescent 
aptamers (Terazono et al, 2010). Aptamers are single stranded nucleic acids that interact and 
bind to a target sequence. Aptamer labelling is based on the addition of biotinylated single 
stranded DNA which binds to the target cell surface antigen. Fluorescent probe labelling is 
then brought about by the addition of streptavidin secondary molecules (Terazono et al, 
2010). The benefits of this procedure are that labelling is highly efficient and quick. 
Furthermore alternative antibody labelling methods can lead to irreversible conjugation 
which in turn affects the function of the respective cell (Trickett and Kwan, 2003). Other 
labelling methods include fluorescent staining of whole cells as a means to provide a 
backdrop thereby highlighting passage of complexes or transfer through cells (Langevin et al, 
2010).              
1.3.4 Non-viral formulated gene delivery  
1.3.4.1 Polymers  
Polymers (or polycations) are polymeric structures harbouring positively charged residues 
that can be used to bind with nucleic acids (Hartmann et al, 2008). Binding to the negatively 
charged DNA occurs via electrostatic interaction. DNA is not only attached, but also 
condensed to a smaller conjugate due to the phosphate backbone being relaxed by the 
cationic polymer and coiling into a dense structure (Hartmann et al, 2008). The 
polymer/DNA complexes formed as a result are referred to as polyplexes, in which the 
positive charge induced upon the pDNA allows interaction and entry within the negatively 
charged cell membrane (Figure 1.3).  
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Various polymers and also lipid structures have been applied to deliver genes, each with 
advantages and disadvantages. In this section the key polycations are reviewed and how each 
one effectively delivers pDNA (summarised in Table 1.2). 
 
Figure 1.3: Formation of DNA polyplexes. The positively charged residues bind via electrostatic 
interactions with the negatively charged DNA phosphate backbone to produce a complex of net positive 
charge, which allows uptake into target cells. Polymers bind and condense DNA into smaller 
nanoparticles.   
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Dendrimers 
 
MEND 
 
Liposomes 
 
Lu et al, 2011. 
Diagram cited 
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Aldrich®. 
Hanzlikova et 
al, 2009. 
Diagram cited 
from Sigma-
Aldrich®. 
Dutta et al, 
2008; Hartmann 
et al, 2008. 
Diagram cited 
from: Andre et 
al, 1999 
Suzuki et al, 
2008 
Perrie et al, 
2001 
Polymer  Structure References 
Table 1.2: Summary of the key non-viral gene delivery vehicles. The polymers display a network of positively 
charged amine residues which facilitates binding with the negatively charged DNA backbone. Liposomes are lipid 
structures whose structures encapsulate the nucleic acid.  
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1.3.4.1.1 PLL 
Poly-L-lysine (PLL) is a widely used polycation DNA condensing agent which has been 
shown to be effective in inducing confined pDNA structures (Lee and Huang, 1996; Tsai et 
al, 1999). PLL harbours an extensive network of amide groups that facilitates pDNA binding 
(Table 1.2). Benefits offered by PLL include the ease and rapid ability by which it binds with 
DNA, allowing successful delivery of genes (Fu et al, 2011; von Erlach et al, 2011). The 
ability of PLL to effectively produce dense structures and impose a strong cationic charge has 
enabled successful encapsulation within lipid vectors (liposomes) (Lee and Huang, 1996). In 
order to analyse pDNA complexes in regards to gene delivery, the condensed PLL/DNA 
structures must be studied at great depth (Mann et al, 2008; Tsai et al, 1999). The study by 
Mann et al, (2008) showed how PLL-condensed plasmids conferred to rod-like structures 
which may have arisen through extensive plasmid coiling yielding monomolecular 
polyplexes. In terms of polymer length the authors observed how shorter PLL molecules 
produced more dense structures, whereby polyplex sizes of only 60nm were recorded (Mann 
et al, 2008). This is useful for gene delivery studies whereby specialised cells allow entry to 
smaller incoming cargo. Therefore the advantages of using PLL over other polymers include 
its ability to bind DNA through electrostatic interaction thereby condensing it (Luo and 
Saltzman, 2000). Further benefits of PLL over other polymer counterparts include its low 
cytotoxicity, cost, application to a wide range of cells and versatility whereby it can undergo 
chemical modification for tailor made transfection studies (Luo and Saltzman, 2000; Fu et al, 
2011; von Erlach et al, 2011).  
1.3.4.1.2 PEI 
Polyethylenimine (PEI) is a popular polymer employed for non-viral gene delivery and 
functions similarly to that of PLL by facilitating cellular uptake (Neu et al, 2005; Ali and 
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Mooney, 2008; Hanzlikova et al, 2009). The PEI polycation exhibits a large extensive 
polymeric structure harbouring amide groups which contributes towards its overall cationic 
charge (which favours electrostatic binding with the negatively charged nucleic acid 
phosphate backbone) (Ali and Mooney, 2008). PEI not only condenses pDNA into confined 
forms but has been found to offer benefits such as providing protection from endosomal 
cleavage (major obstacle of non-viral gene delivery) and facilitating nuclear transport 
(Dunlap et al, 1997; Pollard et al, 1998). The structure and cationic charge of PEI is an 
advantage because following interaction with the negatively charged pDNA, bending of the 
usually rigid nucleic acid occurs leading to efficient DNA condensation and packaging, 
which ultimately enhances potential gene expression (Hartmann et al, 2008). This was 
reported previously whereby PEI/DNA was found to be efficiently transfected within smooth 
muscle cells (Hanzlikova et al, 2008). PEI also displays a low risk of cytotoxicity and 
reduced cost contributing towards its popularity within the field (Akhtar, 2006). However 
there are drawbacks, which primarily stems from its in vivo stability. Such complexes have 
been observed to be excluded from circulation leading to a build up of complexes within the 
reticuloendothelial (RE) organs (e.g liver) (Ko et al, 2009). The RE system refers to groups 
of cells of differing organs, capable of the uptake of nanoparticles (Brewer et al, 2012). 
Studies employing PEI have recorded modest transfection efficiencies (reporter gene 
expression). Excessive amounts of PEI have been reported to be quite cytotoxic which is in 
contrast to previous studies (Breuing et al, 2005). Although facilitating DNA packaging, the 
strong cationic charge of PEI may lead to association with non-specific components (Neu et 
al, 2005). A previous report addressed this issue by coating polyplexes with lipids which 
masks such excessive charges (Ko et al, 2009). Another issue is that PEI can exhibit a range 
of molecular weights and conformations which lends itself to being too polydisperse 
(Hartmann et al, 2008). This is an issue as such characteristics can affect the potency of the 
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cationic charge induced on pDNA and in turn greatly affects the degree of conjugation with 
the nucleic acid. In spite of such drawbacks, the simplicity, modest cost and ease by which it 
forms pDNA polyplexes (as highlighted in previous studies; Park et al, 2008; Hanzlikova et 
al, 2009; Ali and Mooney, 2008) continues to make it a predominant non-viral polymer gene 
delivery tool. PEI based systems were found to display sustained gene expression within the 
circulatory system, thus highlighting recent advances regarding the polymer (Ko et al, 2009). 
1.3.4.1.3 MEND 
Gene transfer can also take place through a multifunctional envelope-type nano device 
(MEND) (Suzuki et al, 2008; Kogure et al, 2004). This device consists of condensed pDNA 
coated with lipids to aid cellular integration in a manner similar to viral vectors (Khalil et al, 
2006). Although MEND has recently been applied for non-viral gene transfer and displayed 
promising results, there are limitations. The formulated MEND/PLL/DNA complex displayed 
a large size that was not feasible for gene transfer (Khalil et al, 2006). This led to designs of a 
new form of MEND that would allow packaging of pDNA conjugates which does not 
compromise the size of the resulting complex. Condensed pDNA were further compacted 
within lipid bilayers and tagged with arginine residues to facilitate specific cellular 
recognition and entry (Suzuki et al, 2008) (Table 1.2). Mono-cationic detergents (MCDs) 
were employed to further condense pDNA thereby reducing the size of the complex. MCDs 
exhibit hydrophobic residues that have been found to depress pDNA (Khalil et al, 2004). The 
addition of the MCD condensed pDNA to a lipid envelope improved cellular entry via 
electrostatic interaction. In fact lipid coating of the nucleic acid significantly enhanced 
transfection in HeLa cells. Condensed pDNA complexes were found to be transfected into 
cells more efficiently than naked DNA and controls lacking a lipid coating did not enter cells. 
Therefore these studies stress the importance of both pDNA compaction and lipid coatings 
which greatly facilitates cellular recognition. 
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1.3.4.1.4 Dendrimers 
Formulated gene transfer can also take place via dendrimers. Dendrimers are branched three 
dimensional components which offer the benefit of cellular networking and trafficking of 
DNA (Dutta et al, 2008) (Table 1.2). Dendrimers are of a relatively small size and their 
particular structure offers the advantage of avoiding degradation via the reticuloendothelial 
system (RES) (Dutta et al, 2008). Dendrimers harbour terminal amine residues which 
contribute towards a cationic charge (Tripathi et al, 2003). These polymers consist of large 
moieties of positively charged amino acids which interact with pDNA via hydrophobic 
electrostatic interactions in a more effective manner than fellow polycations (Zeng and 
Zimmerman, 1997). This may be due to the branched structure which aids in networking, 
allowing greater interaction with pDNA resulting in greater electrostatic binding that 
essentially eases the rigid phosphate backbone of pDNA (Lechardeur et al, 1999; Bielinska et 
al, 1997). Although cytotoxicity was reported previously (Bielinska et al, 1997), recent 
analysis highlighted improved safety issues (Zhang et al, 2007). Hydrophobic interaction 
allows dendrimers to bind and condense DNA efficiently into smaller conjugates. The 
condensed conjugates are then entrapped and bound within dendrosomes which serve as 
delivery vehicles (Dutta et al, 2008). Dendrosomes are advantageous because being vesicular 
they can act as transporters for the harboured dendrimer/pDNA polyplex. By containing the 
pDNA complex the desired therapeutic gene is shielded from intracellular nucleases (Perrie et 
al, 2001). Dendrimer/DNA complexes have also been found to stimulate T-helper cell 
responses indicating its ability to induce an immune response (Dutta et al, 2008). Dendrimers 
can also undergo modification in which the cationic charge may be masked which reduces 
non-specific binding and cytoxicity (Dutta et al, 2008). Despite encouraging results, 
dendrimers do fall short in terms of pDNA delivery to specific cellular compartments. 
Competition between negatively charged molecules and that of plasmids for binding upon the 
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polymer may lead to premature release (Perrie and Gregoriadis, 2000; Zelphati and Szoka, 
1996). 
1.3.4.1.5 PAA 
Poly(amidoamines) (PAAs) are a form of dendrimer and have recently generated interest 
because unlike its polycation counterparts, methods have been devised that allow the design 
and construction of a more potent and defined pDNA polyplex. For instance PEI and PLL 
polymers are polydisperse and can also lead to aggregation (Tsai et al, 1999). Intricate 
alterations to the PAA sequence can lead to changes in the chemical orientation of amide 
groups. By doing this a more potent monodisperse system is constructed thereby reducing 
non specific binding, cytoxicity and aggregation (Hartmann et al, 2008). Modification of 
PAA amine groups minimises the negatively charged repulsions ever present on the DNA 
backbone, leading to a more relaxed nucleic acid structure that is susceptible to coiling 
(Bloomfield, 1996). Therefore PAA modification enhances DNA condensation and 
packaging. By producing such encouraging results the tailor-made polyplex method 
described may pave the way for future designs of non-viral gene delivery methods.     
1.3.4.2 Lipids 
A major drawback concerning pDNA delivery is susceptibility towards nuclease degradation 
(Lewis and Babiuk, 1999; Gregoriadis, 1998; Davis, et al, 1993). Such events restrict the 
amount of plasmid transferred to the nuclei, thereby reducing gene expression (Perrie et al, 
2001). Various studies have analysed how pDNA may be delivered to target cells when 
encapsulated within cationic liposomes (Gregoriadis et al, 1997; Perrie et al, 2001) (Table 
1.2). Liposomes are lipid complexes which allow attachment of nucleic acids through 
electrostatic binding (Perrie et al, 2001). Not only do liposome complexes shield the 
harboured pDNA from nucleases but such vehicles have been found to transport nucleic acids 
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to antigen presenting cells (APCs) thereby amplifying any potential immune response 
(Gregoriadis, 1998). The lipid content enables liposomes to be taken up via endocytosis by 
APCs within draining lymph nodes (Velinova et al, 1996). Liposomes have been identified to 
express encoded antigen and in doing so increasing the immune response (Gregoriadis, 
1998). 
1.3.4.2.1 Cationic liposomes 
Lipid/DNA complexes are referred to as lipoplexes, which have been found to transport 
pDNA to target sites leading to efficient gene expression (Lee and Huang, 1996; Khalil et al, 
2006). Electrostatic interactions allow the incorporation of negatively charged pDNA within 
cationic liposomes. Alternatively positively charged polyplexes can be encapsulated within 
anionic liposomes. Both methods have improved gene expression (Lee and Huang, 1996).  
An important parameter to consider is lipid content with liposomes often containing specific 
lipids such as dioleoyl phosphotidylethanolamine (DOPE) or cholesterol. The application of 
DOPE is beneficial because it binds with fellow lipids which lead to the release of entrapped 
DNA when the pH decreases (Farhood et al, 1995). This is an advantage as many host cell 
degradative enzymes operate at an acidic pH. Therefore release of DNA avoids nuclease 
exposure. Cholesterol is required for stability and some reports have suggested a role for 
specific targeting (Allen and Chonn, 1987). The significance of liposomal constituents has 
been stressed in the literature and has been linked with improved pDNA uptake. Lipids such 
as 1,2-dioleoyl-3-(trimethylammonium) propane (DOTAP) seem to enhance pDNA 
incorporation. Perrie and co-workers (2001) injected mice with liposomes consisting of 
differing amounts of lipids. Antibody responses were recorded and were highest in models 
injected with either DOTAP or DOPE (Perrie et al, 2001). Therefore the design and 
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composition of such vesicles is important in entrapping, releasing the DNA, and also 
stimulating immune responses.  
1.3.4.2.1.1 Application of cationic liposomes 
Lipid content has been found to play a major role in gene delivery and studies have reported 
successful lipoplex gene transfer resulting in gene expression as well as inducing specific 
immune responses. For instance one study formulated a cationic liposome consisting of N-(2-
Hydroxyethyl)-N,N-dimethyl-2,3-bis(tetradecyloxy)-1-propanaminium bromide (DMRIE) 
and DOPE (Margalith and Vilalta 2006). This lipoplex harboured an antigen which encoded a 
glycoprotein of rabies. Vaccine delivery and antigen expression was assessed by 
administering mice with either DMRIE/DOPE lipoplex formulations or standardised rabies 
vaccines. Results showed how mice treated with DMRIE/DOPE/pDNA vaccines displayed 
protective sustained antibody titres which lasted longer than control groups (Margalith and 
Vilalta, 2006). Results also included how a small dose of the DMRIE/DOPE/pDNA vaccine 
induced protective titres that were far beyond the standard threshold (responses quantified by 
a rapid fluorescence focus inhibition test – RFIT). This is beneficial as it is desirable to 
restrict the amount of cationic lipids administered to a minimal amount that can sustain 
protective responses, which lasted for up to 125 days (Margalith and Vilalta, 2006). However 
in   comparison   to   fellow   cationic   liposome  Vaxfectin™, the DMRIE/DOPE/pDNA vaccine 
was not as effective in inducing antibody responses.  
1.3.4.2.1.2 Magnetofection 
Although liposomes have been found to successfully deliver pDNA, there are drawbacks 
which include lack of potency (low gene expression and modest antibody responses) and non 
specific binding. However magnetic nanoparticles may significantly improve lipoplex uptake. 
Research by Ino et al, (2008) mentioned how the coupling of pDNA with magnetized 
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cationic liposomes led to effective complex uptake when induced with a magnetic force. The 
method, termed magnetofection has been analysed previously (Scherer et al, 2002; Gersting 
et al, 2004). Magnetofection occurs on the basis of a magnetic force which physically pulls 
and attracts the lipoplex towards the target cell. Ino and colleagues (2008) harnessed this 
method by constructing magnetic cationic liposomes (MCLs) which consisted of small 
magnetite molecules. MCLs can then be coupled to lipoplexes to form MCL/lipoplexes 
(Nagatani et al, 1998).  
Reporter gene expression of MCL/lipoplexes was compared with that of non-magnetic 
lipoplexes. Magnetite molecules were mixed with the lipoplexes which allowed magnetite 
nanoparticle congregation on the surface of the desired cell (Shinkai et al, 1996). Uptake and 
gene expression was greater than non-magnetic controls. Furthermore optimal uptake was 
observed after only 5 minutes highlighting the swift delivery magnetofection has to offer The 
MCL/lipoplexes did not affect cell growth nor induce cytoxicity (Ino et al, 2008). In fact 
similar results were reported previously which employed lower MCL doses (Ito et al, 2004). 
Reports have identified successful gene expression and minimal safety issues regarding a 
wide range of cell types such as aortic endothelial cells (Ito et al, 2005) and mesenchymal 
stem cells (Shimizu et al, 2007).  
1.3.4.2.1.3 Elastic liposomes 
Elastic liposomes are dynamic structures that can penetrate and deliver pDNA through 
extreme barriers such as the transdermal skin barrier. Elastic liposomes are composed of 
phospholipids and ethanol which are responsible for its elastic tendencies (Manosroi et al, 
2009). An advantage of these complexes is its stability whereby storage for as long as 8 
weeks at temperatures as high of 45ºC did not hinder cellular uptake. (Manosroi et al, 2009). 
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An additional benefit is that the incorporation of ethanol enables free radicals to be mopped 
up, which are often the cause of DNA degradation (Evans et al, 2000).   
Few studies have reported successful transdermal drug delivery due to the stratum corneum 
(SCM) barrier of the skin. With the incidence of skin diseases rising, drug formulations 
designed to penetrate such a barrier is in major demand. The employment of elastic 
liposomes may provide an answer as they facilitate delivery by penetrating the SCM, which 
increases the porosity of the skin (Manosroi et al, 2009). However drug delivery and gene 
expression through standard liposomes have not been as effective, leading to the design of a 
novel elastic form of cationic liposomes with the aim of bypassing rigid barriers. The 
components of elastic liposomes provide its elasticity by lowering the melting point which 
allows increased interaction. It is suggested ethanol may come into contact with fellow elastic 
components such as phospholipid head regions which enhances fluidity (Touitou et al, 2000). 
These beneficial characteristics along with the ability to extend the release of nucleic acids 
enable elastic liposomes to become effective gene delivery tools (Choi and Marbach, 2005). 
Elastic liposomes were found to enhance transdermal gene uptake, with gene expression 
being observed in viable epidermis and dermis (VED) (beyond SCM barrier) (Manosroi et al, 
2009).  
1.4 Mammalian cell targets and uptake 
In order for pDNA to be used as a viable therapeutic product that requires delivery to target 
cells (regardless of polyplex or lipoplex formulation), mammalian cell uptake studies are 
crucial. For instance Chinese hamster Ovary (CHO) cells are employed for recombinant 
protein production and key primary immune cells are studied to trigger specific immune 
responses for the antigen of interest.  
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1.4.1 Chinese hamster ovary (CHO) cells 
Non-viral methods have been tested within mammalian cells such as Chinese hamster ovary 
(CHO) cells, as these systems allow high protein expression and can be successfully scaled 
up in culture (Liu et al, 2008; Derouazi et al, 2004). Short term transient transfection of CHO 
cells using polyplexes has been reported to result in high protein yields (Schlaeger and 
Christensen, 1999; Reisinger et al, 2009) and successfully scaled up. CHO cells play a 
prominent role in the synthesis of recombinant proteins with production occurring through 
culture of either adherent or suspended cells (Wurm, 2004). Adherent CHO cells are those 
that can be transiently transfected and produce recombinant proteins. For instance adherent 
CHO cells have been successfully utilised to produce the drug; erythropoietin (Epogen, 
Amagen) (Wurm, 2004). However suspended CHO cell cultures are also very much the norm 
in regards to recombinant protein synthesis due to increased growth capacity. Therefore CHO 
cells are a key source of recombinant protein production.      
1.4.2 Dendritic cells (DCs)  
Dendritic cells (DCs) are key components of the immune system which function by binding 
and collecting antigens. Following recognition, DCs present the antigen of interest through 
selective surface markers termed major histocompatibility complex (MHC) class-I molecules. 
MHC is cell surface molecule which interacts with blood cells called T-cells and participates 
in antigen presentation. MHC molecules present antigens to T-cells which express receptors 
specific for the antigen of interest (Marieb, 2004). There are various classes of MHC 
molecules which present antigens to certain T-cells. For example MHC class-I molecules 
present antigens to T-cells expressing receptors specific for the cell surface marker CD8 
(cluster of differentiation 8), these are referred to as CD8+ T lymphocytes (Marieb, 2004). In 
contrast MHC class-II molecules present antigens to T-cells expressing receptors specific for 
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CD4 (cluster of differentiation 4), which are termed CD4+ lymphocytes (Marieb, 2004). 
Following antigen presentation, T-cells become activated. When activated T-cells function by 
releasing small proteins referred to as cytokines which aid in the immune response (Ueno et 
al, 2011). Following antigen presentation T-cells differentiate into effector cells (Finkleman 
et al, 1996). DCs also function by presenting antigens to B cells, which release antibodies 
specific for the antigen of interest. It is these functions that researchers aim to exploit in the 
production of vaccines that target DCs and why they are referred to as antigen presenting 
cells (APCs). DCs are often located in peripheral tissues such as the skin whereby the 
likelihood of antigen interaction is highest (Banchereau et al, 2000). There are various types 
of DCs which can be classified according to their location; cutaneous DCs such as langerhan 
cells (LCs), the dermis DCs and macrophages (Valladeau and Saeland, 2005). 
DCs are key sentinels of the immune system. They bridge both arms of immunity; the innate 
and adaptive response. The innate form of immunity refers to the immediate deployment of 
antimicrobial proteins and various cells as a means to prohibit foreign pathogen invasion. The 
adaptive arm of immunity is primed into response following exposure to a foreign antigen, 
which then specifically recognises and targets the foreign pathogen culminating in 
immunological memory for future attacks (Marieb, 2004). Therefore DCs are an ideal 
therapeutic target for polyplex gene delivery, and DNA vaccination.   
1.4.2.1 Innate response  
The innate arm of the immune system recognises foreign microbial agents, molecular 
pathogens and nucleic acids. This function is brought about via pathogen recognition 
receptors (PRRs) (Stevenson et al, 2010). An example of PRRs is toll-like receptors (TLRs) 
which are expressed on DCs and detect foreign DNA as well as other types of molecules 
(Stevenson et al, 2010). However DNA detection is not exclusive to TLRs. Takaoka et al, 
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(2007) reported that DNA-dependent activator of interferon-regulatory factors (DAI) 
recognises and binds DNA. Absent in melanoma 2 (AIM2) is another complex that detects 
DNA. It does this by recruiting a protein complex (AIM2 inflammasome) which stimulates 
caspase I, which functions by releasing the cytokine IL-1β (Fernandes-Alnemri et al, 2009). 
An alternative DNA detection pathway involves ribonucleic acid (RNA) polymerase III 
(RNA pol III) and retinoic acid-inducible gene I (RIG-I) (Stevenson et al, 2010). These two 
complexes work in partnership whereby RNA pol III transcribes the DNA to RNA which 
activates the RIG-I complex, which is involved in type I interferon production (Chiu et al, 
2009). Interferons (IFN) are proteins produced in response to pathogen infection (Marieb, 
2004). IFNs are proteins classed as cytokines which function by increasing viral or pathogen 
detection, by increasing antigen presentation to T-cells, which in turn enhances the immune 
response directed towards foreign antigen (Stevenson et al, 2010). Previous reports identified 
how stimulator of interferon genes (STING) performs as a DNA sensing agent of innate 
immunity (Ishikawa et al, 2009). Further PRR DNA detection systems also include high 
mobility group box (HMGB) (Yanai et al, 2009). This is summarised in Figure 1.4. 
1.4.2.2  Adaptive response 
The adaptive arm of immunity is involved in the activation of T-cells such as CD4+ T cells 
(Marieb, 2004). CD4+ T cells are white blood cells which are critical in maximising the 
immune response towards a foreign antigen by signalling the recruitment of antibodies 
specific for the antigen of interest (Marieb, 2004). If DNA vaccines are to be successful, then 
gene transfer must attract T-cell activity. Stevenson et al, (2010) stated that a successful DNA 
vaccine must incorporate sequences encoding for an adjuvant (pharmacological agent that 
amplifies an immune response). An example of a widely used adjuvant is tetanus toxin (TT) 
in which sequences derived from the adjuvant are encoded in the same vector as the antigen 
(Rice et al, 2008). The antigen fused adjuvant is presented to DCs, which express MHC-II 
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protein receptors which specifically recognise the adjuvant (Stevenson et al, 2010) (Figure 
1.5). The MHC-II surface markers bind and present the DNA antigen which signals CD4+ T 
cells specific for the TT adjuvant. Such action primes the T cells to differentiate into effector 
cells to respond towards the presented DNA antigen (Stevenson et al, 2010).            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4: Innate immune response leading to cytokine production. Innate arm of immunity 
entails the activation of various DNA sensing agents, which ultimately culminates in cytokine 
synthesis as a means to direct an immune response towards DNA antigen. 
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Figure 1.5: Adaptive immune response leading to T cell differentiation which leads to 
antibody production. Adaptive arm of immunity entails antigen presentation, enhanced via 
adjuvant sequences, which then attract adjuvant specific T cells to direct immunity towards the 
antigen of interest. TT refers to the adjuvant tetanus toxin.  
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1.4.2.3 Measuring activation of DC in regards to polyplex uptake 
DCs are characteristic in that they express various cell surface markers such as MHC proteins 
and cluster of differentiation 1a (CD1a) which are all distinctive, but generally function by 
presenting foreign antigens. Interestingly studies have shown how exposure of DCs to 
chemical treatment and allergens alters DC surface marker expression leading to the 
activation of such cells (Hulette et al, 2002). Therefore DC surface marker expression is used 
as a predictor of the sensitization potential of a chemical (Hulette et al, 2002). Very few 
studies have actually focused upon the uptake of DNA polyplexes within DCs and whether 
uptake activates DCs. Therefore DC surface marker expression is a key indicator for cell 
activation.   
1.4.3 Polyplex uptake within mammalian cells  
1.4.3.1 Mechanism of polyplex uptake 
The characterisation of pDNA complexes and their design, either as poly- or lipoplexes needs 
to be done with considerations towards the cellular uptake pathways in mind. After all, 
characterisation and design is based on the notion of delivering the encoded antigen to its 
intracellular target in order for its therapeutic function to take effect. However the plasma 
membrane poses a major obstacle towards such targets (Khalil et al, 2006). Endocytosis 
(cellular incorporation of foreign components) is widely regarded as the manner in which 
such vectors enter target cells (Khalil et al, 2006 and Zuhorn et al, 2002). Following 
endocytosis, the newly internalised (successful entry) molecules are entrapped within vesicle-
like structures. These vesicles fuse with lysosomes which then degrade the internalised 
contents (Khalil et al, 2006). Therefore the design of novel polymer based gene delivery 
systems must enable endosomal release to avoid intracellular lysosomal degradation. In order 
to do so knowledge of the uptake mechanisms is necessary. 
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1.4.3.1.1 Endocytosis  
Endocytosis refers to the process of internalisation of extracellular material within the cell 
and has been credited for polyplex uptake (Gould and Lippincott-Schwartz, 2009; Pinchon et 
al, 2010). Therefore polyplexes should be designed to maximise uptake through such 
mechanisms. Endocytosis can be subdivided into two main pathways; clathrin mediated 
endocytosis (CME) and clathrin independent pathways such as caveolae and 
macropinocytosis. 
1.4.3.1.1.1 Clathrin mediated endocytosis (CME) pathway 
The clathrin mediated endocytosis (CME) pathway is widely regarded as the predominant 
mechanism of polyplex cellular uptake (Takei and Haucke, 2001). The CME pathway is 
important as it oversees the continual supply of nutrients, growth factors and antigens. The 
transferrin loaded iron molecules that are essential for iron metabolism are internalised via 
CME (Khalil et al, 2006). Molecules taken up by the CME pathway are initially recognised 
by specific receptors. These receptors recognise certain ligands immobilised to the molecule 
of interest. Uptake leads to the build up of ligand/receptor complexes on coated pits of the 
membrane. These pits are made up of clathrin which form a polymeric structural lattice 
(Khalil et al, 2006). Subsequently such pits pinch off from the membrane forming clathrin 
coated vesicles (CCVs). The clathrin coating on these vesicles (containing ligand/receptor 
complexes) disintegrates leading to the formation of immature endosomes (vesicles 
containing foreign components) (Khalil et al, 2006). These endosomes come into contact 
with lysosomes which are characterised by a reduction in pH (approximately pH 5) whereby 
lysosomal enzymes degrade the vesicular contents. Therefore in terms of the CME pathway it 
is desirable to design a pDNA polyplex than can be incorporated within CCVs to maximise 
cellular entry but crucially enable endosomal release to avoid lysosomal degradation.  
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As mentioned previously aspects of both poly- and lipoplexes are designed to allow 
endosomal release thereby avoiding DNA degradation. In the case of lipoplexes, the pH 
sensitive lipid DOPE is often incorporated because at an acidic pH the lipid undergoes a 
conformational change which disrupts the membrane allowing release of the pDNA complex 
(Farhood et al, 1995). Lysosomal degradation is also overcome to some degree by PLL and 
PEI, whose structure allows it to become protonated (unlike other polymers) that ultimately 
results in osmotic damage to endosomes allowing the polyplex to be released. However this 
form of release is dependent on the type of polycation employed of which previous studies 
have mainly focused on PEI. Therefore a defined pH range for existing polycations needs to 
be applied. A more universal method could be employed for the variety of polycations 
available that would allow a defined pH range that could trigger endosomal release. This was 
postulated previously (Walker et al, 2005) whereby polyplexes were coated with a 
hydrophilic compound such as polyethylene glycol (PEG) to shield the true surface charge of 
the polyplex thereby reducing cytotoxicity, interaction with non specific targets and potential 
particle increase (Orgis et al, 1999; Ward et al, 2001 and Choi et al, 1998). This particular 
shielding is brought about via pH sensitive linkers (such as acetals and hydrozones, 
Tomlinson et al, 2003; Murthy et al, 2003 and Greenfield et al, 1990) or liposomes, which 
when in the circulatory system evades the true surface charge of the conjugate, but when 
incorporated within the endosomal system at an approximate pH of 5 hydrolytic cleavage 
occurs resulting in the liberation of the complex (Walker et al, 2005). This has been strongly 
correlated with increased gene expression within target cells. pH sensitive DNA complexes 
have been found to enter cells and display improved transfection efficiencies and reduction in 
non-specific target associations (Lehtinen et al, 2008). Such examples are intriguing as they 
effectively employ chemical linkers as pH toggles to allow the timed release of pDNA 
complexes. 
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1.4.3.1.1.2 Caveolae pathway 
However there are alternative uptake pathways that avoid lysosomal contact such as the 
caveolae pathway. Caveolae are membrane bound vesicle-like structures that harbour large 
amounts of cholesterol (Khalil et al, 2006). Caveolae have been observed to uptake and 
incorporate foreign viruses. The first step of caveolae uptake involves association with the 
plasma membrane, in which the foreign cargo becomes encapsulated within a caveolae 
vesicle (Khalil et al, 2006). These vesicles interact with transport organelles termed; 
caveosomes which take up the newly internalised cargo under non-acidic conditions. This is 
an advantage as it avoids lysosomal degradation (Ferrari et al, 2003). Internalised cargo is 
then transported to the endoplasmic reticulum or golgi for processing. Therefore in regards to 
gene delivery it would seem polyplex uptake would be more appropriate through such 
mechanisms in order to avoid DNA damage and maximise gene expression (Khalil et al, 
2006). Additional benefits of the caveolae pathway include uptake of molecules as large as 
500nm (Rejman et al, 2004). However main drawbacks include that the process of uptake is 
very slow, the vesicles itself are very confined and the fluid volume for pDNA uptake is 
minute. Therefore the amount of pDNA incorporated and expressed is actually relatively low 
in comparison to the CME pathway (Schnitzer et al, 1994).                             
1.4.3.1.1.3 Macropinocytosis 
An alternative CME independent pathway is macropinocytosis. This process entails the 
envagination of the plasma membrane to form large vesicles (Amyere et al, 2002). 
Macropinocytosis stems from the ruffling of the plasma membrane when cells are exposed to 
stimulators or growth factors (Khalil et al, 2006). Ruffling entails actin polymerisation which 
causes a thin outward extension from the membrane. This extension closes in to form a 
macropinosome, which are large vesicles enabling uptake in a non-specific manner (Conner 
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and Schmid, 2003). Macropinosomes are desirable gene transport targets as they avoid 
lysosomal degradation and being large (of up to 5µm) macropinosomes can harbour a large 
amount of pDNA complexes which could maximise potential gene expression (Khalil et al, 
2006). Furthermore because macropinosomes are somewhat porous, they can allow efficient 
gene release into the cytosol (Khalil et al, 2006).  
Despite the positive attributes drawbacks do include that uptake is dependent on the type of 
polymer employed. Goncalves et al, (2004) identified how macropinocytosis was hindered 
when the PLL was employed. Therefore the type of endocytic uptake mechanism is likely to 
depend on the choice of polycation. Additionally modest gene expression has been reported 
when nucleic acids have been taken up via macropinocytosis, which is why current polymers 
such as PLL and PEI are often applied as they are successfully internalised via the 
predominant CME or caveolae pathway.        
1.4.3.1.2 Nuclear import of DNA complexes 
1.4.3.1.2.1 Importin complex 
If DNA polyplexes are to be employed for therapeutic purposes, then understanding the 
nuclear entry mechanisms are important. Few studies have reported detailed mechanisms of 
polyplex or naked DNA nuclear entry. While many reports focus on reporter gene expression 
as an end point parameter, the mechanisms leading directly to gene expression is important 
and understanding such processes can lead to improved yields.       
Nuclear entry of DNA and other large macromolecular components involves many protein 
complexes working in tandem (Ao et al, 2007). Various transport proteins operate by hauling 
components to the nucleus. One example is importin-7 (Imp7) which is part of a large family 
of factors involved in the continuous shuttling of proteins between the cytoplasm and nucleus 
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(Fassati et al, 2003). Imp7 has been specifically implicated in the nuclear uptake of viral 
DNA; HIV-I (Zaitseva et al, 2009). Zaitseva and colleagues reported how knockdown (KD) 
of Imp7 reduced nuclear DNA accumulation and plasmid DNA gene expression. Nuclear 
DNA trafficking brought about by Imp7 KD was independent to that of RNA uptake 
(Zaitseva et al, 2009).        
DNA nuclear import is summarised in Figure 1.6. Imp7 works in conjunction with various 
protein factors by binding to 3 key sites. Firstly the N-termini of Imp7 bind with the protein; 
Ran (related nuclear protein, which is GTPase dependent). Secondly Imp7 interacts with Ran 
ligands and finally with nucleoporins which constitute the nuclear pore complex (NPC) 
(Gorlich and Kutay, 1999). The first step of import involves binding of DNA to the nuclear 
import receptor in the cytoplasm (Figure 1.6). This complex then interacts with the NPC, 
through recognition of specific amino acid residues (Fassati et al, 2003). The NPC/DNA 
complex is then transported through the NPC pore facilitating entry into the nucleoplasm. 
Once the DNA is successfully transported, the complex segregates and is transported back to 
the cytosol to begin another import cycle (Fassati et al, 2003).          
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Figure 1.6: Importin-7 (Imp7) mediated uptake of viral DNA. Nuclear import receptor binds to its DNA 
cargo. The nuclear import receptor-DNA complex is then recognised by the NPC which grants passage 
through the nuclear pore. 
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1.4.3.1.2.2 NLS attachment 
An alternative approach to enhance nuclear delivery of pDNA complexes is by physical 
attachment of nuclear localisation signal (NLS) peptides. NLSs are required to facilitate the 
nuclear entry of proteins and could favour pDNA nuclear entry (Paschal, 2002). NLS 
peptides facilitate nuclear entry by importin-mediated active transport (Zanta et al, 1999). 
NLSs are recognised by various importin proteins, in particular importin-α (Impα)   which 
exhibits affinity for a sequence on the NLS. This interaction triggers the recruitment of 
importin-β (Impβ)  which leads to the formation of a complex consisting of the polyplex/NLS 
conjugate combined with the importin proteins, which collectively are granted nuclear access 
via the NPC (Fernandez and Rice, 2009) (Figure 1.7). NLSs can be covalently attached to 
plasmids or with the polycations (Talsma et al, 2006). The use of NLS peptides to enhance 
nuclear entry of pDNA has been reported previously showing signs of promising results, but 
ultimately yielding insufficient gene expression (Pouton et al, 2007; Ciolina et al, 1999; 
Bremner et al, 2004; Nagasaki et al, 2003). In regards to clinical vaccination, incorporation 
of site specific ligands such as NLSs within DNA polyplexes can lead to improved gene 
expression which in turn can stimulate and increase immune response through T cell antigen 
presentation (Talsma et al, 2006). The application of NLSs to a wide range of structures is 
also appealing whereby a recent study covalently attached an NLS peptide to that of a pDNA 
intercalating agent and also those of liposomes (Zhang et al, 2009). Both poly- and lipoplexes 
were found to yield significantly improved gene expression than their respective controls by 
almost 3 fold (Zhang et al, 2009).  
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Figure 1.7: Nuclear uptake of DNA polyplexes via NLS attachment. The NLS peptide contains 
sequences that are recognised by Impα  and   Impβ which is then recognised by the NPC to allow nuclear 
passage. 
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1.5 Physical administration of DNA complexes  
Physical administration of DNA is important in order to maximise cellular uptake and 
targeted delivery to achieve gene expression and desirable therapeutic effect.  
1.5.1 Gene gun 
Nucleic acid administration via gene gun (GG) (also commonly known as or particle 
mediated epidermal delivery, PMED) involves the coating of gold particles with pDNA and 
its direct delivery to the intracellular target by particle bombardment (Biewenga et al, 1997; 
Fuller et al, 2006). This method exploits small inert particles as delivery vehicles that can be 
accelerated to the point of facilitating cellular penetration through the epidermis (Fuller et al, 
2006). The GG method contrasts to that of needle vaccinations in that it involves the direct in 
vivo entry of the DNA.   Coated   particles   are   in   essence   behaving   like   ‘bullets’   which   are  
triggered and accelerated by to achieve cellular penetration (Biewenger et al, 1997). 
Electrical discharges or wavelength pulses have been successfully used as tools  to  ‘fire’  the  
particles towards target cells (Biewenga et al, 1997).  
One of the first studies to apply GG delivery was that Klein et al, (1987) who suggested that 
the particle bombardment would result in penetration through the plant cell wall and enable 
pDNA delivery and expression. Soon application of GG to mammalian cells was successfully 
reported (Williams et al, 1991) and optimized further where such devices have since been 
applied in clinical trials (Fuller et al, 2006). The principle of GG delivery occurs on the basis 
of pDNA coated particle bombardment (usually upon the epidermis). Therefore its efficiency, 
optimisation and novel design are reliant on various physical boundaries (Sanford et al, 1993; 
Biewenga et al, 1997). The speed at which particles are fired towards the target is a major 
factor. This is because it is desirable to introduce pDNA coated particles at maximal speed to 
enable cellular entry, without jeopardising the structural integrity of the host cell membrane 
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(Biewenga et al, 1997). The physical characteristics of coated particles can dictate the speed 
at which it is delivered (Biewenga et al, 1997). Gold particles are often employed for GG 
delivery due to being non-toxic, exhibiting a suitable size and being unreactive, which all 
favour pDNA binding and cellular entry unlike other particle candidates (Russel et al, 1992; 
Fuller et al, 2006). Electrical discharge or changes in gas pressure have been successfully 
applied to enable particle bombardment (Biewenga et al, 1997). The latter has been applied 
more effectively for the delivery of particles at great velocities through inducing uniform 
pressure distribution. In gas pressure devices, the GG is composed of a chamber which 
houses the gas and confined by a form of membrane disk (Biewenga et al, 1997). When a 
specific amount of pressure is induced, the disk is broken resulting in a pulse that ripples 
through a neighbouring chamber that harbours a particle coated disk coated and such pressure 
applied forces the particles through the screen of the gun upon the exposed tissue (Sanford et 
al, 1993). Helium is often employed due to having a low density thereby facilitating greater 
acceleration (Takeichi et al, 1992).  
The clinical efficiency of the GG method was reported, when compared with that of 
intramuscular (IM) injection. GG delivery of an encoded antigen vector was found to elicit 
CD4+ T cells that reduced the development of diabetes within diabetic mouse models (Goudy 
et al, 2008). This was in stark contrast to IM administration whereby little or no effect was 
observed coupled with undesirable side effects (Tisch et al, 2001; Weaver Jr et al, 2001). In 
fact even when the amount of DNA introduced within mouse models was 100 times less than 
that loaded via IM delivery, expression was still vastly superior (Goudy et al, 2008). This 
indicates the potent penetration that GG can offer whereby particle loaded plasmids are 
transported to the cytoplasm thereby avoiding the intracellular membrane boundaries that 
often restrict gene delivery (Fuller et al, 2006). Additionally it was observed how GG 
delivery   of   the   β   cell   autoantigen   led   to   significant   reduction   of   type   1   diabetes   onset.   In 
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contrast IM delivery of pDNA had no effect within 100% of treated mouse models 
developing type 1 diabetes.  
1.5.2 DNA tattoo  
DNA tattooing is an alternative form of nucleic acid administration which leads to effective 
introduction and subsequent expression of the gene of interest. DNA tattooing is an invasive 
technique entailing continuous perforating of the skin thereby causing immediate 
inflammation (Gopee et al, 2005). Although damage induced may not be quite applicable for 
immediate clinical trials, the wound generated recruits leukocytes, cells involved in cytokine 
secretion which is important for inducing specified immune responses (Pokorna et al, 2008). 
Unlike IM injection, tattooing entails pDNA delivery through a much greater surface area of 
the skin, thereby maximising the amount of cells likely to uptake DNA (Pokorna et al, 2008). 
DNA delivery via tattooing has actually been found to be more effective in terms of gene 
expression than that of IM delivery or GG (Sakurada et al, 2003; Baxby, 2002). The study 
carried out by Pokorna and colleagues is one of only a few publications to highlight how 
DNA tattooing induces greater innate and adaptive immune responses than counterpart 
procedures. In terms of adaptive responses, 100% of mice developed antibodies specific for 
the antigen delivered via tattooing, in comparison to 53% of mice administered via IM 
injection (Pokorna et al, 2008). Also antigen specific antibodies of those mice vaccinated via 
tattooing were up to 2000 times greater than injected models. Furthermore DNA tattooed 
mice generated antigen specific antibodies 16 times greater than their injected counterparts 
even in the presence of an adjuvant (Pokorna et al, 2008). In terms of innate responses 
Pokorna et al, (2008) reported an increase in IFN-γ  cytokine levels in tattooed treated mice. 
Therefore such results indicate DNA tattooing as a useful procedure, albeit invasive, but 
effective in terms of inducing both innate and adaptive responses. It is suggested that 
tattooing induces a more robust immune response by possibly enhancing uptake of both non-
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APCs and local APCs (through the large area of skin covered). The invasive nature of the 
procedure has been attributed towards recruiting local immune cells.   
1.5.3 Needle injection 
IM needle injection offers an alternative route towards stimulating host immune responses. 
IM needle vaccination involves the direct insertion of the respective nucleic acid. The 
purpose of such a procedure is that the nucleic acid encoding the antigen of interest interacts 
with APCs which via cross-presentation (Figure 1.5), are delivered to T cells (Belakova et al, 
2007). Such a mechanism is an example of the adaptive response initiated by needle 
vaccinations which potentially leads to MHC-class II T cell response (Bivas-Benita et al, 
2005).  
Although the GG and DNA tattooing exhibit positive attributes, they do display various 
drawbacks such as the invasive nature posed and safety concerns. In light of this various 
studies have highlighted IM needle delivery as an effective gene vaccination tool. For 
instance Tanghe et al, (2000) compared the immunogenicity of mice when vaccinated via IM 
needle and epidermal GG. Immunogenic responses were greater in mice injected via IM 
needle vaccination unlike that of GG treated mice. Tanghe and co-workers (2000) found how 
mice treated via needle injections elicited a greater amount of antibodies than those of GG 
treated group.     
1.5.4 Electroporation  
An alternative method of DNA administration is electroporation (EP) which facilitates 
delivery through the induction of an electrical current at the site of administration. This leads 
to the formation of a porous membrane facilitating gene entry (Ulmer et al, 2006). EP has 
proven to be an effective manner in delivering nucleic acids, whereby small quantities of 
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even a microgram of DNA has led to detectable gene expression (Miao et al, 2001). This was 
highlighted in a previous study which observed improved antibody production and T-cell 
activity within primates as a result of EP mediated gene delivery (Otten et al, 2006). As 
mentioned in the Chapter, DNA vaccines have the potential to induce desirable innate and 
adaptive immune responses in the form of T-cell responses which was reported following EP 
mediated gene administration (Buchan et al, 2005). Thus the physical means by which pDNA 
enters the host cell is important, which stems from the porosity of the physical barrier 
(several microns), allowing safe passage of the nucleic acid. 
1.6 Aims and Objectives  
The aim of this work was to study non-viral gene delivery and how parameters such as DNA 
topology affect biophysical characteristics and uptake in mammalian cells. Non-viral gene 
delivery has generated interest in regards to recombinant protein production and treatment of 
various diseases. This is because unlike viral vector delivery, non-viral methods are 
considered safer (viral gene delivery systems can induce an immune response towards the 
vector), can be scaled up for manufacture and avoids issues such as potential insertional 
mutagenesis (mutation caused by the insertion of additional DNA within host organism). 
However unlike viral vectors, gene delivery via non-viral methods is relatively modest. 
Therefore understanding the parameters that affect DNA uptake is critical.  
In terms of novelty the aim of this study was to analyse the impact of DNA topology on 
polyplex biophysical characteristics, mammalian cell uptake and potential nuclear import. 
This is important as very few studies have analysed this area which is important in regards to 
potential therapeutic applications. Furthermore the impact of DNA topology on polyplex 
uptake in variety of mammalian cells has not been reported particularly in dendritic cells 
which are key immune cells. 
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In this study a non-viral gene delivery system consisting of PLL complexed with a 6.8kb 
plasmid was formulated. Formation of PLL/DNA polyplexes are considered to display the 
suitable size and charge for successful gene delivery (Tsai et al, 1999). Therefore the 
application of DNA polyplexes has generated much interest. In this study uptake (defined as 
the intake of materials by a cell or tissue leading to its permanent or temporary retention) of 
PLL/DNA polyplexes was studied in three mammalian cell types; CHO cells, HeLa cells and 
DCs. DCs are of particular importance as they are key sentinels of the immune system and 
function by binding and collecting foreign antigens. Therefore one of the key goals of the 
project was to study polyplex uptake, gene expression (plasmid encoded lacZ [β-
galactosidase] reporter gene) in all three cell types, and ability of polyplexes to alter DC 
phenotype. 
The key objectives of this study included: 
1. To formulate PLL/DNA polyplexes and analyse biophysical characteristics which 
included PLL/DNA surface charge, size, ability to evade nuclease degradation, ability 
of PLL to bind DNA, the effect of pDNA topology on biophysical characteristics and 
the impact of plasmid vector size. 
2. To investigate the uptake of polyplexes within mammalian cells and whether 
biophysical characteristics impact on cellular uptake and reporter gene expression. 
3. Report the mechanism of cellular uptake undertaken by DNA polyplexes. Nuclear 
import of DNA polyplexes which has important implications for gene delivery and 
potential therapeutic applications was addressed in this study. 
4. Study whether uptake of polyplex DNA stimulates an anti-viral innate immune 
response, which is important for potential therapeutic applications. 
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This study combines biophysical analysis of PLL/DNA polyplexes with that of mammalian 
cell uptake studies to deduce if key parameters such as DNA vector topology have an effect 
on mammalian cell uptake. Knowledge of factors such as DNA vector topology, cellular 
uptake, mechanism of nuclear import, gene expression profiles, and the ability to induce 
innate anti-viral immune responses will aid in the design of improved non-viral gene delivery 
systems.     
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2: Materials and Methods 
2.1 Plasmid DNA preparation 
The plasmids;;  pSVβ  (6.8kb) (Promega, Southampton, UK) is ampicillin resistant, pSELECT-
NGFP-zeo (3.8kb) (InvivoGen, USA) is zeomycin resistant and pGEc47 (56.5kb) (Deutsche 
Sammlung von Mikroorganismen und Zellkulturen GmbH, Germany) is tetracycline 
resistant. Plasmids were transformed and propagated within Eschericheria coli (E. coli) 
DH5α   cells. The   pSVβ   plasmid   was   selected   as   it   is   of   a   conventional   size   (6.8kb)   for  
transfection studies and has been used in previous studies regarding PLL polyplex 
characterisation (Tsai et al, 1999). Plasmid maps are provided in Appendix I. 
2.1.1 Culture medium and propagation  of  DH5α  host  cells 
Luria Bertani (LB) medium (LB broth Lennox, Fisher Bioreagent, Loughborough, 
Leicestershire) was used for cell culturing along with Nutrient Agar CM0003 (Oxoid, 
Basingstoke, Hampshire) for the production of agar plates. The appropriate amount of 
antibiotics was added for selection of the desired plasmid (100µg/ml ampicillin, 25µg/ml 
zeomycin and 100µg/ml tetracycline). Cultures was grown overnight for approximately 16 
hours at 37ºC within a rotary incubator at 250 rpm. In terms of pGEC47, cultures were grown 
for 36 hours. The cultures were then treated with glycerol (50% of total volume) which 
served as stocks and stored at -80ºC.  
2.1.2 Plasmid DNA purification 
Plasmids were routinely purified via Qiagen mini (small scale cultures) and maxi kits (large 
scale cultures) (Qiagen, Crawely, West Sussex). Plasmids were purified in accordance to the 
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manufacturer’s  protocol.  Purified  plasmids  were  analysed  via  agarose  gel  electrophoresis  and  
quantified by a NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies).   
2.1.3 Production of linear and nicked (open circular) plasmids 
Purified supercoiled (SC) pDNA samples were both nicked and digested to generate open 
circular (OC) and linearised topologies. These samples were analysed upon a 1% agarose gel 
along with a naked untreated SC sample which served as a control. Restriction digestion was 
carried out using PstI and BamHI enzymes (New England Biolabs). These enzymes were 
chosen as they cut at a single site upon the respective plasmid. Open circular (OC) forms 
were generated via the enzyme; Nt.BstNBI as this catalyses a single strand break (New 
England Biolabs). Generation of both linear- and OC-pDNA was carried out in accordance to 
the  manufacturer’s   instructions (New England Biolabs). Plasmids treated with the nicking 
enzyme were incubated at 55ºC for 1 hour while restriction digested samples were incubated 
at 37ºC for the same period. Following restriction digestion and nicking, enzymatic reactions 
were halted by heat treatment at 80°C for 20 minutes followed by purification of the DNA 
via chloroform-phenol extraction (Sigma). DNA was further purified via ethanol precipitation 
which entailed treatment of DNA with 2.5 volumes of 100% ethanol followed by 0.1 volume 
of 3M Sodium Acetate (Sigma) and incubation at -80°C for 1 hour. Samples were centrifuged 
on a bench top centrifuge for 20 minutes at maximum speed. DNA pellets were than washed 
with 70% ethanol and centrifuged for 10 minutes and DNA pellets were resuspended in 
endotoxin free TE buffer (10mM Tris-Cl, pH 8.0, 1Mm EDTA) (Qiagen).    
2.2 Agarose gel electrophoresis   
1% agarose gels were prepared by dissolving 1g of agarose (Sigma) in 100ml Tris-Borate 
EDTA (TBE) 10x concentrate (Sigma). This was then treated with 500µg/ml ethidium 
bromide (Sigma). Agarose gels were usually run at 100V and 100mA for 1 hour. DNA 
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samples were run alongside a TrackItTM 1kb Plus DNA Ladder (Invitrogen). For analysis of 
the pGEc47 BAC, a BAC-Tracker™  Supercoiled DNA Ladder (Epicentre® Biotechnologies) 
was employed. 
2.2.1 Southern blot analysis 
Biotinylated DNA (see below) along with a biotinylated 2-Log DNA ladder (0.1-10 kb) (New 
England BioLabs), which served as a positive control, were run upon a 1% agarose gel for 
approximately 1 hour. The gel was then treated with 0.2M HCl (Sigma Aldrich) at room 
temperature for 10 minutes, after which the gel was then rinsed in double distilled water 
(ddH2O), followed by three 15 minute period washes with 0.4M NaOH (Sigma Aldrich). A 
small cover tray was then submerged with 10x SSC (saline sodium citrate stock [300mM 
sodium citrate, pH 7.0, containing 1M sodium chloride]) (Sigma Aldrich) which acted as the 
transfer buffer. Filter paper soaked with transfer buffer was layered upon the tray and covered 
with plastic wrap, with the exception of an excision made in the shape of the gel thereby 
facilitating sole wick transfer through the gel. The gel was placed upon the excision site made 
and a 0.45µm nitrocellulose membrane (Protran BA-85, Whatman) cut to the size of the gel 
was placed directly above the gel and stacked with paper towels to facilitate transfer by the 
conventional wick procedure overnight. The following day the membrane was removed and 
rinsed briefly with ddH2O and then cross linked within a CL-1000 ultraviolet cross linker 
(UVP). Subsequently the membrane was then blocked for at least an hour in 1% BSA/PBS 
followed by addition of streptavidin – horse radish peroxidase (Amersham Bioscience) for 15 
minutes. Three 15 minute washes with PBS (phosphate buffered saline [137mM NaCl, 
2.7mM KCl, 4.3mM Na2HPO4 and 1.47mM KH2PO4, pH 7.4]) was then followed by 
treatment with  ECL   reagent   (Amersham  ECL  Plus™,  GE  healthcare).   The  membrane  was  
then developed through autoradiography. For dot blots, biotinylated DNA was spotted 
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directly upon the membrane, which was then blocked, probed and processed as mentioned 
previously.  
2.3 Production and characterisation of  PLL/DNA polyplexes  
Plasmids of differing topologies were bound with poly-L-lysine hydrobromide (PLL) (Sigma) 
of molecular weight, 9600. This was in accordance to that of Tsai et al, (1999). A constant 
amount of DNA (20µg) was added to PLL, each of varying charge ratios. These samples 
were treated with 100µl 10mM HEPES buffer stock and made up to 1ml with Millipore 
filtered (0.2µm filter) water to form final concentration of 1mM HEPES buffer. Calculation 
of the amount of PLL which yields the desired charge ratio was deduced from Lollo et al, 
(2002). Individual aliquots of DNA and PLL of equal volume (500µl each dissolved in 1mM 
HEPES buffer) were prepared and then mixed. Once the nucleic acid was added to the 
condensing agent, samples were left at room temperature for 30 minutes. A smaller total 
volume of 100µl was used for polyplexes prior to the addition of cells for transfection.    
2.3.1 Zeta Potentials measurements  
The zeta potentials of the polyplexes were recorded via a Malvern Zetasizer Nanoseries 
instrument (Malvern Instruments, Malvern). A polystyrene standard (Malvern Instruments) 
was employed to calibrate the system. Following this 700µl of the PLL/DNA polyplex was 
loaded within the system and zeta potentials were recorded. The temperature was set to 25ºC, 
along with the dispersant cell viscosity (to which values for water were used). Also the 
instrument was set to allow a 5 minute incubation period prior to measurements in order to 
allow the desired temperature (25ºC) to be attained. Following this zeta potentials were 
recorded whereby an average of 5 readings were taken. 
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2.3.2 Dynamic light scattering (DLS) assays    
Polyplex mean diameters were deduced by dynamic light scattering (DLS) measurements 
(90° angle scattering laser) via a Malvern Zetasizer Nanoseries instrument (Malvern 
Instruments, Malvern), whereby measurements were recorded at 25ºC. Prior to size 
measurements a low volume 45µl glass cuvette was rinsed with 70% ethanol and Millipore 
filtered water. The system was then blanked with 45µl Millipore filtered water (to reduce the 
particle count rate to less than 20kcps) followed by size measurements (nm) of which an 
average of ten readings were recorded. 
2.3.3 DNA intercalating dye studies  
2.3.3.1 Ethidium bromide assay – quantification of DNA condensation induced by 
PLL 
Polyplexes were quantitatively analysed in terms of pDNA packaging and condensation via 
an ethidium bromide fluorescence assay. 10µg of polyplex DNA was treated with 2µg 
ethidium bromide and made up to a total volume of 200µl. These samples were loaded upon a 
standard 96 well plate along with a control consisting of 10µg of purified plasmid 
(corresponding to the respective topology) and 2µg ethidium bromide as mentioned 
previously. Samples were analysed via a Safire2 plate reader at an emission wavelength of 
591nm and excitation wavelength of 366nm (slit width of 20nm). Fluorescent values were 
expressed as a percentage of a naked DNA control 
2.3.3.2  TOTO-3 fluorescence assay – quantification of DNA condensation 
induced by PLL 
The dye; TOTO-3 (Dimeric Cyanine Nucleic Acid Stains – Invitrogen) was added to 10µg of 
polyplex DNA at a final concentration of 4µM and fluorescence was measured (excitation: 
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642nm and emission: 660nm). Fluorescent values were expressed as a percentage of a naked 
DNA control.  
2.3.4 Ethidium bromide staining of DNA prior to PLL binding 
In order to view the DNA that was eventually to be condensed by PLL, 20µg DNA was 
stained with 1µg ethidium bromide and then complexed with PLL as previously mentioned. 
Samples were analysed by electrophoresis using agarose gels without ethidium bromide for a 
short time period of only 10 minutes in order to view DNA complexed to PLL.    
2.3.5 Release of PLL-bound pDNA 
DNA was released from PLL by treating polyplex samples with 0.5% SDS (sodium dodecyl 
sulphate) (Sigma) and heating samples at 96°C for ten minutes. DNA was then precipitated 
with 70% ethanol.  
2.3.6 Benzonase nuclease protection assay 
In order to test the potential in vivo stability of polyplexes (of varying charge ratios), samples 
were treated with Benzonase nuclease (Novagen). 0.2µg polyplex DNA was treated with 50 
units of the nuclease and incubated for 30 minutes at 37ºC. This was carried out in 
conjunction with suitable controls (naked untreated pDNA and an untreated polyplex). 
Within this 30 minute period at 5 minute intervals, samples were extracted and analysed via 
1% agarose gel electrophoresis. The enzyme was inactivated via treatment with 100mM 
NaOH at 70C for 30 minutes. DNA samples were extracted via precipitation with 70% 
ethanol. 
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2.4 Labelling of polyplexes 
2.4.1 Fluorescent tagging of PLL 
PLL was tagged with a fluorescent marker, Oregon Green 488, succinimidyl ester 
(Invitrogen) according to the protocol executed by Godbey et al, (1999). Unbound dye was 
removed by spin column purification in accordance to the manufacturer’s   protocol 
(Invitrogen). Successful tagging was confirmed by analysing the fluorescence of tagged PLL 
to that of unlabelled PLL via a safire2 plate reader at an excitation wavelength of 488nm and 
an emission wavelength of 521nm (slit width of 20nm) in addition to the protocol provided 
by the manufacturer (Invitrogen).   
2.4.2 Labelling of pDNA 
Naked pDNA was directly biotinylated (Mirus Label IT tracker Intracellular Nucleic Acid 
Localization Kit) according to the manufacture’s  protocol. DNA was labelled at a 0.25:1 v:w 
ratio of reagent per µg of DNA. Free biotin was removed from the DNA via DNA ethanol 
precipitation with 70% ethanol according to the manufacture’s   protocol. Presence of 
biotinylated DNA was then confirmed through Southern Blot analysis. Plasmid DNA was 
alternatively labelled via the nucleic acid fluorescent stain; TOTO-3 (Dimeric Cyanine 
Nucleic Acid Stains – Invitrogen) at a final concentration of 4µM. The fluorescent stain 
exhibits excitation and emission spectra of 642 and 660nm respectively for analysis via 
confocal microscopy. To confirm successful TOTO-3 tagging, labelled polyplex fluorescence 
was measured by a safire2 plate reader at the specific fluorophore spectra along with the 
appropriate controls which included naked TOTO-3 stained DNA, TOTO-3 labelled 
DNA/PLL complex, unlabelled naked DNA and unlabelled DNA/PLL complex. Additionally 
labelled TOTO-3 DNA was spotted onto PLL (labelled via Oregon Green tagging) coated 
coverslips which were subsequently mounted onto slides for confocal microscopy analysis. 
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PLL coated coverslips were prepared by treating coverlsips with 50µg/ml PLL for 30 minutes 
at room temperature. Coverslips were washed and then used for further analysis. Further 
confirmation of successful TOTO-3 DNA labelling entailed spotting TOTO-3 labelled DNA 
upon coverslips for a period of 10 minutes at room temperature and then treating such 
samples with a 50µl of Flow-Check Fluorophore beads (Beckman Coulter). 
2.5 Mammalian cell culture 
2.5.1 Chinese hamster ovary (CHO) cell culture  
Chinese hamster ovary cells (CHO) which were adherent, were cultured in 5ml GIBCO® 
RPMI (Roswell Park Memorial Institute) Media 1640 (5% foetal calf serum [FCS] and 1% 
penicillin:streptomycin [PS]) (Invitrogen) in a 37°C, 5% CO2 incubator. Prior to transfection 
media   was   aspirated   and   cells   were   washed   with   Hank’s   Buffered   Salt   Solution   (HBSS) 
(Invitrogen) and then treated with 1x concentrate trypsin (2.5% trypsin which contains 25g/L 
trypsin and 8.5g/L NaCl) for 3 minutes at 37°C. Cells were then neutralised with media. 
From this a 10µl sample of cells was strained with Trypan Blue (Invitrogen) and counted. 
Approximately 1 x 106 CHO cells were seeded upon sterilised 22 x 22mm coverslips (VWR 
International), which were mounted within 6-well plates (Helena Biosciences) and incubated 
for approximately 41hours.     
2.5.2 Generation of human monocyte-derived dendritic cells (DCs) 
This study was approved by the joint University College London/University College London 
Hospitals National Health Service Trust Human Research Ethics Committee and written 
informed consent was obtained from all participants. 
Monocyte-derived human dendritic cells (DCs) were initially produced via selection of 
CD14+ cells. Human blood samples were treated with HBSS at a volume ratio of 1:0.5ml. 
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Samples were then extracted using heparinised syringes and transferred to tubes containing 
Lymphoprep (Axis-Shield). Samples were centrifuged at room temperature, 800xg for 20 
minutes. Interface layer was removed and transferred to tubes containing HBSS. Samples 
were centrifuged at room temperature at 800xg for ten minutes. Supernatant was discarded 
and the cell pellet was dissolved in 5ml HBSS. This cell suspension was washed three times, 
with each wash step entailing; centrifuging at room temperature at 400xg for 5 minutes, 
discarding the supernatant and re-suspending in 5ml HBSS. After the third wash spin step, 
sample was re-suspended in cold MACS buffer (PBS, 10% FBS + 2mM EDTA) 
(400µl/100x106 cells). Anti-CD14 beads (Miltenyi Biotec) (50µl/100x106 cells) were added. 
Samples were incubated on ice for 30 minutes. Following this 10ml MACS buffer was added 
and samples were centrifuged at 400xg for 5 minutes at room temperature. Supernatant was 
discarded and re-suspended in 4ml cold MACS buffer. This was then passed through a sterile 
filter and collected. The filtered cell suspension was then was then passed through a MACS 
column which was attached to a pre-cooled MACS magnet. This was followed by the 
addition of MACS buffer (wash step). Collection of CD14+ cells was achieved by adding 5ml 
cold MACS buffer and detaching column from the magnet. Sample was topped up with 
RPMI media 1640 and centrifuged at 400g for 5 minutes at room temperature. Supernatant 
was discarded and pellet re-suspended in DC differentiation media (RPMI, 10%FCS, GM-
CSF [granulocyte-macrophage colony-stimulating factor] +IL4). Cells were seeded for 4 days 
at 37°C, 5% CO2. 
2.5.3 HeLa cells    
HeLa cells were employed for importin-7 (Imp7) knock down (KD) studies. Control HeLa 
cells and Imp7 KD cells were kindly provided by Dr Ari Fassati (Wohl Virion Centre, UCL) 
in which KD was carried out previously (Zaitseva et al, 2009). Two controls were employed; 
HeLa cells containing an shRNA targeting the Discosoma corallimorpharian DsRed mRNA 
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(DxR) and HeLa cells that were back complemented with an Imp7 cDNA containing two 
silent mutations conferring resistance towards Imp7 gene silencing (Back Imp7). Two Imp7 
KD clones were also employed; clone 2 (Cl2) and clone 4 (Cl4) (Zaitseva et al, 2009).  HeLa 
cells  were   cultured   in  Delbecco’s  modified  Eagle’s  medium   (DMEM)   (GIBCO®), with the 
addition of 10% FCS, 2mM glutamine and 1µg/ml puromycin at 37°C in 5% CO2.    
2.6 Mammalian cell uptake studies 
2.6.1  Bolus transient transfection (for adherent cells) 
Following seeding (48 hours), media was aspirated and replaced with fresh media lacking 
serum. Samples were left to incubate at room temperature for 10 minutes. 2µg of polyplex 
DNA (total DNA mass as deduced from nanodrop spectrophotometer analysis) was then 
added to the media and incubated at 37°C. Polyplexes were prepared at charge ratios of; +1.6 
for SC- and OC-pDNA, and +5 for linear-pDNA. This particular charge ratio was selected 
due to recommendation by previous biophysical polyplex studies (Tsai et al, 1999). This 
particular charge ratio was also used for PEI polyplexes (Dunlap et al, 1997). Linear-pDNA 
required a higher charge ratio to satisfy a net positive charge necessary for transfection 
studies. Following the desired duration of transfection, samples were extracted and media 
aspirated. Cells were washed once with HBSS. Subsequently cells were treated with 1ml 
3.8% paraformaldehyde and incubated for 15 minutes. This was followed by washing with 
PBS and the addition of 1ml 0.2% Triton-X (in PBS) for 10 minutes. In regards to confocal 
microscope analysis, coverslips were removed and mounted onto a microscope slide with 
DAPI mounting medium (Vectashield). In the case of transfected samples which were to be 
analysed by flow cytometry, samples were processed in BD FACS Calibur tubes (BD 
FACSCalibur) whereby washing steps entailed centrifugation at 1400rcf for 5 minutes. 
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2.6.2 Reverse transfection (for non-adherent cells) 
Polyplexes were spotted (each spot contained either 2µg pDNA for confocal microscopy 
analysis or 20µg pDNA for gene expression studies) on PLL (50µg/ml) coated 22 x 22mm 
coverslips (VWR International) for 1 hour at room temperature in the dark. Subsequently 
cells were seeded (with the respective media, RPMI, DMEM or DC differentiation media) on 
the PLL coated coverslips and incubated at 37°C for the desired time. Following this cells 
were removed and processed as mentioned previously.  
2.6.3 Gene expression analysis 
Cells were seeded within 6-well plates (Helena Biosciences) for 48 hours to an approximate 
confluency of 80%. Subsequently cells were then transfected with polyplexes at the desired 
charge ratio for 48 hours. Following this period mammalian cells (CHO, DC or HeLa) were 
analysed   for   β-galactosidase expression to which the plasmid   (pSVβ)   encodes.  Expression 
was detected using a colorigenic β-Gal Assay Kit (Invitrogen). The number of blue cells 
detected under a Ti-E light microscope (Nikon) connected with a Fi-1 CCD camera (Nikon), 
in 5 fields of view was expressed as a percentage of total cells.        
2.6.4 Labelling of mammalian cells 
Mammalian cells (CHO, HeLas and DCs) fixed to 22 x 22mm coverslips (VWR 
International) were stained following transfection with HCS  CellMask™  Stains  (Invitrogen) 
for a period of 30 minutes according   to   the   manufacture’s   protocol.   The   stain   displays  
excitation and emission spectra of 556 and 572nm respectively. 
2.6.5 Intracellular tracking  
To deduce uptake mechanisms, transfection experiments were repeated as previously 
mentioned, however this time incorporating specific endocytic markers. Transfected cells 
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were treated with a Rab5 antibody (Cell Signalling Technology) at a 1:100 dilution factor 
(10µg/ml) and incubated at 4°C overnight. The Rab5 antibody (source: rabbit) reactivity 
includes human, mouse, rat, hamster, and monkey. Cells were then washed three times with 
PBS and probed with the appropriate secondary fluorescent antibody; anti rabbit IgG (H+L), 
F(ab’)2 Fragment (Alexa Fluor® 488 conjugate) (Cell Signalling Technology) at a 1:100 
dilution factor for 2 hours at room temperature protected from light. Rab5 is a marker for 
early endosomes particularly in the clathrin mediated endocytic (CME) pathway.  
Alternative endocytic markers were also employed. Transfection experiments were repeated 
as before; however cells were treated with anti-caveolin-1 antibodies (reactivity includes 
mouse, rat, hamster, dog, human, Chinese hamster) (Abcam) at a dilution factor of 1:500 
(20µg/ml) at 4°C overnight. Caveolin-1 antibody is a specific marker for the caveolae 
endocytic pathway. The following day cells were washed three times with PBS and treated 
with anti rabbit IgG (H+L) secondary FITC conjugated antibody (Abcam) at a dilution factor 
of 1:100 for 2 hours at room temperature protected from light.  
2.6.6 Pathway inhibition experiments 
In order to confirm the role of the CME pathway, the inhibitor; chlorpromazine hydrochloride 
(CMZ) (Sigma) was dissolved in RPMI media and applied to CHO cells at a final 
concentration of 10µg/ml for 2 hours at 37°C (Vercauteren et al, 2010) prior to transfection 
with polyplexes and probing of endocytic markers. CHO cells were also treated with 400µM 
genistein (Sigma) at 37°C for 2 hours (Vercauteren et al, 2010). Genistein is an inhibitor of 
the caveolae endocytic pathway. Samples were analysed by confocal microscopy or flow 
cytometry.  
Control commercial endocytic markers were studied. Transferrin (Tran) (Invitrogen) and 
cholera toxin subunit B (CTB) (recombinant) (Invitrogen) were added to CHO cells (both at 
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10µg/ml each at 37°C for 20 minutes) according to Nagabhushana et al, (2010); Skretting et 
al, (1999), and  the  manufacturer’s  protocol. Dilutions and storage buffers of antibodies were 
made in PBS.  
2.6.7 Confocal microscopy  
2.6.7.1 Fixed cell analysis 
A Leica SP2 confocal microscope (Division of Infection and Immunity, UCL) was used to 
view cells that were mounted on the appropriate slides. Fluorescence images were collected 
using a scan speed of 400 Hz and 8 frame averaging. Nuclei were detected using 4,6-
diamidino-2-phenylindole (DAPI) (Vectashield) (excitation: 360nm, emission: 460nm). DNA 
was detected via TOTO-3 (Dimeric Cyanine Nucleic Acid Stains – Invitrogen) (excitation: 
642nm, emission and emission: 660nm). DNA was also detected via Alexa Fluor 633 
streptavidin (excitation: 632nm, emission: 647nm). PLL was detected via Oregon Green 488 
(Invitrogen) (excitation: 488nm, emission 524nm) and cell labelling was detected by HCS 
CellMask™ (Invitrogen) (excitation: 556nm, emission: 572nm). To confirm whether 
polyplex uptake has occurred, images were taken as 3-D sections. Ten sections of each 
image, each of 0.2µm in thickness were taken. Mid section images were taken to confirm true 
polyplex uptake along with projection images of all slices (referred to as z-stack projection 
images). 
2.6.7.2 Live cell imaging    
HeLa cells were seeded (approximately 5x105 cells per well) overnight on an 8 well 
chambered glass coverslip (Lab-TekTM) at 37°C. The following day the media was removed 
and replaced with RPMI 1640 (1x) media without phenol red (Invitrogen). Cells were treated 
with 5µg/ml Hoechst 34580 nuclear stain (Invitrogen) for 2 hours at 37°C. The coverslips 
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were then mounted upon a Leica SPE2 inverted microscope with sequential channel capture. 
The microscope chamber temperature was set at 37°C and fluorescently labelled polyplexes 
(containing 2µg DNA) were added to the cells and imaging was carried out immediately to 
monitor transient transfection in real time. Images were recorded every 2 minutes up to 1 
hour. Slice-by-slice sectioned images of single cells were captured at a thickness of 0.2µm. A 
total of 10 image slices were taken at each time point. Each frame of the time lapse series was 
processed on ImageJ software.      
2.6.7.3 Quantification of uptake 
To quantify uptake approximately 30 cells from each slide were randomly selected under the 
DAPI filter and the number of cell associated polyplexes were counted and classified on the 
basis of their intracellular location (cell periphery, cytosol or nuclei of the respective cell) 
using ImageJ software and fluorescent co-localisation. If no fluorescent overlap between the 
polyplex and the CellMask™ occurs, complexes are defined as being at the cell periphery. If 
some overlap between the polyplex and the CellMask™ occurs, complexes are classified as 
located within the cytosol. Complete overlap between polyplex and nuclear stain is classified 
as nuclear association. The number of polyplexes within each cellular compartment was 
expressed as a percentage of the total number of polyplexes counted within the group of 30 
cells. The number of cells (30) was selected as this was found to be statistically sufficient for 
quantification as recommended by previous studies (Akita et al, 2004; Chen et al, 2008). 
Each experiment was repeated in triplicate. Slides were blinded with regard to experimental 
condition before counting to reduce possible bias. 
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2.6.8 Flow cytometry  
A FACS Calibur 2 flow cytometer was employed to analyse transfected CHO and DC 
populations of approximately 1x106 cells. Transfected cells were suspended within 300µl 
PBS and stored at 4°C prior to analysis upon a FACS Calibur 2 flow cytometer. 
2.7 Quantitative polymerase chain reaction (Q-PCR) 
2.7.1 RNA extraction 
HeLa cells (DxR control, Back Imp7, Cl2 and Cl4 Imp7 KD) were seeded in 6-well plates 
(approximately 1 x 106 cells per well) for 48 hours. Cells were transfected with polyplexes 
containing 20µg or 0.2µg pDNA for 4 hours (time required to stimulate anti-viral response). 
Following this cells were centrifuged (1400 rcf for 5 minutes) to attain pellets and RNA was 
extracted via   an   RNeasy   Mini   Kit   (Qiagen)   according   the   manufacturer’s   guide.   All  
subsequent reactions were carried out in RNase free conditions.     
2.7.2 Removal of DNA contaminants  
Removal of DNA contaminants from purified RNA samples was achieved via a DNA-freeTM 
Kit (Applied Biosystems). Protocol was carried out in accordance to the manufacturer. 
Purified RNA was stored at -80°C.   
2.7.3 Reverse transcription (cDNA synthesis) 
Production of the cDNA template was carried out via an Omniscript® Reverse Transcription 
Kit (Qiagen)   according   to   the   manufacturer’s   handbook.   All   subsequent   reactions   were  
carried out in DNase free conditions. 
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2.7.4 Taq man polymerase chain reaction 
Q-PCR was performed in a final reaction volume of 25µl containing 1x PCR buffer including 
Taq man polymerase enzyme (Platinum® Quantitative PCR Super Mix-UDG w/ROX, 
Invitrogen) along with 7.5µM of each primer (forward, reverse and probe) according to the 
manufacturer’s   protocol.   Primer   sequences   were   as   follows;;   GAPDH   (glyceraldehyde 3-
phosphate dehydrogenase) forward:  5’-GGCTGAGAACGGGAAGCTT-3, GAPDH reverse: 
5’-AGGGATCTCGCTCGCTCGCTCGCTCCTGAA-3’, GAPDH   probe:   5’FAM-
TCATCAATGGAAATCCCATCCCATCACCA-3’  which  was  fluorescently  labelled  with  6-
carboxyfluorescein (FAM, at a filter setting of 520nm). GAPDH is a housekeeping gene 
whose expression remains constant and was measured as a control. IFIT2 (interferon induced 
protein with tetratricopeptide repeats-2) was probed for expression. Along with the 1xPCR 
buffer, the 25µl was supplemented with IFIT2 mix (Applied Biosystems) which contained the 
IFIT2 forward, reverse and probes. The Q-PCR reaction was supplemented with 5µl cDNA 
and Millipore filtered water was added to the master mix (to compensate the final volume to 
25µl). Q-PCR was performed on an Eppendorf MasterPlex. Cycle conditions included; 55°C 
for 2 minutes, 95°C for 10 minutes; 95°C for 15 seconds and 60°C for 1 minute for 40 cycles. 
Data attained via an Eppendorf MasterPlex was recorded as Ct (cycle threshold) values. The 
Ct value refers to the number of cycles required for the fluorescent signal to cross the 
threshold (beyond background fluorescence). Ct values are inversely proportional to the 
amount of target DNA sample present, hence high Ct values equate to low gene expression. 
Ct values were normalised against those of housekeeping genes whose expression remains 
constant (GAPDH). Ct values were normalized with those of the housekeeping gene GAPDH 
to yield delta Ct (dCt) values (dCt = IFIT2 Ct – GAPDH Ct). 
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2.8 DC phenotype measurements 
Polyplexes containing 20µg of pDNA were reverse transfected into DCs (approximately 1.9 
x106 cells per well). Two wells were used and designated for transfected cells and 
untransfected cells as a control. Cells were transfected for a period of 48 hours. After this 
cells were carefully transferred to a 5ml collection tube through gentle pipetting action in 
order to loosen attachment to the PLL coated coverslip. Cells were centrifuged at 1400rcf for 
5   minutes   and   the   supernatant   was   discarded.   The   pelleted   DCs   were   then   probed   for   β-
galactosidase activity via an ImaGene GreenTM C12FDG lacZ Gene Expression Kit 
(Invitrogen)   according   to   the   manufacturer’s   protocol.   Cells   were   centrifuged   and  
resuspended in PBS, to which 100µl was aliquoted to tubes each containing 2µl antibodies 
for the following DC surface markers; IgG1, IgG2b, CD1a, DC-SIGN, CD11c, MHC-I, 
MHC-II, CD40, CD80, CD83 and CD86 (BD Pharmingen). Antibodies were fluorescently 
labelled with far red dyes phycoerythrin (PE) or allophycocyanin (APC) which do not 
overlay with the green fluorescence corresponding to β-galactosidase positive cells. 
Treatment of transfected and untransfected DCs with the antibodies entailed a 20 minute 
incubation period at room temperature in the dark. Cells were then centrifuged and 
resuspended in 300µl PBS and analysed by flow cytometry.        
2.9 Statistical analysis  
Student’s   t-test and one-way ANOVA were employed to deduce levels of statistical 
significance. Level of significance selected was p = 0.05. Bonferroni’s   Multiple  
Comparison’s  Test  (GraphPad  Prism)  was  used  for  statistical  analysis for Q-PCR studies (p = 
0.05).  
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3. Characterisation of DNA polyplexes 
 
Non-viral gene delivery is increasingly becoming the focus of biotechnology industries as it 
avoids safety hazards brought about by viral delivery of DNA. Many studies have focused on 
the use of polymers as a means of gene delivery. Such polymers bind to DNA and condense it 
to form small nanoparticles that facilitate cellular uptake (Hartmann et al, 2008). Polymers 
are also referred to as polycations as they harbour an excess of positively charged residues 
which neutralises the negatively charged DNA backbone through electrostatic interaction. 
Such interaction results in the formation of polycation/DNA complexes – referred to as 
polyplexes.  
In this study poly-L-lysine (PLL), a widely used polymer was employed to bind with pDNA 
for potential non-viral gene delivery. Benefits offered by PLL include the ease and rapid 
ability by which it binds with pDNA, allowing successful delivery of genes (Fu et al, 2011; 
von Erlach et al, 2011). The current chapter focused on the biophysical characterisation of 
polyplexes such as the charge, size, degree of pDNA condensation induced by PLL and 
nuclease resistance of DNA polyplexes. Moreover the chapter addresses whether key factors 
such as DNA topology, ionic strength, charge ratio (ratio of PLL to pDNA) and plasmid size 
affect polyplex characterisation. Factors such as DNA topology are important from regulatory 
viewpoints (Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious 
Disease Indications – FDA, 2007) and therefore characterisation of PLL/DNA polyplexes is 
critical in regards to understanding and optimising non-viral gene delivery strategies.  
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3.1 Preparation of different DNA topologies 
Plasmids can display a variety of conformations. Plasmids often exhibit a natural supercoiled 
(SC) condensed structure. Alternatively pDNA can be cut (via restriction enzymes) at 
specific nucleotide sites to generate an uncoiled linear form (Anada et al, 2005). Plasmids can 
also have one strand nicked resulting in open circular (OC) forms (refer to Chapter 1, section 
1.1.2). Therefore to study the effects of DNA topology on polyplex biophysical 
characteristics, linear and OC (as well as using SC) forms of the same plasmid (6.8kb) were 
generated. Restriction digestion (Figure 3.1a and 3.1b) and plasmid nicking (3.1c and 3.1d) 
were carried out via enzyme treatment as described in Chapter 2, section 2.1.3. Samples were 
analysed via agarose gel electrophoresis. Linearization and nicking of the plasmid occurred 
rapidly at less than 10 minutes. Production of OC- and linear-pDNA was confirmed by 
agarose gel electrophoresis whereby OC-, linear- and SC-pDNA have distinct electrophoretic 
mobilities (refer to Chapter 1, section 1.1.2). DNA migrates through the gel on the basis of 
size whereby the condensed SC form is the smallest which facilitates electrophoretic 
migration through the gel. The linear form containing a double strand cut is larger and 
migrates slower, followed by OC-pDNA which migrates the slowest (Figure 3.1e).       
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Figure 3.1: Restriction digestion and nicking of  the  pSVβ  (6.8kb) plasmid. Assays were carried out in short 
and extended time courses. Restriction digestion (A-B) was carried out via the PstI enzyme and OC forms (C-
D) were generated via Nt.BstNBI. Electrophoretic mobilities corresponding to different DNA forms (E). The 
amount of enzymes used was 1 unit per µg of DNA as recommended by the manufacturer, New England 
Biolabs. 
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3.2 Confirmation of polyplex formation 
Confirmatory assays are critical in order to identify successful complex formation. PLL and 
the respective nucleic acid (pSVβ, 6.8kb) form DNA polyplexes on the basis of electrostatic 
interactions. The present study focused on the interaction between the plasmid of varying 
topology (SC, OC or linear-pDNA) and that of PLL (molecular weight 9600). 
3.2.1 Polyplex zeta potential measurements   
Zeta potential studies enable a good method of characterising the surface charge of DNA 
polyplexes. This is important as surface charge is a key factor of non-viral gene delivery. The 
aim of this particular experiment was to measure zeta potentials of PLL/DNA polyplexes to 
confirm PLL interaction, and whether DNA topology affects this. A constant amount of 
pDNA (20µg) was added to varying amounts of PLL (2.67-66.67µg) in order to vary the 
PLL/DNA charge ratio. The charge ratio refers to the ratio of positively charged amine 
groups of PLL to that of the negatively charged phosphate groups of pDNA (high charge 
ratio values correspond to greater amounts of PLL and net positive charge). Formation of 
polyplexes is a rapid process that occurs almost instantaneously when cationic polymer and 
anionic phosphate groups interact (Hartmann et al, 2008). SC-pDNA showed an efficient 
charge neutralisation, losing its net negative charge with PLL at ratios of 0.6 or above (Figure 
3.2). OC-pDNA required a slightly higher ratio of PLL (approximately +1) to neutralise the 
plasmid net negative potential. In contrast linear-pDNA complexes exhibited a more gradual 
conversion towards a net positive surface charge requiring a ratio of at least +2 to neutralise 
the overall negative charge.  
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3.2.2 Gel retardation and observation of DNA released from PLL 
To further confirm successful polyplex formation, complexes were analysed by agarose gel 
electrophoresis. This experiment was selected as a change in surface charge, as detected in 
Figure 3.2, would be validated by electrophoretic analysis. The formation of polyplexes was 
associated with a decreased ability to bind ethidium bromide (EtBr) (due to PLL/DNA 
interaction restricting EtBr intercalation and fluorescence), and reduced electrophoretic 
migration (as a result of the change in zeta potential) (Figure 3.3a). Reduced EtBr staining 
appeared to occur at the same PLL/DNA ratio for all three topologies.  
Figure 3.2: Zeta potential measurements of DNA polyplexes. The surface charge of SC-pDNA, 
OC-pDNA and linear-pDNA polyplexes made at different PLL/DNA ratios (1mM HEPES, pH 7.5), 
was estimated by measuring the particle zeta potentials as described in Chapter 2, section 2.3.1. The 
figure shows the mean and standard error (SE) of 5 replicate measurements. The experiment was 
repeated 3 times independently. One-way ANOVA was employed to deduce levels of statistical 
significance (p < 0.05) between complexes of differing DNA topologies. 
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Figure 3.3: Confirmation of polyplex formation and observation of PLL-bound DNA. Agarose gel 
electrophoresis of DNA polyplexes (complexes prepared in 1mM HEPES, pH 7.5). (A). EtBr binding after 
SDS mediated removal of PLL (B). Surface charge measurements of SDS treated polyplexes and naked DNA 
controls (C). SC-pDNA, OC-pDNA and linear-pDNA polyplexes were formed at PLL/DNA charge ratios of 
+1.6 for SC-pDNA and OC-pDNA, and +5 for linear-pDNA. Figure 3.3c shows the mean and SE of 5 
replicate measurements. The experiment was repeated 3 times independently. One-way ANOVA was 
employed to deduce levels of statistical significance (p < 0.05) between complexes of differing DNA 
topologies.     
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Although conventional gel electrophoresis is useful in confirming polyplex formation, 
electrophoretic detection of high charge ratio complexes is restricted (through lack of EtBr 
fluorescence). Therefore the aim of this particular experiment was to confirm the presence of 
DNA within complexes at high charge ratios. Polyplexes were treated with SDS detergent 
and boiled (96°C for 10 minutes), to remove the PLL. The removal of PLL restored the 
ability of pDNA of all topologies, to bind EtBr. Complete polymer removal did not occur as 
evident by the reduced electrophoretic mobilities (Figure 3.3b). Samples that were boiled 
with SDS underwent a DNA precipitation reaction to purify and isolate the liberated DNA as 
described in Chapter 2, section 2.3.5. 
The zeta potentials of polyplexes treated with SDS were measured (Figure 3.3c). The zeta 
potentials of SDS treated polyplexes displayed an increased cationic charge than those of 
naked DNA controls, regardless of topology. This may be due to existing PLL binding and 
may account for the reduced electrophoretic mobility observed in Figure 3.3b.   
3.2.3 Pre-staining with EtBr and electrophoretic identification of PLL-bound DNA 
The experiment shown in Figure 3.3 tested the ability of PLL to exclude EtBr from 
polyplexes and the electrophoretic detection of DNA released from PLL. However it was 
important to detect DNA whilst complexed to PLL, which was the aim of this particular 
experiment. When EtBr was allowed to bind with DNA prior to polyplex formation, DNA 
(whose fluorescence is usually excluded as with the control preformed complexes) can be 
identified (Figure 3.4). Moreover polyplexes that were pre-stained with EtBr prior to 
formation seem to exhibit a greater cationic surface charge than that of polyplexes stained 
post formation resulting in differing electrophoretic velocities when the gel was stained with 
EtBr. This may be due to the positive charge of the ethidium exocyclic amines which are 
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important for electrostatic interaction (Nafisi et al, 2007). Furthermore EtBr binds to DNA 
and unwinds it, which in turn effects pDNA topology and hence a change in mobility 
(Neugebauer et al, 2007). The aim of Figure 3.4 was to confirm the presence of DNA in its 
complexed form with PLL and so electrophoresis was carried out for a short time period (10 
minutes), after which the gel was stained to view complexed DNA (Chapter 2, section 2.3.4). 
This would account for the similar electrophoretic mobility observed for complexes stained 
post complexion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.4 Size measurements of PLL/DNA polyplexes 
Polyplex size is a key determinant of non-viral gene delivery. An experiment was carried out 
whereby polyplex size was estimated using dynamic light scattering (DLS). Complex mean 
diameters were recorded (Figure 3.5). Size was found to be topology dependent. At varying 
Figure 3.4: Identification of PLL-bound DNA when pre-stained with ethidium bromide. SC-
pDNA, OC-pDNA and linear-pDNA polyplexes were formed at PLL/DNA charge ratios of +1.6 for 
SC-pDNA and OC-pDNA, and +5 for linear-pDNA, prior to the addition of EtBr. The fluorescence 
of the EtBr stained complexes was measured as described in Materials and Methods. 
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charge ratios SC-pDNA polyplexes displayed mean diameters of up to 200nm. OC-pDNA 
polyplexes were larger, with sizes increasing with charge ratio. For SC- and OC-pDNA 
complexes the polydispersity index (PI) was 0.20-0.22 (narrow range of size characteristics 
of which a broad range corresponds to a PI value of 1); however that of linear-pDNA 
polyplexes was much higher for the Malvern instrument to read. Linear-pDNA complexes at 
the equivalent charge ratios displayed a much larger size and at a charge ratio of +5 exhibited 
a mean diameter of >1000nm. This may be due to the addition of excess polycation, which in 
turn increases aggregation. Therefore polyplex sizes were in the order (largest first) of 
Linear>OC>SC-pDNA polyplexes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5: Polyplex size measurements at varying charge ratios. Polyplex (prepared in 1mM 
HEPES, pH 7.5) size measurements attained via dynamic light scattering (DLS). The figure shows 
the mean and SE for 10 readings. The figure shows the mean and SE of 5 replicate measurements. 
The experiment was repeated 3 times independently. One-way ANOVA was employed to deduce 
levels of statistical significance (p < 0.05) between complexes of differing DNA topologies. 
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3.2.5 Quantifying the degree of DNA condensation by PLL 
Analysing the degree by which PLL condenses the nucleic acid is important in terms of 
observing the efficiency of the polymer to package the DNA cargo. Two fluorescent DNA 
intercalating agents were employed to stain the DNA; EtBr and TOTO-3. 
3.2.5.1 EtBr fluorescence assays 
EtBr is a fluorophore whose fluorescence is greatly enhanced when it is bound (i.e. 
intercalates) within DNA strands. Binding of PLL and the resulting DNA condensation 
restricts EtBr intercalation, and hence decrease fluorescence. Fluorescent values (which were 
expressed as a percentage of each DNA topology without PLL) for all three topological 
plasmid complexes decreased dramatically following the addition of PLL (Figure 3.6). At 
low ratios, SC-pDNA fluorescence is reduced most efficiently, followed by linear-pDNA, 
and then OC-pDNA. At higher charge ratios all forms of the plasmid severely restrict EtBr 
intercalation, although SC continues to give the lowest fluorescence. Usually pDNA exhibits 
a rigid structure owing to repulsions of the negatively charged phosphate backbone. However 
interaction with the positively charged PLL relaxes these repulsions resulting in the pDNA 
structure being able to bend and coil, which severely restricts DNA access for EtBr, 
especially in the case of SC-pDNA complexes (Hartmann et al, 2008). In regards to DNA 
topology, complexes containing SC-pDNA were most able to restrict EtBr fluorescence 
unlike that of OC- and linear-pDNA complexes. This may be attributed to the condensed 
nature of the supercoiled form along with PLL induced packaging of the DNA. 
Although PLL condenses pDNA thereby reducing EtBr intercalation, such condensation 
could block interactions with external factors. However in many cases the DNA and polymer 
often dissociate in endosomes (vesicles which transport newly internalised materials). This 
occurs particularly within acidic conditions whereby enzymes operating at an acidic pH are 
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released by host cells to degrade foreign components. The advantages of polymers such as 
PLL is that they can become protonated at low pH and cause osmotic damage to the 
endosome allowing release of the DNA into the cytosol for subsequent nuclear import (Shim 
et al, 2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.5.2 TOTO-3 Fluorescence assay 
An alternative intercalating agent was also applied to polyplexes to measure fluorescence 
exclusion and hence the ability of PLL to condense the nucleic acid. The dye; TOTO-3 
(Dimeric Cyanine Nucleic Acid Stains – Invitrogen) was added to the polyplexes at a final 
concentration of 4µM and fluorescence was recorded. Like EtBr, TOTO-3 fluoresces when 
interwoven between free nucleic acid strands. The percentage of dye fluorescence decreased 
Figure 3.6: Quantitative analysis of the ability of PLL to exclude ethidium bromide from DNA. 
Ethidium bromide (EtBr) dependent fluorescence of PLL/DNA polyplexes of different topologies. 
The figure shows the mean and SE of 3 independent experiments. One-way ANOVA was employed 
to deduce levels of statistical significance (p < 0.05) between complexes of differing DNA 
topologies. 
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quite rapidly, particularly for polyplexes containing SC- and OC-pDNA at higher charge 
ratios (Figure 3.7). At a charge ratio of +1.2, polyplexes containing SC-pDNA displayed a 
TOTO-3 fluorescence of 33.4% (percentage of naked DNA control). However when the PLL 
concentration increased fluorescence was further reduced highlighting the efficient dye 
exclusion induced by PLL. A very similar pattern was observed for OC-pDNA complexes. In 
contrast linear-pDNA polyplexes were unable to effectively exclude fluorescence despite 
increased amounts of PLL. Although polyplexes were able to reduce TOTO-3 fluorescence, 
there is a discrepancy between Figures 3.6 and 3.7. TOTO-3 is a more sensitive and stable 
intercalating agent than EtBr by approximately 50 fold (Rey et al, 1992), which could 
account for the greater percentage of fluorescence detected.     
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7: Quantitative analysis of the ability of PLL to exclude TOTO-3 from DNA.  TOTO-3 
fluorescent assay of polyplexes harbouring SC-, OC-, or linear-pDNA. Fluorescence was expressed as 
a percentage of a naked DNA control. The figure shows the mean and SE of 3 independent 
experiments. One-way ANOVA was employed to deduce levels of statistical significance (p < 0.05) 
between complexes of differing DNA topologies. 
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3.3 Polyplex robustness studies  
3.3.1 Polyplex nuclease exposure 
To test the stability of polyplexes to nucleases which are prevalent in vivo, samples were 
treated with bezonase nuclease. This nuclease was selected as it is employed for downstream 
removal of nucleic acids in recombinant protein production. 50 units of bezonase were 
employed as this has been previously found to degrade majority of DNA in cells (Grabski et 
al, 1999), and would therefore provide a measure of polyplex robustness. Polyplexes were 
exposed to the nuclease for a period of 30 minutes. At 5 minute intervals samples were 
extracted and analysed via agarose gel electrophoresis. Although in regards to SC-pDNA 
faint DNA bands at 5 minutes post exposure are present, nuclease treatment seemed to 
degrade the majority of DNA present (Figure 3.8). Little or no bands were observed for OC- 
and linear-pDNA complexes. As no bands were observed for treated and untreated samples, 
more sensitive detection methods were required to clarify whether nuclease degradation has 
occurred.  
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Figure 3.8: Gel electrophoresis displaying polyplex exposure to bezonase nuclease. 
Polyplexes (containing 2µg pDNA) exposed to 50 units of bezonase nuclease. Polyplexes 
were prepared at charge ratios of; +1.6 for SC- and OC-pDNA, and +5 for linear-pDNA. 
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3.3.2 Quantification of the remaining amount of DNA post nuclease exposure 
The amount of DNA remaining post nuclease exposure was quantified and expressed as a 
percentage of an untreated DNA control. Figure 3.9 shows how the majority of the DNA that 
did remain after nuclease attack, comprised mainly of SC- and OC-pDNA while linear-
pDNA polyplexes were susceptible to attack. Regardless of DNA topology the percentage of 
DNA remaining decreases by over 50% following 10 minutes of nuclease treatment. At 5 
minutes post nuclease exposure, the percentage of SC- and OC-pDNA are approximately 
30% of the untreated controls, which may correspond to the very faint bands observed in 
Figure 3.8. DNA was quantified by a NanoDrop ND-1000 Spectrophotometer (NanoDrop 
Technologies) as described in Chapter 2, section 2.1.2. 
 
 
 
 
 
 
 
 
 
 
Figure 3.9: Percentage of polyplex DNA remaining following nuclease exposure. 
Polyplexes (containing 2µg pDNA) were prepared at charge ratios of; +1.6 for SC- and 
OC-pDNA, and +5 for linear-pDNA. The figure shows the mean and SE of 3 
independent experiments. One-way ANOVA was employed to deduce levels of statistical 
significance (p < 0.05) between complexes of differing DNA topologies. 
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3.3.3 Naked DNA exposure to nuclease 
As a control experiment naked pDNA (SC-, OC- and linear-pDNA) were exposed to the 
nuclease for the same time period and analysed via agarose gel electrophoresis. As shown, 
the nuclease completely degraded all forms of the plasmid, regardless of DNA topology, with 
little or no resistance towards degradation (Figure 3.10). This is shown by the lack of DNA 
bands in comparison to untreated controls. This may indicate the protective attributes PLL 
has to offer in terms of nuclease resistance.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10: Gel electrophoresis displaying naked pDNA exposure to bezonase 
nuclease. Naked pDNA (2µg pDNA) exposure to 50 units of bezonase nuclease.  
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3.3.4 Southern blot analysis  
Since polyplex formation inhibited EtBr staining, an alternative method of detecting DNA 
and monitoring nuclease degradation was used. Following nuclease treatment polyplex DNA 
was probed via Southern blot (Figure 3.11). DNA was biotinylated and probed by a 
streptavidin antibody (refer to Chapter 2, section 2.2.1). The strongest biotin signal 
corresponding to DNA was that of polyplexes containing SC-pDNA whereby the DNA signal 
was observed for up to 20 minutes post exposure. The probing of DNA allowed a more 
sensitive detection of the remaining amounts of nucleic acid. In contrast to Figure 3.8, the 
membrane blot showed how the polyplex DNA (SC-form) is cut into two fragments whose 
signal intensity decreases with time of enzyme exposure. Similar observations were found for 
OC-pDNA polyplexes and in line with Figure 3.9. Very weak DNA signals were identified 
for the linear form, suggesting it was much more susceptible towards nuclease degradation.  
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Figure 3.11: Southern blot detection of polyplex DNA following nuclease exposure. Polyplexes 
were prepared at charge ratios of; +1.6 for SC- and OC-pDNA, and +5 for linear-pDNA. 
Biotinylated DNA was probed by streptavidin-HRP antibody, and detected via chemiluminescence.    
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3.3.5 Gel electrophoresis of purified DNA post nuclease exposure 
As an alternative approach to studying polyplex DNA post nuclease exposure, polyplexes 
were purified immediately after nuclease treatment using a commercial kit routinely 
employed for pDNA purification (Chapter 2, section 2.1.2). Purification involved the removal 
of proteins and other contaminants thereby isolating the desired DNA product. Purified 
nuclease treated polyplex DNA samples for all three topologies are shown in Figure 3.12. 
Faint DNA bands were observed for SC-pDNA polyplexes, whereas very little DNA was 
detected for that of OC- or linear-pDNA complexes.  
 
 
 
 
 
 
 
 
 
 
 
 
A 
Figure 3.12: Agarose gel electrophoresis of nuclease treated polyplexes that subsequently 
underwent pDNA purification. Polyplexes were prepared at charge ratios of; +1.6 for SC- 
and OC-pDNA, and +5 for linear-pDNA.  
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3.3.6 Quantification of the amount of purified pDNA post nuclease exposure 
The amount of purified DNA remaining following nuclease treatment was quantified and 
expressed as a percentage of naked DNA (same amount that was bound with PLL) that 
underwent the same purification process (Figure 3.13). Following both nuclease and 
purification (5 minutes post exposure) the majority of DNA was degraded. However SC-
pDNA still constituted a large proportion of the DNA that did survive attack. There appeared 
to be approximately 9% of SC-pDNA remaining following exposure which was more than 
double the amount of OC- and linear-pDNA. The trend of stability is as follows: 
SC>OC>linear pDNA, which all severely decrease following 15 minutes post nuclease 
treatment which is consistent with the enzyme assay and Southern blot. The experiment of 
Figure 3.13 does suggest mini-prep purification does remove polymer bound DNA. Mini-
prep purification entails spin columns which retain and purify plasmids. Unbound plasmids 
are larger in size than small polyplexes which may be lost during retention of larger DNA 
molecules. However it is clear that SC- or OC-pDNA when bound to PLL is much more 
resistant to nuclease attack than linear-pDNA. DNA was quantified by a NanoDrop ND-1000 
Spectrophotometer (NanoDrop Technologies) as described in Chapter 2, section 2.1.2. 
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3.4 Effect of ionic strength on polyplex formation and biophysical characterisation  
Ionic strength can have a major impact on the biophysical characteristics of DNA polyplexes. 
The presence of salts can disrupt the PLL/DNA interaction thereby potentially perturbing the 
transport of DNA cargo and hence ultimately gene expression. Therefore the aim of the 
following sets of experiments was to study the effects of high ionic strength on polyplex 
formation and characterisation. To mimic the cellular ionic environment polyplexes were 
prepared in 150mM NaCl and also in PBS (phosphate buffered saline). Characteristic 
analysis such as size, zeta potential and DNA condensation studies were carried out and 
compared to polyplexes prepared in low salt solutions. Polyplexes containing either SC-, OC- 
Figure 3.13: Quantification of purified DNA post nuclease treatment. Polyplexes were prepared at 
charge ratios of; +1.6 for SC- and OC-pDNA, and +5 for linear-pDNA. The figure shows the mean and 
SE of 3 independent experiments. One-way ANOVA was employed to deduce levels of statistical 
significance (p < 0.05) between complexes of differing DNA topologies. 
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or linear-pDNA were prepared and analysed at charge ratios of +1.6 (for SC- and OC-pDNA) 
and +5 (for linear-pDNA) respectively.  
3.4.1 The effect on polyplex size when formed in high salt concentration buffer       
Previous studies have reported that high ionic strength impacts on polyplex size (Jeong et al, 
2011). To investigate whether this was true of the present study, the diameter of polyplexes 
was estimated using DLS. As shown in Figure 3.14 size is topology dependent. SC-pDNA 
polyplexes were the smallest (mean diameter of <140nm). OC-pDNA polyplexes were larger 
at just over 300nm, while linear-pDNA complexes had diameters of approximately 840nm. 
When formed in high ionic strength solutions, polyplex sizes increased dramatically, 
presumably the presence of salts causes aggregation to the PLL/DNA interaction. However it 
is clear when made up in 1mM HEPES (pH 7.5) polyplexes consisting of SC-pDNA seem 
well equipped for cellular entry, an observation consistent with previous data (Tsai et al, 
1999). This may be due to the pre-existing dense structure of SC-pDNA which when bound 
to PLL, is condensed further to a much more confined form.  
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3.4.2 Impact on polyplex surface charge when formulated in high salt concentration 
buffer  
Zeta potential studies provide a good technique for characterising the surface charge of non-
viral gene delivery systems. Surface charge is a key parameter in determining gene delivery. 
The zeta potential of complexes produced in various buffers was measured (Figure 3.15). An 
additional control was added whereby complexes were produced in 0.2µm filtered water. 
These complexes along with those prepared in 1mM HEPES displayed cationic surface 
charges. However the zeta potential of complexes prepared in either 150mM NaCl or PBS is 
significantly reduced to a more neutral surface charge suggesting PLL/DNA interaction is 
Figure 3.14: The effect of high ionic strength on polyplex size. Polyplexes were prepared in either 
1mM HEPES, 150mM NaCl and PBS (pH 7.5). The polyplexes had PLL/DNA ratios of +1.6 for SC-
pDNA and OC-pDNA, and +5 for linear-pDNA respectively. Points represent mean and SE for 10 
readings. The experiment was repeated 3 times independently. One-way ANOVA was employed to 
deduce levels of statistical significance (p < 0.05) between complexes of differing DNA topologies 
produced in different buffers. 
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perturbed by the presence of salts causing a relaxation of the strong cationic charge induced 
by PLL.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.4.3 The effect of ionic strength on DNA condensation by PLL 
Results from Figures 3.14 and 3.15 suggest the presence of salts did impact on the 
biophysical characteristics of DNA polyplexes, particularly at the vesicular ionic 
environment (150mM NaCl). Both surface charge and sizes were disrupted indicating the 
presence of salts perturbs PLL/DNA electrostatic interaction. To gain further insight into this, 
DNA condensation by PLL was studied by an EtBr assay (Figure 3.16). EtBr fluorescence is 
Figure 3.15: The effect of high ionic strength on polyplex surface charge. Polyplexes were 
prepared at charge ratios of; +1.6 for SC- and OC-pDNA, and +5 for linear-pDNA. The figure 
shows the mean and the SE of 5 replicate measurements. The experiment was repeated 3 times 
independently. One-way ANOVA was employed to deduce levels of statistical significance (p < 
0.05) between complexes of differing DNA topologies produced in different buffers. 
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reduced most effectively for polyplexes containing SC-pDNA in a topology dependent 
manner when prepared in low salt concentrated buffer, as shown previously (Figure 3.6). OC-
pDNA complexes display similar exclusion profiles, while complexes containing linear-
pDNA are least effective in restricting EtBr intercalation, and therefore are more accessible. 
However EtBr fluorescence rises over 5 fold for SC- and OC-pDNA complexes made up in 
150mM NaCl. Similar observations were noted for complexes made up in PBS. Such results 
strongly suggest the presence of salts does disrupt PLL/DNA interactions leading to a 
decrease in PLL induced DNA condensation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.16: The effect of high ionic strength on the ability of polyplexes to restrict ethidium 
bromide fluorescence. Polyplexes were prepared at charge ratios of; +1.6 for SC- and OC-
pDNA, and +5 for linear-pDNA. The figure shows the mean and SE of 3 independent 
experiments. One-way ANOVA was employed to deduce levels of statistical significance (p < 
0.05) between complexes of differing DNA topologies produced in different buffers. 
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3.4.4 Electrophoretic analysis of DNA and polyplex formulations  
As shown previously both size and surface charge are affected when the ionic strength is 
increased. Moreover the ability to restrict EtBr fluorescence is reduced and so to further 
analyse the effect of ionic strength on the physical characteristics of polyplexes, samples 
were analysed via gel electrophoresis (Figure 3.17). Both electrophoretic mobility and EtBr 
fluorescence is reduced which is in line with Figure 3.3a. Despite polyplexes produced in 
high salt concentrations and displaying a relatively neutral charge, the ability to reduce EtBr 
fluorescence seems to be independent of charge as shown in the gel. Although, when 
polyplexes are formulated in 150mM NaCl and PBS, fluorescence is observed (situated in the 
well as a result of the change in charge) which is in line with Figure 3.16. Additionally the 
corresponding formulations seemed to have virtually no effect on electrophoretic mobility or 
ability to stain naked uncomplexed DNA (Figure 3.17b).        
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.17: Electrophoretic analysis of polyplexes and naked pDNA formulated in differing 
buffers. Electrophoretic analysis of polyplexes (A) and naked DNA (B) in different formulation 
buffers. Polyplexes were prepared at charge ratios of; +1.6 for SC- and OC-pDNA, and +5 for linear-
pDNA.  
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3.5 The effect of plasmid DNA size on polyplex formation and characterisation 
Plasmid DNA size is a key factor that can affect polyplex formation and various physical 
attributes required for non-viral gene delivery. Plasmid size is a key area of interest in regards 
to gene therapy and vaccination. Large plasmids (>30kb) offer the advantage of larger 
therapeutic DNA insert, whereas smaller plasmids (>5kb) are of decreased sizes which 
minimises issues regarding cellular and nuclear uptake. In this section of the chapter a 
simultaneous comparison of the effect of plasmid size on PLL interaction is presented. Two 
plasmids were studied; a 3.8kb plasmid and a bacterial artificial chromosome (BAC) 
displaying a size of 56.5kb (both plasmids studied were in the SC conformation).  
3.5.1 The effect of nucleic acid size on polyplex zeta potential 
Zeta potentials of polyplexes containing either a 3.8 or 56.5kb nucleic acid of varying charge 
ratios was measured (Figure 3.18). It is clear that pDNA size affects interaction with PLL in 
terms of charge, whereby the smaller 3.8kb plasmid displayed a rapid charge neutralisation 
(at a charge ratio of 0.6) and increase to a more cationic charge. In contrast the BAC 
exhibited a neutral charge even when the charge ratio increased to +10. This may be due to 
the larger anionic phosphate backbone of the BAC whereby more positively charged polymer 
is required to neutralise the charge. This is important and would have important implications 
for further downstream studies such as cell uptake assays.   
3.5.2 Electrophoretic analysis and confirmation of polyplex formation  
Binding of PLL to either plasmid, regardless of size, caused a rapid decrease in EtBr 
fluorescence as shown by gel electrophoresis (Figure 3.19). Fluorescence was reduced 
rapidly at low charge ratios. Moreover electrophoretic mobility was retarded which is in line 
with Figure 3.18 in terms of surface charge. Furthermore even though the 56.5kb BAC is 
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essentially neutralised by PLL, some fluorescence and migration is observed, which may 
reflect the decrease in positive charge. Both small and large plasmids were subjected to 
nicking and restriction digestion to confirm analysis (Figure 3.19a and b).        
 
 
 
 
 
 
 
 
 
 
Figure 3.18: The effect of nucleic acid size on polyplex surface charge. Polyplexes were prepared 
in 1mM HEPES, pH 7.5. The figure shows the mean and SE of 5 replicate measurements. The 
experiment was repeated 3 times independently. One-way ANOVA was employed to deduce levels 
of statistical significance (p < 0.05) between complexes of differing pDNA sizes. 
 
 
Figure 3.19: Electrophoretic confirmation of both small and large nucleic acids. Confirmation 
achieved via nicking and restriction digestion of the 3.8kb plasmid (A) and 56.5kb (B) BAC. 
Electrophoretic analysis of PLL/DNA polyplexes containing either the 3.8kb plasmid (C) or the 
56.5kb BAC (D).    
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3.5.3 Polyplex size analysis  
DLS was used to measure complex mean diameters and the effect of pDNA size on polyplex 
size. Polyplex size shows dependence on nucleic acid size (Figure 3.20). Polyplexes 
containing the 3.8kb plasmid exhibit sizes within the region of 100-137nm. Despite a larger 
charge ratio of +10 and containing a greater concentration of PLL to facilitate DNA 
condensation and charge neutralisation, complexes containing the 56.5kb BAC were 
measured to be approximately <900nm. Such observations may be due to the existing large 
BAC structure (mean diameter of the naked BAC was 468.14nm), which with the addition of 
the polymer may form a larger complex. However nucleic acid size clearly affects polyplex 
size, with smaller plasmids being efficiently condensed by PLL, which is a critical parameter 
for uptake studies.         
 
 
 
 
 
 
 
 
 
 
Figure 3.20: The effect of nucleic acid size on polyplex mean diameter. Polyplexes were prepared in 
1mM HEPES, pH 7.5 for size measurements attained via dynamic light scattering (DLS). Points 
represent mean and SE for 10 readings. The experiment was repeated 3 times independently. One-way 
ANOVA was employed to deduce levels of statistical significance (p < 0.05) between complexes of 
differing pDNA sizes. 
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3.5.4 The effect of nucleic acid size on DNA condensation 
An EtBr fluorescence exclusion assay was performed to deduce whether nucleic acid size 
affects the ability of PLL to condense it and hence exclude EtBr intercalation. Figure 3.21 
shows how the 3.8kb plasmid displays a reduced EtBr fluorescence profile than its 52kb 
counterpart. The 3.8kb plasmid is more efficiently packaged by PLL resulting in reduced 
EtBr DNA intercalation. The ability of PLL to effectively condense the 3.8kb plasmid is 
consistent with the smaller sizes observed in Figure 3.20. Although the 3.8kb pDNA polyplex 
excluded EtBr access, >20% fluorescence was recorded which is greater than previous 
measurements with the larger 6.8kb pDNA polyplex. This may be due to smaller DNA 
molecules being bound to larger polymers which may allow DNA access.    
 
 
 
 
Figure 3.21: The effect of nucleic acid size on PLL induced DNA condensation. The figure shows 
the mean and SE of 3 independent experiments. One-way ANOVA was employed to deduce levels of 
statistical significance (p < 0.05) between complexes of differing pDNA sizes. 
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3.6 Discussion 
Non-viral gene delivery has centred on the use of polycation-based techniques. Polycations 
are polymer based systems which bind and condense pDNA into smaller particles for gene 
delivery (Tiera et al, 2011). Various types of polycations have been successful in delivering 
pDNA (Ali and Mooney, 2008; Dutta et al, 2008; Liu et al, 2011). However gene expression 
remains low which could be due to the prevalence of host cell nucleases which can degrade 
pDNA following separation from the polymer within the endosome (polymer becomes 
protonated to allow DNA to escape from degradative enzymes which operate at a low pH). 
This is important as sustained expression is necessary for therapeutic purposes. For this to 
happen gene transfer most overcome various molecular barriers. In order to achieve this, the 
key factors that affect polycation DNA complexes (polyplexes) must be analysed.  
The present chapter focused on the characterisation of pDNA polyplexes and the key factors 
that affect complex biophysical properties in regards to potential uptake in mammalian cells. 
Plasmid DNA was complexed with poly-L-lysine (PLL) to form DNA polyplexes. Parameters 
such as DNA topology, plasmid size, polyplex size, charge ratio and stability amongst others 
were investigated. Understanding such parameters will improve the design of effective non-
viral gene delivery vehicles in bio-processing.   
3.6.1 DNA topology 
Plasmid DNA (pDNA) can exhibit a variety of topological conformations and such structural 
discrepancies may affect potential pDNA gene expression. Plasmids usually confer to a 
supercoiled (SC) compact form (Brown, 2001). A strand breakage leads to open circular 
(OC)-pDNA (Cherng et al, 1999), while restriction digestion of the strand leads to linear-
pDNA. Conventional gene delivery studies have long employed SC-pDNA which is 
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presumed to be more stable than other conformations (Hsu and Uludag, 2008). However OC-
pDNA which consists of a single nick may not differ in biological activity and the accessible 
nature of the linear-pDNA conformation may favour gene expression (Anada et al, 2005). 
Few studies have actually compared DNA of differing topologies in regards to polyplex 
biophysical analysis and uptake. Reports have produced conflicting results with topology 
being a major factor (Remaut et al, 2006) or having no significant impact (Hsu and Uludag, 
2008) (Summarised in Table 3.1). 
3.6.1.1 Polyplex confirmation  
In this study a 6.8kb plasmid of three differing topologies was complexed with PLL, and 
analysed in terms of biophysical characterisation. Polyplex formation was confirmed by 
charge neutralisation which occurred rapidly for SC- and OC-pDNA, whereas linear-pDNA 
required more PLL to produce a net positive charge. Such observations have been attributed 
towards the selective affinity of polycations towards DNA of differing topology (Bronich et 
al, 2000). Moreover linear-pDNA display a more open and accessible structure and so may 
require more PLL to neutralise the exposed phosphate backbone. A study by von Groll et al, 
(2006) required three times the amount of recommended lipofectamine agent for linear-
pDNA to produce a lipoplex with a cationic charge necessary for cellular uptake. In that 
study linear-pDNA lipoplexes displayed necklace-like structures whereas SC-pDNA was 
more spherical (von Groll et al, 2006). Therefore the large surface area of the linear form 
may require greater charge neutralisation.      
3.6.1.2 Polyplex sizes 
Polyplex size is important as various physical barriers limit cellular uptake and ultimately 
gene expression. Size measurements of PLL/DNA complexes were recorded via dynamic  
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light scattering (DLS). Regardless of polyplex buffer formulation, complexes containing SC-
pDNA were found to be the smallest at just <200nm followed by OC-pDNA and linear-
pDNA polyplexes (Figure 3.5 and Table 3.1). The results may be due to the pre-existing 
dense structure of SC-pDNA, which is then further compacted by PLL. These results are 
consistent with previous reports which identified larger aggregated complexes in regards to 
linear-pDNA (Hsu and Uludag, 2008; von Groll et al, 2006). This is shown in Table 3.1 
whereby studies focusing on DNA topology identified smaller complex sizes for those 
containing SC-pDNA. However as the charge ratio increased polyplex sizes increased which 
may be due to excess amounts of polymer added which could lead to aggregation rather than 
further DNA condensation.  
Despite reporting smaller complex sizes for those containing SC-pDNA, Cherng et al, (1999) 
(Table 3.1) reported how polyplex size was independent of DNA topology with all three 
DNA forms displaying reduced mean diameters (>100nm for each topology when formulated 
in HEPES buffer, pH 7). Those results differed to the present study whereby a significant 
difference in size was recorded, particularly regarding linear-pDNA polyplexes. The large 
size of the linear-pDNA polyplex (>1000nm at high charge ratio [PLL to DNA] of +5) may 
be due to the greater amounts of PLL added to the nucleic acid leading to an increase in size 
and polydispersity (large size range detected). The high charge ratio necessary for charge 
neutralisation for linear-pDNA polyplexes may also be a hindrance in regards to uptake, 
whereby excess polycation has been found to cause aggregation due to interaction with 
negatively charged blood molecules (Christie et al, 2010).  
Nucleic acid condensation by polycations has been credited with the reduction in pDNA size. 
Detailed knowledge and exploitation of this process would improve future analysis. Nucleic 
acid condensation is important whereby the existing compact structure must be relaxed and 
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made accessible to the polymer, which then results in further bending and coiling (Eisenberg, 
1987). Recent studies which produced PLL/DNA complexes, used atomic force microscopy 
(AFM) to identify how condensed pDNA display rod and torroid structures (Osada et al, 
2010). The authors proposed a quantized folding model to explain the mechanism of DNA 
condensation. Osada and colleagues reported how condensed pDNA rod structure folds upon 
itself multiple times in a regulated manner. This may occur more readily for SC-pDNA which 
may account for the topology dependent size profiles identified in the present analysis. 
However from this study it is clear that polyplexes containing SC-pDNA display smaller 
sizes than OC- and linear-pDNA in a topology dependent manner.      
3.6.1.3 DNA condensation assays 
DNA polyplexes were treated with fluorescent intercalating dyes to quantify the degree to 
which PLL condenses pDNA. Complexes containing SC-pDNA were found to reduce 
intercalation much more efficiently than OC- and linear-pDNA polyplexes. The cationic PLL 
relaxes the anionic charge of the rigid phosphate backbone causing the structure to bend and 
coil (Hartmann et al, 2008). This seems to occur most effectively for SC-pDNA. In contrast 
linear-pDNA allows intercalation to occur much more readily. Although employing a 
different polymer to that of the present study, Cherng et al, (1999) reported how SC-pDNA 
complexes were most efficient at excluding intercalating dyes. Therefore in regards to gene 
delivery, SC-pDNA polyplexes seem quite efficient due to the effective packaging of DNA.  
However despite the inability to effectively restrict EtBr fluorescence in this study, linear-
pDNA has been shown to be efficiently condensed. Viral genomes containing DNA in the 
linear form,  can  be  as  large  as  1000kb,  but  can  be  effectively  packaged  within  a  viral  particle  
of     ̴  100nm (Ledley, 1996). In order to carry out such functions, viruses utilise ATP driven 
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molecular motors to package the high density genomes which could be exploited for non-
viral purposes (Ray et al, 2010). 
3.6.1.4 Stability 
For non-viral gene delivery to be applied therapeutically, the gene of interest must stay intact 
and avoid degradation by nucleases which are prevalent in vivo. Polyplexes were exposed to 
bezonase nuclease. The aim of the nuclease experiments was to analyse the effect of DNA 
topology on polyplex resistance towards nuclease attack. When exposed to nucleases 
complexes containing SC-pDNA were found to be the most resistant (Figure 3.11), which is 
consistent with the results of Remaut et al, (2006) (Table 3.1). The half life of transfected 
SC-pDNA was found to be within 50 minutes (Lechardeur et al, 1999). In this study Southern 
blot detection of SC-pDNA polyplexes persisted up to 20 minutes post nuclease exposure 
(Figure 3.11). The Southern blot experiment is a more sensitive method of detection than 
ethidium bromide staining via electrophoresis (Figure 3.8). This is because DNA was 
biotinylated prior to complex formation and probed after formation and exposure to enzymes, 
via streptavidin antibodies. However ethidium bromide is unable to intercalate between DNA 
strands within the polyplex due to PLL induced condensation. As ethidium bromide only 
fluoresces when bound to DNA, detection is restricted as a result. Polyplexes containing 
linear-pDNA were most susceptible to nuclease attack (Figure 3.11). DNA condensation 
studies revealed how the linear form exhibits a more open and accessible structure which may 
make it prone to nuclease attack. In contrast SC-pDNA complexes are smaller, compact and 
dense, thereby restricting exposure of the DNA cargo. OC-pDNA polyplexes displayed 
similar nuclease resistance to that of the SC form, which may be due to similarities in 
structure (Cherng et al, 1999). Therefore nuclease studies highlighted in this chapter 
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recommend DNA in the SC form for future uptake studies, due to displaying greater nuclease 
resistance.   
3.6.1.4.1 Methods to improve polyplex nuclease resistance 
However susceptibility of polyplexes to nuclease cleavage can be improved. For instance 
incorporation of poly(ethylene glycol) (PEG) which is a non-ionic hydrophilic polymer may 
increase nuclease resistance. PEG is beneficial as it interacts with DNA to form polyion 
complex (PIC) micelles. These micelles surround the DNA, thereby shielding it and nuclease 
resistance was found to be significantly improved (DNA in the intact SC form was observed 
2 hours after exposure to DNase I) (Wakebayashi et al, 2004). Stabilization by PEG is 
important, as previous studies found how PLL/DNA complexes lacking PEG degraded within 
the blood (Mullen et al, 2000).  
However incorporation of PEG within polyplexes can bring about non-specific interactions 
with cellular components. This is a problem as it can lead to the premature release of the 
DNA cargo (Christie et al, 2010). Research groups have previously found how oligopeptides 
can effectively and stably transport nucleic acids (Wadhwa et al, 1997; Niidome et al, 2000). 
Oligopeptide/DNA complexes were of 20 nm in size and displayed DNase I resistance for up 
to 1 hour longer than non-complexed DNA (van Rosenberg et al, 2004). Oligopeptides were 
reported to condense DNA at specific sites which may restrict pDNA exposure to nucleases 
(van Rosenberg et al, 2004). The reduction in size and resistance towards nuclease cleavage 
identified  in  van  Rosenberg’s  study  may  account  for  the  nuclease  resistance  displayed  by  SC-
pDNA polyplexes in comparison to that of OC- and linear-pDNA complexes.              
The condensed and compact structure of SC-pDNA polyplexes may alleviate nuclease 
digestion. Studies have shown how chemically identical DNA molecules can be distinguished 
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by structural differences. Less compact DNA underwent type I restriction nuclease digestion 
which occurs via DNA translocation (Keatch et al, 2004). However the translocation 
mechanism is blocked when the DNA is condensed by a polycation. Nucleotide recognition 
and cleavage is restricted when the DNA is coiled, unlike that of OC- or linear-pDNA. The 
uncondensed accessible structure such as the linear form is a suitable substrate for the 
translocation mechanism leading to restriction digestion (Keatch et al, 2004).   
Therefore the results of the present chapter indicate the importance of DNA topology in 
regards to biophysical characterisation of PLL/DNA polyplexes. Parameters such as size, 
surface charge, charge ratio, DNA condensation and nuclease resistance are heavily 
influenced by DNA topology which are summarised in Table 3.1. Plasmids in the SC 
conformation are recommended for non-viral gene delivery studies.     
3.6.2 Ionic strength  
DNA polyplexes need to overcome various molecular and chemical barriers when 
transporting the DNA cargo. Nuclease resistance is a key pre-requisite, along with non-
specific binding with blood components. However a key requirement of polyplexes is ionic 
stability (Neu et al, 2006). Ionic physiological conditions have been found to disrupt 
polycation/DNA interactions previously. Guo and Lee (2001) reported how PEI/DNA 
polyplexes formulated in high salt solutions (150mM NaCl) led to aggregation of particles. 
This was in agreement with the present study, whereby polyplex formation was perturbed 
when formed in high salt solutions. Regardless of DNA topology, PLL/DNA polyplex size 
increased dramatically (>1500nm) when formulated in high salt solutions mimicking 
physiological conditions (Figure 3.14). Ionic disruption of PLL/DNA formation was 
confirmed by a reduction in positive zeta potential measurements and DNA condensation 
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studies (Figures 3.15 and 3.16). If DNA polyplexes are to be employed therapeutically they 
must overcome changes in pH and salt concentrations. This is important in regards to various 
cellular and extracellular compartments whereby such parameters vary. A review by Park et 
al, (2010) discusses the use of pH-responsive polymers which allow the safe transport of 
DNA in compartments sensitive to pH and salt concentration. Another way of tackling ionic 
disruption is by cross linking polymers with disulphide bonds (Neu et al, 2006). Interaction 
occurs via polymer amine groups which secure the polyplex and maintained particle size and 
cationic charge during high ionic strength (Neu et al, 2006).  
Triblock copolymers have been applied for polyplex gene delivery, which are stable towards 
pH buffering and variable salt concentrations. These systems refer to the combined use of 
three polymers, each with a specific function aimed to maximise gene delivery (Christie et al, 
2010). One macromolecule will stabilise the polyplex (such as PEG), a second polycation 
condenses the DNA cargo, and finally a hydrophobic segment allows for ionic stabilisation. 
An example is that of Oishi et al, (2006) whose polyplex consisted of PEG-
blockpoly(silamine) (PSAO)-block-poly{2-(N, N-dimethylamino)ethyl methacrylate] 
(PAMA). By incorporating various polymers to simultaneously resist nuclease cleavage, 
condense DNA and stabilise in physiological ionic conditions, gene delivery is enhanced and 
such complexes have yielded higher gene expression (Oishi et al, 2006). However such 
systems are highly polydisperse and cytotoxic to host cells.     
3.6.3 Plasmid size 
Conventional gene delivery studies analyse plasmids that are <15kb in size (Baker and 
Cotten, 1997). However in regards to gene therapy a large DNA insert is advantageous, 
particularly for therapeutic purposes where long term gene expression is vital. Recent studies 
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have analysed bacterial artificial chromosomes (BACs) expressing a 135kb genomic DNA 
insert   for   Friedreich’s   ataxia   (FRDA)   (Gimenez-Cassina et al, 2011). The BAC was 
formulated within a herpes simplex virus type 1 (HSV-1) vector and injected within mice. 
Gimenez-Cassina’s   team   reported   high   vector   transduction   along   with   sustained   gene  
expression for almost 75 days. Baker and Cotten, (1997) formulated BAC plasmids of up to 
170kb, which were condensed with PEI (polyethylenimine) and conjugated to an adenovirus. 
Their combined viral/polycation approach yielded a tenfold increase in delivery compared to 
conventional methods. This provided the motivation for the present study whereby a 56.5kb 
BAC plasmid was complexed with PLL to form DNA polyplexes and analysed along with a 
smaller plasmid (3.8kb) undergoing the same procedure. When bound to PLL, the BAC 
polyplexes were both large (>900nm in diameter) and polydisperse. This was similar to the 
results of Baker and Cotten (1997), whose complexes were >500nm in size when formulated 
within HEPES buffer. The major disadvantage of the PLL/BAC polyplex was its inability to 
undergo charge neutralisation, even at extremely high charge ratios (Figure 3.18). In contrast 
the 3.8kb pDNA polyplexes (of varying charge ratios) displayed cationic charges, were 
>100nm in size and this compactness was reflected in EtBr fluorescence exclusion studies 
(Figures 3.20 and 3.21). Therefore in regards to the present study, PLL/BAC polyplexes seem 
unfeasible for gene delivery due to their large size, inability to be effectively condensed, and 
its failure to display a strong cationic charge. Moreover large BACs grown in E.coli are 
laborious to purify due to low copy numbers. Therefore in terms of bio-processing gene 
delivery through such means is extremely limited. 
Therefore this chapter reveals how DNA topology clearly affects PLL/DNA polyplex 
characterisation. Parameters such as charge, size, DNA condensation and nuclease resistance 
are all affected by topology with the SC form displaying the most favourable characteristics. 
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Therefore in line with current FDA guidelines, plasmids in the SC conformation should be 
employed for non-viral gene delivery studies. Parameters such as ionic strength and plasmid 
vector size should be considered in order to maximise uptake and gene expression into host 
cells.  
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3.7 Chapter Summary 
 Biophysical characterisation of PLL/DNA polyplexes was affected by DNA vector 
topology. The SC is recommended for uptake studies as complexes displayed: 
o Charge neutralisation at lower charge ratio of 0.6 (ratio of PLL to DNA), 
unlike that of linear-pDNA polyplexes which required a charge ratio of at least 
+2 to display a neutral charge. 
o Smaller sizes when measured by dynamic light scattering (DLS). SC-pDNA 
polyplexes were found to be approximately <200nm, whereas OC- and linear-
pDNA complexes were larger at <400nm and <1000nm respectively.   
o Efficiently condensed by PLL as measured by ethidium bromide (EtBr) and 
TOTO-3 intercalating dye fluorescence studies. Complexes containing SC-
pDNA reduced EtBr fluorescence to only 4%, unlike linear-pDNA at 20%.  
o Greater nuclease resistance as shown by Southern blot detection of the 
remaining amounts of DNA post exposure which was more sustained than 
OC- and linear-pDNA complexes.  
 When produced in high salt solution the PLL/DNA interaction was disrupted. This led 
to increased sizes and a decrease in DNA condensation and cationic charge. This is 
important in terms of considerations for mimicking the vesicular ionic environment. 
 Plasmid vector size affected polyplex characterisation with smaller plasmids 
complexed with PLL displaying smaller sizes (>100nm), charge neutralisation at 
lower charge ratios and effective DNA condensation, unlike that of larger DNA 
vectors (>1000nm mean diameter).  
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4. Visualising DNA and poly-L-lysine (PLL) by fluorescent 
labelling 
 
Bio-processing of non-viral gene delivery vehicles requires monitoring of the DNA cargo. 
Labelling of polyplexes is a critical procedure that allows tracking of its intracellular fate. In 
this chapter fluorescent labelling of DNA and the polycation vector; poly-L-lysine (PLL) was 
studied. Fluorescent labelling is important as it can be monitored by a variety of techniques 
such as fluorescent confocal microscopy, spectrophotometry analysis, flow cytometry and 
live cell imaging amongst others. Polyplex labelling is important in regards to transfection 
studies, as it can reveal the path taken by DNA and enable greater understanding of the 
cellular mechanisms involved (Godbey et al, 1999).  
In this study a dual labelling technique was employed whereby PLL and the DNA cargo were 
individually stained. This labelling strategy was employed in order to deduce whether DNA 
and PLL share the same intracellular fate or whether their paths are independent post 
transfection. Both direct and indirect methods of DNA labelling were explored in this 
chapter. Indirect labelling entailed fluorescent antibody detection of biotinylated DNA, 
whereas direct labelling involved staining through intercalating agents. Validation of 
labelling through fluorescent tagging was addressed in this chapter.   
4.1 Labelling of PLL 
4.1.1 Fluorometry analysis 
Previous analyses focusing on polycation mediated gene delivery have employed various 
fluorophores and/or antibodies specific for the polymer of interest. The current study dual 
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labelled the polyplex which first entailed labelling the PLL. The polycation was labelled with 
a green fluorescent tag; Oregon Green-488 (Invitrogen) in a procedure similar to that of 
Godbey et al, (1999) (succinimidyl ester linkage). Unbound dye was removed by spin 
column purification in accordance to the manufacturer’s   protocol (Invitrogen) (refer to 
Chapter 2, section 2.4.1). The fluorescent signal of the labelled PLL was measured by 
fluorescent spectrophotometry (Figure 4.1). Tagged PLL showed dose-dependent emission at 
521nm, while native PLL gave no signal. The labelling efficiency was found to be 1.21 
Oregon Green dyes per PLL molecule.     
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Fluorometry analysis of labelled PLL. Detection of labelled PLL at an excitation and 
emission spectra of 488 and 521nm respectively. The figure shows the mean and standard error 
(SE) of 3 independent experiments. One-way ANOVA was employed to deduce levels of statistical 
significance (p < 0.05) between unlabelled and labelled PLL.  
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4.1.2 Confocal microscopy analysis of labelled PLL 
In order to confirm successful labelling of PLL that would enable fluorescent detection via 
confocal microscopy a number of experiments were conducted. Firstly coverslips were coated 
with fluorescently labelled PLL (50µg/ml) to immobilise the polycation on the glass surface. 
Labelled PLL could be detected on the coverslips through the Oregon Green fluorescence. 
PLL distribution was non-uniform, with aggregates of PLL at specific areas upon the 
coverslip. In contrast unlabelled PLL-coated coverslips displays no fluorescence (Figure 4.2).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2: Confocal microscopy detection of Oregon Green labelled PLL. PLL 
(50µg/ml) was coated on coverslips, mounted on slides and analysed via fluorescent 
confocal microscopy.  
 
Oregon Green  labelled PLL Unlabelled PLL 
Overlay 
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4.1.3 Identification of labelled PLL when   ‘mock   transfected’   within Chinese 
hamster ovary (CHO) cells  
To deduce whether PLL labelling can be detected in mammalian cells, Chinese hamster ovary 
(CHO) cells  were   ‘mock’   transfected with Oregon Green labelled PLL for one hour. Cells 
were fixed with paraformaldehyde and stained with DAPI (nuclear stain) and HCS 
CellMaskTM (cytosolic stain) and observed by confocal microscopy (Figure 4.3). Aggregates 
of PLL were observed at the periphery of the CHO cell (presumably the aggregated native 
PLL exhibiting a large size to readily enter the cell). Importantly the PLL retains the Oregon 
Green   label   through   the   ‘transfection’,   fixation  and   staining  protocols   and  can   therefore  be  
used to localise the PLL for confocal microscopy studies.    
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Overlay 
Figure 4.3: Confocal microscopy observation of labelled PLL when  ‘mock’  transfected in CHO 
cells. Coverslips were mounted on microscope slides using DAPI (4',6-diamidino-2-phenylindole) 
mounting medium which is a nuclear blue stain displaying excitation and emission spectra of 358 and 
461nm respectively. CHO cells were stained using the HCS  CellMask™  Stains   (Invitrogen)   at   an  
excitation and emission spectra of 556nm and 572nm respectively. Cells were fixed with 
paraformaldehyde, permeabilised and stained, followed by mounting with DAPI.   
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4.2 DNA labelling 
Stable labelling of the nucleic acid cargo is critical in order to track transfected polyplexes. 
Labelling should be maintained and not jeopardise function.    
4.2.1 Indirect labelling of DNA - biotinylation 
Initially the pDNA was biotinylated and probed with a labelled streptavidin fluorophore. The 
biotinylation procedure incorporated a DNA precipitation step in order to remove any 
unbound biotin from the nucleic acid with the aim of reducing false positive signals. DNA 
was labelled at a 0.25:1 v:w ratio of reagent per µg of DNA (Chapter 2, section 2.4.2). 
Biotinylation of pDNA was confirmed by Southern blot (Figure 4.4). As shown the detection 
of the biotin/avidin DNA signal via chemiluminescence clearly corresponded to the nucleic 
acid samples run via agarose gel electrophoresis. This signal increases with DNA 
concentration upon the membrane.   
In addition to the Sothern blot, a dot blot procedure was carried out whereby biotinylated 
DNA of differing concentrations (serial dilutions) were spotted directly onto a nitrocellulose 
membrane and probed as before (Figure 4.5). Clear intense signals are detected, which are in 
line with that of the positive control, suggesting that the nucleic acid has successfully been 
biotinylated. Dot blots provide a simple and quick assay to detect successful biotinylated 
samples; however such a procedure does not provide information about the size of the 
labelled product to which the conventional Southern blot does.  
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Figure 4.4: Southern blot detection of biotinylated DNA. Transfer of biotinylated DNA from 
the agarose gel (A) to the nitrocellulose membrane (B). The biotinylated DNA upon the 
membrane was detected by probing with a streptavidin-HRP (horse radish peroxidase) antibody 
which was confirmed via chemiluminescence. 
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However as PLL condenses the pDNA, it is important to analyse whether PLL binding with 
biotinylated DNA jeopardises streptavidin probing (hence detection of DNA). In order to 
address this biotinylated DNA (SC-form) was complexed with PLL at a high charge ratio 
(ratio of PLL to DNA) of +1.6. The biotinylated DNA complex was then detected via dot blot 
Figure 4.5: Dot blot confirmation of biotinylated DNA. Labelled DNA was spotted directly 
upon the membrane. Membrane was blocked with 1% BSA/PBS for 1 hour, followed by probing 
with streptavidin-HRP antibody and detection via chemiluminescence.   
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analysis (Figure 4.6). PLL binding and induced condensation does restrict streptaavidin 
access towards the biotin, reducing the signal intensity in comparison to naked biotinylated 
DNA. The limits of detection of biotinylated DNA within complexes was 0.1µg, at least ten 
fold higher than that of free uncomplexed biotinylated DNA (lane 2, Figure 4.6). This is 
consistent with previous studies showing that biotinylation of DNA complexes did not affect 
streptavidin binding and retained biological function (Leahy et al, 1996). However the 
condensation induced by PLL may limit the sensitivity of detection of complexes within the 
cell.   
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6: Dot-blot displaying the effect of PLL condensation on the ability to probe the 
nucleic acid with streptavidin-HRP antibody. SC-pDNA was formulated at a charge ratio of 
+1.6. 
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To study whether labelling is maintained post transfection, labelled complexes were 
transfected within CHO cells and observed via confocal microscopy. Figure 4.7 displays 
confocal microscopy images which show labelled DNA polyplexes (biotinylated DNA 
complexed with PLL) at one hour. CHO cells were also stained (with HCS CellMaskTM – 
cytosol) to show passage of complexes. For all three major topologies (SC-, OC- and linear-
pDNA) DNA observation (far red channel) is quite restricted. Complexes containing 
biotinylated SC-pDNA exhibit limited fluorescence which may be due to the dense structure 
of the topological form, coupled with PLL induced condensation (Figure 4.7a). This may 
culminate in restricted access for the streptavidin probe. A similar observation is also true for 
complexes containing biotinylated OC-pDNA. However linear-pDNA exhibited a much more 
improved signal (Figure 4.7c).  
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Figure 4.7: Fluorescent confocal microscopy imaging of biotinylated DNA complexes when transfected 
within CHO cells. The far red colour was selected in order to distinguish from the Oregon Green labelled PLL. 
SC-pDNA complexes (A), OC-pDNA complexes, (B) and linear-pDNA complexes (C). Polyplexes (containing 
2µg) were produced at charge ratios of +1.6 (SC and OC-pDNA) and +5 (linear-pDNA). The biotinylated DNA 
was probed with a Texas Red labelled streptavidin antibody. CHO cells were stained with HCS CellMaskTM, 
while nuclei were stained with DAPI. Images show polyplexes at 1 hour post transfection. 
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4.2.2 Direct labelling of DNA – intercalating fluorescent dyes 
Although labelling via biotinylation enabled detection of pDNA in the cell, the sensitivity of 
the method was poor. Furthermore the method required permeabilisation and staining of the 
cell with streptavidin conjugates. An alternative direct method of identifying the nucleic acid 
was analysed. Various studies have employed families of fluorescent intercalating dyes, 
major examples of which are the Dimeric Cyanine Nucleic Acid Stains (Invitrogen). These 
dyes are potent intercalating agents which offer great specificity and stability upon DNA 
binding (up to 1000 fold increase in fluorescence when interwoven between DNA strands) 
(Rye et al, 1992). Such dyes offer far more stability (approximately 50 fold greater) than that 
of ethidium bromide, a fellow intercalating agent (Rye et al, 1992). In this study the Dimeric 
Cyanine Nucleic Acid stain; TOTO-3 (excitation: 642nm, emission: 660nm) was employed to 
label the pDNA (Chapter 2, section 2.4.2). This particular far red stain was selected as it can 
be combined with existing dyes employed for other components. Experiments were 
undertaken to test whether such a stain firstly bound to the nucleic acid and also whether 
fluorescent intensity can allow direct detection of DNA for confocal microscopy studies.  
2µg of naked pDNA was treated with 4µM TOTO-3   according   to   the   manufacturer’s  
protocol. In order to detect the stained DNA, samples were spotted onto coverslips coated 
with fluorescently labelled PLL (Figure 4.8). DNA immobilised to the bound PLL and was 
identified by co-localisation of the red (DNA) and green (PLL) fluorescence. Unlike 
biotinylated labelling steps, intercalating dyes bypass probing and washing procedures due to 
their specific affinity. 
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Another method was also employed to visualise the stained DNA. TOTO-3 labelled DNA 
was spotted on coverslips coated with fluorescent beads. These particular beads fluoresce at 
various wavelengths (can be visualised under green, red and blue filters). Figure 4.9 shows 
how the DNA binds to the beads allowing identification of the nucleic acid. Although the 
Figure 4.8: Confocal microscopy observation of TOTO-3 stained DNA. DNA (2µg) was 
stained with TOTO-3 at a final concentration of 4µM. Labelled DNA was spotted onto a PLL 
(50µg/ml) coated coverslip and mounted on a slide for fluorescent confocal microscopy 
analysis. 
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beads can be observed at different fluorescent filters, the DNA is only visualised within the 
far red filter, showing no leakage at differing channels.  
 
 
 
 
 
 
 
 
 
 
 
  
  
In order to further validate the results of Figure 4.9, TOTO-3 labelled DNA was visualised in 
the near red filter which is used to observe the HCS CellMaskTM stain. This experiment is 
important as fluorescence spectra of TOTO-3 and HCS CellMaskTM are quite similar. 
Importantly Figure 4.10 shows no leakage of fluorescence between the different channels 
Far red channel 
DAPI   channel 
Figure 4.9: Confocal microscopy observation of TOTO-3 stained DNA via fluorescent bead 
detection. DNA (2µg) was bound to fluorescent beads and is exclusively identified in the far red 
channel. No fluorescence is leaked into other channels.  
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when analysing labelled polyplex DNA and CHO cells which were fluorescently stained. 
TOTO-3 stained DNA is exclusively visualised in the far red filter (TOTO-3 excitation: 
642nm and emission: 660nm) rather than the near red filter used to visualise the HCS 
CellMaskTM stain (excitation 556nm and emission: 572nm). The aim of this particular 
experiment was to analyse whether fluorescent leakage occurs between the channels, not the 
study of uptake (which is analysed in subsequent chapters). The key take home message from 
this particular experiment is that TOTO-3 labelled DNA fluorescence is not observed when 
viewing the CellMaskTM labelled CHO cells (and vice versa). 
   
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10: Confocal microscopy observation of TOTO-3 stained DNA in far 
and near red channels. Polyplexes containing TOTO-3 stained DNA (2µg) was 
transfected into CHO cells which were stained with HCS CellMaskTM . DNA is 
exclusively identified in the far red channel. No fluorescence is leaked into other 
channels.  
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A control microscope slide was prepared whereby PLL itself (no DNA) was spotted on the 
coverslip mounted on a slide. Separate images of the same slide were taken in both the FITC 
(Oregon Green labelled PLL settings) and far red (TOTO-3 stained DNA) channels (Figure 
4.11). There was no evidence of any spillover of the Oregon Green signal into the TOTO-3 
channel confirming that the signal observed in this channel in Figure 4.8 and Figure 4.9 was 
due to TOTO-3 stained DNA.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11: No spill over of PLL fluorescence in DNA fluorescent channel. Detection of labelled 
PLL (50µg/ml) demonstrating that fluorescence does not spill over into the far red channel when the 
same image is captured under the far red channel thereby confirming no false positive images. 
 
Oregon Green labelled PLL Far red channel 
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4.2.2.1 Identification of TOTO-3 labelled DNA polyplexes post transfection 
Plasmids were labelled with TOTO-3 (4µM) and complexed with PLL. Polyplexes were 
analysed by fluorescent confocal microscopy (Figure 4.12). Regardless of topology the DNA 
is very visible and can be tracked quite quickly, which is critical for further studies. 
Polyplexes were prepared at charge ratios of +1.6 (SC- or OC-pDNA) and +5 (linear-pDNA) 
as these complexes are of equal surface charge and will be employed for further transfection 
studies.  
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A B C 
Figure 4.12: Fluorescent confocal microscopy imaging of TOTO-3 labelled DNA complexes when 
transfected within CHO cells. SC-pDNA complexes (A), OC-pDNA complexes, (B) and linear-pDNA 
complexes (C). Polyplexes (containing 2µg) were produced at charge ratios of +1.6 (SC and OC-pDNA) 
and +5 (linear-pDNA). CHO cells were stained with HCS CellMaskTM, while nuclei were stained with 
DAPI. Images show polyplexes at 1 hour post transfection. 
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4.3 Characterisation of labelled polyplexes                               
Labelling the nucleic acid, either through biotinylation or a DNA intercalating agent coupled 
with PLL binding, which is also labelled, brings up the question as to whether such labelling 
alters the structure of the polyplex or its biophysical characteristics. In order to address this 
issue labelled polyplexes were analysed through a variety of characterisation assays. 
Polyplexes were prepared at charge ratios of +1.6 (for SC- and OC-pDNA) and +5 (for 
linear-pDNA), as deduced from the previous chapter (Chapter 3). 
4.3.1 Size measurements  
The sizes of labelled and unlabelled complexes were measured via dynamic light scattering 
(DLS) (Figure 4.13). Labelling of DNA or polycation (irrespective of DNA topology) does 
not affect size measurements. Regardless of the method of labelling; polyplex size shows 
dependence on DNA topology. The observation that polyplex size is independent of method 
of labelling is important considering its employment as a delivery vehicle. Slight aggregation 
was detected for OC-pDNA complexes (when the DNA was stained with TOTO-3) with 
diameters peaking at 695nm. Mean diameters were larger than those of biotinylated and 
unlabelled samples. This is similar to that of linear-pDNA polyplexes stained with TOTO-3. 
Severe aggregation was recorded for all three linear-pDNA polyplex samples. 
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4.3.2 TOTO-3 fluorescence assay 
The Dimeric Cyanine Nucleic Acid Stain; TOTO-3 is a potent nucleic acid stain, which was 
shown to label DNA to a high degree. One approach to quantifying the level of fluorescence 
of the labelled DNA, was a via a fluorometry assay (Figure 4.14). Labelled and unlabelled 
DNA samples, along with naked and complexed DNA were analysed. The RFU (relative 
fluorescence units) were greatest for naked DNA samples that were stained with the dye 
(regardless of DNA topology). Fluorescence decreased when pre-stained DNA was 
complexed with PLL. This may be due to DNA condensation induced by PLL, which restricts 
DNA intercalation and fluorescence. Unlabelled naked DNA displayed moderate RFU which 
is presumably due to autofluorescence.       
Figure 4.13: DLS measurements of labelled polyplexes. 2µg pDNA was stained with 4µM 
TOTO-3. 2µg DNA was biotinylated at a 0.25:1 v:w ratio of reagent per µg of DNA. Polyplexes 
were prepared at charge ratios of; +1.6 for SC- and OC-pDNA, and +5 for linear-pDNA. The 
figure shows the mean and SE for 10 readings. The figure shows the mean and SE of 5 replicate 
measurements. The experiment was repeated 3 times independently. One-way ANOVA was 
employed to deduce levels of statistical significance (p < 0.05) between labelled and unlabelled 
complexes of differing DNA topologies.  
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4.3.3 Electrophoretic analysis 
Agarose gel electrophoresis was employed to analyse the electrophoretic mobility and 
ethidium bromide (EtBr) fluorescence, and whether labelling affected such parameters. 
Labelling of naked DNA with either TOTO-3 or biotin does not hinder electrophoretic 
mobility pDNA (regardless of topology) (Figure 4.15). As expected electrophoretic mobility 
and EtBr fluorescence is reduced for polyplexes (regardless of labelling) due to PLL induced 
DNA condensation and change in surface charge. EtBr fluorescence is limited for naked 
DNA stained with TOTO-3 (Figure 4.15, lane 1C). This may be due to the pre-existing 
Figure 4.14: Fluorometry assay of TOTO-3 labelled DNA complexes along with unlabelled controls 
at an excitation and emission spectra of 642 and 660nm respectively. 2µg pDNA was labelled with 
4µM TOTO-3 dye. Polyplexes were prepared at charge ratios of; +1.6 for SC- and OC-pDNA, and +5 for 
linear-pDNA. The figure shows the mean and SE of 3 independent experiments. One-way ANOVA was 
employed to deduce levels of statistical significance (p < 0.05) between unlabelled and TOTO-3 stained 
samples.   
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TOTO-3/DNA intertwined strands which may restrict and compete with EtBr for access. The 
results from Figure 4.15 demonstrate that labelling (through biotin or TOTO-3 staining) does 
not alter electrophoretic mobility, and indicates no major disruption to the physical nature of 
polyplexes that could jeopardize the aim of attaining mammalian cell entry.        
 
 
              
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.15: Agarose gel electrophoresis of labelled and unlabelled pDNA (naked and 
complexed). 2µg pDNA was stained with 4µM TOTO-3. 2µg DNA was biotinylated at a 0.25:1 v:w 
ratio of reagent per µg of DNA. Polyplexes were prepared at charge ratios of; +1.6 for SC- and OC-
pDNA, and +5 for linear-pDNA. 
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4.4 Discussion  
In this chapter fluorescent labelling was analysed in regards to visualising both DNA and 
polymer. This is important in terms of monitoring the path taken by the pDNA and PLL and 
whether they share the same intracellular fate post transfection. Moreover in terms of bio-
processing it is important to monitor the DNA cargo and whether it remains intact. This is 
important from regulatory viewpoints and allows greater understanding of the pathway 
undertaken by polyplexes following potential uptake.    
4.4.1 PLL Labelling  
PLL was labelled with a green fluorescent tag which bound via a succinimidyl ester linkage. 
This was done in accordance to Godbey et al, (1999), who observed efficient and sustained 
labelling of PEI. In this study quantitative analysis revealed how PLL was effectively labelled 
(Figure 4.1) and qualitative studies showed how fluorescence can be detected when   ‘mock  
transfected’  into CHO cells (Figure 4.3). This is important in terms of tracking the polymer 
and its association with DNA through dual labelling. Fluorescent labelling plays a central role 
in studies monitoring the trafficking of complexes and gives an insight into the mechanism of 
cellular entry. By fluorescently labelling PEI, endocytic mechanisms of DNA polyplex 
uptake was recorded (Godbey et al, 1999). PLL like many polymers can be covalently 
attached to many fluorophores, allowing effective labelling whilst maintaining native 
function.  
However despite fluorescently labelling PLL via succinimidyl ester linkage, unbound 
polymer can arise which can limit labelling. This requires an additional step to remove 
unbound PLL. Alternative polymer labelling methods include the use of water soluble 
fluorescent dyes such as Cy5, which have been found to effectively label PLL (Lucas et al, 
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2002). The benefits of such dyes include sensitivity which allowed analysis of PLL/DNA 
binding kinetics (Lucas et al, 2002). Polar sensitive fluorescent labels (covalently attached to 
PLL) have recently been employed. These dyes change colour on the basis of the 
environmental polarity and their application has enabled analysis of membrane binding of 
PLL (Postupalenko et al, 2011).    
4.4.2 DNA labelling 
Labelling of nucleic acids is critical in order to follow potential uptake of pDNA. Direct and 
indirect methods of DNA labelling were explored. Indirect labelling was brought about via 
biotinylation and probed by fluorescent streptavidin conjugates. Although detection of DNA 
occurred, the sensitivity of the method was weak (Figure 4.7). In contrast direct labelling of 
DNA was found to be more effective through the use of DNA intercalating agents and 
labelling was maintained during the transfection process (Figure 4.12). Intercalating dyes 
such as TOTO-3 fluoresce only when interwoven between DNA strands. This offers 
specificity and bypasses antibody probing and permeabilisation stages. Moreover such dyes 
have been found to be extremely stable when bound to DNA (Rye et al, 1992). The ability to 
label DNA with TOTO-3 in live and fixed cell analysis was reported previously. TOTO-3 
staining was found to be most effective in samples probed with other fluorophores (Suzuki et 
al, 1997). Using 3-D confocal microscopy fluorescent intercalating dyes have been found to 
be extremely useful in determining DNA ploidy (Ploeger et al, 2008). The TOTO-3 dye 
employed in the present study is part of the Dimeric Cyanine Nucleic Acid Stains family 
(Invitrogen). Fluorophore members of this family exhibit such a strong affinity for DNA that 
studies have employed such dyes to assess structural changes in DNA polyplexes (Wang et 
al, 2001). When polyplexes are produced at high charge ratios, EtBr fluorescence is 
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restricted. However the sensitivity of TOTO-3 allows complexes to be viewed via confocal 
microscopy.   
Although DNA staining through intercalating dyes has led to stable, effective and persistent 
labelling, there are drawbacks. These include safety issues regarding the use of intercalating 
agents, such as handling and disposal (Hardy et al, 1996). Secondly, intercalating dyes such 
as TOTO-3 and EtBr bind non-discriminately to double stranded nucleic acids. Whilst this is 
a benefit, this can also lead to unspecific binding with host cell nucleic acids. These are key 
points to consider for future analyses.   
4.4.3 Alternative methods of labelling 
To track potential uptake of DNA complexes, DNA and PLL were individually labelled to 
observe whether fluorescence co-localises. Although this facilitates dual tracking, there are 
alternative labelling strategies. Specific alternative labelling methods are available which are 
designed to highlight minute amounts of nucleic acids and polymer. These labelling strategies 
have been used to study the kinetics of DNA/polymer interactions. For instance 
anthraquinone dyes (which intercalate and bind to specific DNA regions) have been used to 
distinguish cytoplasmic and nuclear regions within the cell (Edward, 2009). Such dyes have 
previously been used to show via fluorescence correlation spectroscopy (FCS), how 
nucleosome core particles diffuse through high concentrations of DNA to mimic nuclear 
transport (Margenot et al, 2003).    
Semiconductor quantum dots (QDs) have also been used to monitor uptake of pDNA. QDs 
are nanocrystal structures of minute sizes that facilitate labelling and cellular uptake (van 
Driel et al, 2008). Fluorescent QD labelling of pDNA is widely used and offers benefits such 
as displaying high fluorescence and photostability (Srinivasan et al, 2006). QD labelling of 
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pDNA is brought about through linkers that are covalently attached to the plasmid which 
allow binding of multiple QDs. Such methods have facilitated the analysis of CHO cell 
uptake of DNA (Srinivasan et al, 2006). QD attachment to pDNA has been found to increase 
plasmid folding, leading to a decrease in nucleic acid diameter (Zhang and Liu, 2010). 
Further advantages of QD attachment include sustained labelling, thereby allowing long term 
analysis, in which attachment does not jeopardise functionality (Srinivasan et al, 2006). QD 
labelling in uptake studies has proven extremely useful in monitoring chitosan complexes. In 
that particular study attachment of QDs to DNA did not affect gene expression nor increase 
cytotoxicity (Xiang et al, 2007). 
Fluorescence resonance energy transfer (FRET) is the transfer of energy through the emission 
of fluorescence between two close proximity related fluorophores (Haugland et al, 1969). 
Fluorescence emitted on the basis of proximity allows sensitive and very specific detection.  
This proximity dependent mechanism has been exploited for a wide range of applications. 
For instance FRET has been used to study DNA decondensation when separated from its 
respective polymer (Thibault et al, 2010). Often co-localisation of fluorescence may not be 
adequate to confirm interaction and so the sensitive detection offered by FRET is important 
in regards to polyplex dissociation kinetics (Thibault et al, 2010). FRET has also recently 
been applied to study physical compositions of DNA polyplexes. By using FRET, Ko et al, 
(2011) revealed how fractions of polymer remain unbound to pDNA following complexion. 
FRET has been combined with QD labelling to optimise labelling of endosomes to enhance 
knowledge of uptake mechanisms (Delehanty et al, 2011).  
Chemical and molecular biology techniques have been applied to fluorescently dual label a 
single plasmid. Srinivasan et al, (2009) conjugated rhodamine (red) and fluorescein (green) to 
a single plasmid via peptide nucleic acid linkers (similar to the attachment method of QDs). 
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By dual labelling a single plasmid the authors could monitor any cleavage that occurs 
following uptake through separation of fluorescent signals. This is critically important in 
terms of monitoring intact DNA cargo. This could also allow potential observation of any 
incomplete polymer binding. 
Fluorescent labelling of host cells is also important in highlighting the passage of uptake 
regarding DNA complexes. In this study the host cell and cytoplasm were fluorescently 
labelled with a high content screening (HCS) stain to highlight uptake of polyplexes. This 
staining protocol allowed detection of cells following fixation. Cell staining is important as 
nuclear staining alone is not adequate for uptake studies. Cell staining should be non-invasive 
and allow detection of the cell and its contents in its native form. A major advantage of the 
HCS stain is that labelling masks the cells allowing the uptake of complexes to be monitored. 
However a drawback of this stain is its susceptibility to photo bleaching during confocal 
microscopy analysis. Therefore other forms of cellular labelling are of interest. Antibody 
detection of cells has been applied although probing may affect cell functionality. However 
disadvantages do include permeablisation and probing of cells. Aptamers have been applied 
to detect and reversibly label cells (Herr et al, 2006). Aptamers are biotinylated single 
stranded nucleic acids that interact with cell surface markers (Terazono et al, 2010). 
Populations of cells have been successfully identified via fluorescent QD-linked aptamers, 
which allowed for quantification via flow cytometry. This process is advantageous in that it 
avoids invasive probing and labels can be removed via nuclease treatment (Terazono et al, 
2010). 
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4.4.4 Functionality and characterisation 
Retaining biological function is critical post labelling when monitoring uptake of DNA 
complexes. In this chapter labelling through direct or indirect means did not affect 
characteristic features such as polyplex size (Figure 4.13). Electrophoretic analysis revealed 
observation of labelled complexes (by EtBr staining) was similar to unlabelled controls. 
Direct labelling with TOTO-3 was confirmed by reduced EtBr fluorescence, which competed 
with the dye to intercalate within free DNA strands. These findings are consistent with that of 
Slattum et al, (2003) whereby biotinylation and streptavidin labelling of pDNA did not hinder 
polyplex characteristics (such as size and DNA binding). In fact the study by Slattum et al, 
(2003) recorded how gene expression was not affected by DNA biotinylation. Retention of 
transcriptional activity may be due to the ability of RNA polymerase II to maintain 
recognition of modified bases thereby allowing further translational steps to proceed (Leahy 
et al, 1996). 
Therefore in conclusion PLL labelling via Oregon Green labelling proved to be sufficient in 
terms of detecting the  polymer  via  fluorescent  confocal  microscopy  when  ‘mock  transfected’  
into CHO cells. Direct labelling of DNA through fluorescent intercalating dyes was more 
effective than indirect methods such as biotinylation in terms of confocal microscopy 
analysis. Intercalating dyes are more photostable and bypass probing steps. These labelling 
methods are suitable to monitor and study potential uptake of polyplexes for gene delivery 
studies.  
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4.5 Chapter Summary  
 The PLL component of polyplexes was efficiently labelled with Oregon Green and 
was detected by fluorescent microscopy. 
 DNA topology did not affect labelling through either biotinylation or intercalating 
dyes. 
 TOTO-3 was a more sensitive fluorescent stain for polyplex DNA than biotin/avidin 
detection systems and can be used to observe DNA via confocal microscopy. 
Detection of TOTO-3 stained DNA was clearer allowing more sensitive detection for 
confocal microscopy imaging. Confocal microscopy detection of biotinylated DNA 
was restricted.     
 Labelling in the form of either biotinylation (indirect labelling) or TOTO-3 staining 
(direct labelling) did not affect polyplex size.  
 Labelling (direct or indirect) did not affect electrophoretic mobility or ability to be 
detected by ethidium bromide staining. Although pre-stained TOTO-3 naked DNA 
did exclude ethidium bromide intercalation.   
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5. Polyplex uptake within CHO cells 
 
Non-viral gene delivery into mammalian cells is widely used in the biotechnology industry 
for the production of recombinant proteins requiring post translational modifications as well 
as considered for clinical trials in gene therapy vaccination. Gene transfer through such 
means often entails delivery of nucleic acids that are bound to a cationic polymer 
(polycations) resulting in plasmid DNA (pDNA) – polymer products, often referred to as 
polyplexes (Elouahabi and Ruysschaert 2005). Non-viral methods have been tested within 
mammalian cells such as Chinese hamster ovary (CHO) cells, as these cells allow high 
protein expression and can be successfully scaled up in culture (Liu et al, 2008 and Derouazi 
et al, 2004). Short term transient transfection of CHO cells using polycation polyplexes has 
been reported to result in high protein yields (Reisinger et al, 2009, and Schlaeger and 
Christensen, 1999) and successfully scaled up. 
The current study systematically compares the biophysical properties of supercoiled (SC), 
open circular (OC) and linear forms of the same plasmid complexed with poly-L-lysine 
(PLL), focusing on the intracellular uptake of the three types of polyplexes by CHO cells. 
PLL was specifically selected as a gene carrier due to its effective ability to transfect cells 
and recommendation by key studies (Tsai et al, 1999). Advantages of using PLL over other 
polymers include its ease of DNA binding and condensation (Luo and Saltzman, 2000). By 
labeling both nucleic acid and polycation components of the polyplexes, uptake could be 
followed by confocal microscopy.  
In this chapter polyplexes were transfected into CHO cells. This refers to the process of 
introducing foreign nucleic acids into host cells, often with the aim of expressing a desired 
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protein product (Liu et al, 2008). Uptake (defined as the intake of materials by a cell or tissue 
leading to its permanent or temporary retention) of complexes was monitored qualitatively 
and quantitatively.    
5.1 Observation of polyplex uptake  
5.1.1 Confocal microscopy analysis of DNA polyplexes  
Qualitative analysis of polyplex uptake is important. In this experiment fluorescent confocal 
microscopy was used as a tool to monitor polyplex uptake (Figure 5.1). To confirm whether 
polyplex uptake has occurred, images were taken as 3-D sections. Ten sections of each 
image, each of 0.2µm in thickness were taken. Mid section images were taken to confirm true 
polyplex uptake along with projection images of all sections (referred to as z-stack projection 
images). Details are provided in Chapter 2, section 2.6.7.1. DNA polyplexes (containing 2µg 
of pDNA) were transfected into a population of approximately 1 x 106 CHO cells. In order to 
view whether the DNA and PLL share the same cellular fate, the plasmid was pre-stained 
with a far red fluorophore (TOTO-3) while PLL was tagged with a green dye. The cytosol of 
the CHO cells was stained to show the outline of the cell. This was achieved by using HCS 
CellMask™   (Chapter 2, section 2.6.4), a high content screening fluorescent stain which 
specifically stains the cell cytoplasm. The DNA was stained with an intercalating dye; 
TOTO-3, however unlike ethidium bromide clear fluorescence is observed as TOTO-3 is 
approximately 50 fold more sensitive (Rye et al, 1992). DNA polyplexes were classified on 
the basis of their cellular location (through fluorescent co-localisation). Polyplexes were 
classified as to either being within the periphery of the cell (Figure 5.1a), cytosol (Figure 
5.1b) or nucleus (Figure 5.1c). If no fluorescent overlap between the polyplex and the 
CellMask™ occurs, complexes are defined as being at the cell periphery. If some overlap 
between the polyplex and the CellMask™ occurs, complexes are classified as located within 
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the cytosol. Complete overlap between polyplex and nuclear stain is classified as nuclear 
association. Classification of polyplex location was confirmed as it was consistent in both 
stack and mid section images as shown in Figure 5.1.  
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1: Classification of polyplex cellular location in CHO cells. Mid section (A) and stack projection 
images (B). Confocal microscopy analysis showing the location of polyplexes; cell periphery (linear-pDNA 
polyplexes) (i), cytosol (OC-pDNA polyplexes) (ii) and nucleus (SC-pDNA polyplexes) (iii). Complexes 
were prepared at charge ratios (ratio of PLL to DNA) of +1.6 (for SC- and OC-pDNA) and +5 for linear-
pDNA.  Scale bar represents 5µm. CHO cells were fixed with paraformaldehyde, stained and coverslips were 
mounted on slides.       
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5.1.2 Short time course  
Polyplex uptake within CHO cells was monitored for periods up to 60 minutes. Uptake was 
analysed via confocal microscopy (Figure 5.2). No obvious difference was observed in the 
appearance of polyplexes of different topologies. All polyplexes showed dual staining for 
DNA and PLL, suggesting that the PLL remains closely associated with the DNA during 
passage though the cell (Figure 5.2). The route taken by the polyplexes begins at the cellular 
periphery (Figure 5.2a) and culminates with nuclear association (complete overlap between 
polyplex fluorescence and nuclear stain) by 1 hour (Figure 5.2c). At 60 minutes SC-pDNA 
polyplexes associate with the nuclei (Figure 5.2c). This is in contrast to linear-pDNA 
polyplexes whereby at the same time point, are situated at the cell periphery (Figure 5.2a). 
Complexes appear larger than suggested by initial size measurements (Chapter 3, Figure 3.5), 
which may be due to the cellular ionic environment, an observation in line with size 
measurements in high salt solutions (Chapter 3, Figure 3.14).    
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Figure 5.2: Time course of polyplex uptake in CHO cells as observed via confocal microscopy. 
Polyplexes containing linear- (A), OC- (B), and SC- (C) pDNA (2µg). Polyplexes were prepared at 
charge ratios of +1.6 (for SC- and OC-pDNA) and +5 for linear pDNA. Figure shows mid section 
images.  
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Naked DNA controls showed no fluorescence, even by 60 minutes (Figure 5.3). A large 
number of cells were analysed but no fluorescence corresponding to DNA was observed, 
presumably nucleic acids required PLL to gain cellular entry. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 5.3: Transfection of naked pDNA in CHO cells as observed via confocal microscopy. Naked 
linear- (A), OC- (B), and SC- (C) pDNA (2µg). Figure shows mid section images.       
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Although previous figures showed low magnification images of cells (to monitor potential 
polyplex uptake), approximately 30% of cells were transfected with polyplexes. Figure 5.4 
shows a low magnification image of transfected CHO cells. The image displays CHO cells 
transfected with SC-pDNA polyplexes but the proportion of cells transfected is representative 
for complexes of all DNA topologies. However it must be noted although the proportion of 
cells transfected may be similar for all DNA topologies, uptake into different cell 
compartments and gene expression (as shown later in the chapter) can vary between different 
DNA topologies.   
 
 
 
Figure 5.4: Low magnification image showing the proportion of CHO cells transfected. Cells were 
transfected for 30 minutes with complexes containing SC-pDNA (2µg) at charge ratio of +1.6. Figure 
shows mid section images.       
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5.1.3 Extended time course  
An extended time course was studied whereby complexes were transfected within CHO cells 
for a period of 48 hours and analysed via confocal microscopy (Figure 5.5). SC-pDNA 
polyplexes associated with the nucleus (fluorescence co-localised with nuclear fluorescent 
stain; DAPI), whereas OC- and linear-pDNA polyplexes were located within the cytosol and 
periphery respectively. This indicates uptake shows dependence on DNA topology. Also 
unlike Figure 5.2, DNA and PLL fluorescence are independent of each other, indicating 
possible dissociation and degradation of PLL over the extended course.     
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5: Extended time course of polyplex uptake in CHO cells as observed via confocal 
microscopy. Polyplexes containing linear- (A), OC- (B), and SC- (C) pDNA (2µg). Polyplexes 
were prepared at charge ratios of +1.6 (for SC- and OC-pDNA) and +5 for linear pDNA. Figure 
shows mid section images.  
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5.1.4 Reverse transfection 
The CHO cells employed in the present study were adherent cells, i.e. they were attached to 
the tissue culture surface. Transfection of cells involves addition of polyplexes to the cell 
culture media, which is a conventional method of transient transfection referred to as the 
bolus procedure (Bengali et al, 2009). However many immunological and therapeutic target 
cells are non-adherent. Therefore polyplex uptake must be tested through alternative 
transfection methods. One technique is reverse transfection (RT) which involves 
immobilisation of DNA complexes on a cell adhesive substrate followed by the addition of 
cells (Bengali et al, 2009). This method is advantageous in terms of promoting internalisation 
(uptake in cells) and reducing aggregation (Bailey et al, 2002; Bengali et al, 2005). 
Uptake of DNA polyplexes in CHO cells was analysed via RT and visualised by confocal 
microscopy (Figure 5.6). Labelled polyplexes were spotted onto PLL coated coverslips for 1 
hour at room temperature and protected from light. Adherent CHO cells were trypsinized to 
detach from the surface (the trypsin was inactivated by the addition of media), and added to 
the immobilised polyplexes and incubated for the desired period. Co-localisation of 
fluorescence corresponding to PLL and DNA was not well defined indicating partial 
segregation of the components. Uptake of polyplexes via RT was monitored by confocal 
microscopy, whereby at 60 minutes complexes containing SC-pDNA, were beginning to 
associate with the nucleus (Figure 5.6a). At 60 minutes post transfection OC- and linear-
pDNA complexes were located within the cytosol (Figure 5.6b and 5.6c).  
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Figure 5.6: Time course of polyplex uptake in CHO cells via reverse transfection (RT). Confocal 
microscopy analysis of polyplexes containing SC- (A), OC- (B) and linear- (C) pDNA within CHO cells 
at varying time points. Polyplexes containing 2µg pDNA were spotted onto PLL coated coverslips for 1 
hour at room temperature in the dark. CHO cells were trypsinised and loosened, and then added to 
complexes. Cells were incubated at 37°C for the desired period. Subsequently cells were fixed, stained 
and mounted upon slides. Figure shows mid section images.        
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DNA polyplexes were reverse transfected for an extended period of 48 hours (Figure 5.7). 
Complexes containing SC-pDNA were found to be associated with the nuclei (Figure 5.7a), 
whereas those containing OC- and linear-pDNA were situated at the cell periphery 
respectively. This indicates polyplex uptake may be dependent on DNA topology. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 5.7: Extended time course of polyplex uptake in CHO cells via reverse transfection (RT).  
Confocal microscopy analysis of polyplexes containing SC- (A), OC- (B) and linear- (C) pDNA within CHO 
cells at varying time points. Polyplexes contained 2µg pDNA. Figure shows mid section images. 
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5.2 Quantification of polyplex uptake and gene expression 
The previous figures identified the uptake of polyplexes within CHO cells at various time 
points. However such results required quantification in order to deduce the efficiency of 
polyplexes to gain CHO cell access and induce gene expression (transcription of plasmid 
encoded gene). 
5.2.1 Quantification of DNA polyplex uptake within CHO cells 
The findings from Figure 5.2 were quantified, whereby polyplexes which were transfected 
(via bolus procedure) into CHO cells were analysed via confocal microscopy and the number 
of cell associated complexes were counted and classified on the basis of their intracellular 
location (Figure 5.1). The percentage of complexes within each cellular compartment is 
shown in Figure 5.8. At 10 minutes post transfection, majority of polyplexes regardless of 
DNA topology are situated at the outer periphery of the cell (Figure 5.8). SC-pDNA 
polyplexes enter the cell cytosol by 20-30 minutes and can be observed within the nucleus by 
60 minutes. OC-pDNA complexes display a similar pattern, although uptake and nuclear 
association were less efficient. In contrast entry of linear-pDNA polyplexes is much less 
efficient with very few nuclear associated complexes compared to that of the SC form. 
Details of quantification methodology are provided in Chapter 2, section 2.6.7.3. 
Quantification of polyplex uptake and classification of intracellular location was also 
deduced for polyplexes transfected into CHO cells for an extended time period of 48 hours 
(Figure 5.9). Half of all polyplexes containing SC-pDNA were associated with the nuclei 
with the remainder of complexes predominantly situated within the cytosol. The percentage 
of nuclear associated polyplexes decreased for complexes containing OC- and linear-pDNA 
emphasising the influence of pDNA topology on the efficiency of polyplex cellular uptake. It 
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must be noted though, that nuclear association does not necessarily correspond to gene 
expression due to various molecular barriers and presence of nucleases.          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8: Quantification of polyplex uptake in CHO cells for up to 1 hour. Polyplexes 
(containing 2µg DNA) were prepared at charge ratios of +1.6 (for SC- and OC-pDNA) and +5 for 
linear pDNA. The figure shows the mean and standard error (SE) of 3 independent experiments. 
One-way ANOVA was employed to deduce levels of statistical significance (p < 0.05) between 
complexes of differing DNA topologies in different cell compartments. 
Figure 5.9: Quantification of polyplex uptake in CHO cells at 48 hours. Polyplexes (containing 2µg 
DNA) were prepared at charge ratios of +1.6 (for SC- and OC-pDNA) and +5 for linear pDNA. The 
figure shows the mean and SE of 3 independent experiments. One-way ANOVA was employed to 
deduce levels of statistical significance (p < 0.05) between complexes of differing DNA topologies in 
different cell compartments. 
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5.2.2 CHO cell polyplex gene expression studies 
In this study PLL/DNA polyplex uptake was analysed and quantified by confocal image 
analysis. Non-viral gene delivery and gene expression within CHO cells is important 
particularly in the biopharmaceutical industry whereby CHO cells are often employed for 
recombinant protein production. To analyse the efficiency of PLL/DNA polyplex uptake 
efficiency, polyplex gene expression was measured. The pDNA encodes a lacZ reporter gene 
for β-galactosidase which was measured by X-Gal staining via light microscopy (Chapter 2, 
section 2.6.3). Figure 5.10 shows light microscopy images of β-galactosidase positive cells 
(following X-gal staining) after transfection and gene expression of SC-pDNA polyplexes.  
 
 
 
 
 
 
 
 
 
 
 
Figure 5.10: β-galactosidase detection following staining with X-gal. SC-pDNA polyplexes (containing 
20µg DNA) were transfected into CHO cells for a period of 48 hours to induce gene expression. The 
figure shows non-transfected cells (A) and transfected cells (B) when stained with X-gal. Complexes were 
prepared at charge ratios of +1.6. Scale bar represents 20µm. Images were taken on a Ti-E light 
microscope (Nikon) connected with a Fi-1 CCD camera (Nikon) as described in Chapter 2, section 2.6.3.     
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5.2.2.1 Dose and time dependent course 
To deduce the optimal conditions for gene expression, polyplexes containing DNA of varying 
concentrations were transfected into CHO cells. Gene expression (plasmid encodes a lacZ β-
galactosidase reporter gene) was measured at various time points. Gene expression was found 
to be dependent on dose and DNA topology with complexes containing SC-pDNA displaying 
increased gene expression (Figure 5.11). Optimal gene expression occurs at 48 hours post 
transfection which is concentration dependent. These conditions can then be applied for 
further gene expression analysis.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11: Time and dose dependent gene expression preliminary assay. Polyplexes were 
prepared in 1mM HEPES (pH 7.5). The figure shows the mean and SE of 3 independent experiments. 
One-way ANOVA was employed to deduce levels of statistical significance (p < 0.05) between 
complexes of differing DNA topologies. 
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5.2.2.2 CHO cell polyplex gene expression  
Gene expression of polyplexes of equal surface charge in CHO cells was measured (Figure 
5.10). Gene expression was topology dependent which was highest for that of SC- and OC-
pDNA polyplexes (which were not significantly different to each other p > 0.05). However 
polyplexes containing linear-pDNA were much less efficient in inducing gene expression. 
Complexes containing linear-pDNA were not significantly different to that of naked DNA 
controls highlighting topology dependent gene expression.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.12: Polyplex gene expression within CHO cells. 10µg polyplex DNA was transfected into 
CHO cells for 48 hours. Polyplexes were prepared at charge ratios of +1.6 for SC- and OC-pDNA 
polyplexes and +5 for linear-pDNA polyplexes (1mM HEPES [pH 7.5]). The figure shows the mean 
and SE of 3 independent experiments. One-way ANOVA was employed to deduce levels of statistical 
significance (p <   0.05)   between   complexes   of   differing   DNA   topologies.   Student’s   t-test was 
employed to deduce levels of statistical significance (p < 0.05) between SC- and OC-pDNA 
polyplexes.   
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5.2.2.3 Gene expression at a short time course 
Polyplexes were transfected into CHO cells for shorter times and analysed for gene 
expression (Figure 5.13). By 10 minutes complexes containing SC-pDNA were able to 
induce  β-galactosidase gene expression and even more so by 1 hour. Rapid gene expression 
as early as 1 hour was also reported by Stechschulte et al, (2001) when administering pDNA, 
highlighting the potential of pDNA to be rapidly transcribed. Expression remains topology 
dependent indicating the effective nature of complexes to gain cellular and nuclear access.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.13: Polyplex gene expression within CHO cells for time periods of up to 1 hour. 
10µg polyplex DNA was transfected into CHO cells. Polyplexes were prepared at charge ratios of 
+1.6 for SC- and OC-pDNA polyplexes and +5 for linear-pDNA polyplexes (1mM HEPES [pH 
7.5]). The figure shows the mean and SE of 3 independent experiments. One-way ANOVA was 
employed to deduce levels of statistical significance (p < 0.05) between complexes of differing 
DNA topologies.  
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5.2.2.4 Gene expression at an equal charge ratio 
Polyplex charge ratio (ratio of polymer to DNA) is important in terms of converting the 
negative charge of DNA to a positive charge to facilitate cellular entry. In agreement with 
previous studies (Cherng et al, 1999), SC- and OC-pDNA gives enhanced gene expression 
when the charge for all three complexes are similar; +1.6 for SC- and OC-pDNA, and +5 for 
linear-pDNA (Figure 5.12). However even when the charge ratio for all three complexes are 
the same, gene expression remained topology dependent, which was highest for complexes 
containing SC-pDNA (Figure 5.14). High charge ratio complexes (+5) resulted in lower gene 
expression, whereby at charge ratios of +1.6, gene expression increased twofold.   
 
 
 
 
 
 
 
 
 
 
  
Figure 5.14: Gene expression of polyplexes at equal charge ratios. 10µg polyplex DNA was 
transfected into CHO cells. Polyplexes were formulated at charge ratios of either +1.6 or +5 (1mM 
HEPES [pH 7.5]). The figure shows the mean and SE of 3 independent experiments. One-way ANOVA 
was employed to deduce levels of statistical significance (p < 0.05) between complexes of differing 
DNA topologies at different charge ratios.  
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5.3 Mechanisms of uptake  
In order to study the cellular uptake of polyplexes and its intracellular fate, it is important to 
analyse the mechanisms by which DNA polyplexes are taken up by mammalian cells. The 
literature widely credits the mechanism of endocytosis as means of polyplex cellular entry 
(Pichon et al, 2010). Endocytosis refers to the means by which extracellular molecules enter 
cells (Gould and Lippincott-Schwartz, 2009; Pinchon et al, 2010). Endocytosis can generally 
be subdivided into two branches; the clathrin mediated endocytic (CME) pathway and the 
clathrin independent pathway, such as the caveolae pathway (Rejman et al, 2005). The CME 
pathway involves the formation of clathrin coated pits upon the host cell membrane which 
acts as a docking site for foreign materials (Rejman et al, 2005). These pits eventually form 
into small vesicles which fuse with early endosomes. In contrast the caveolae pathway 
involves the formation of lipid raft structures that interact with incoming complexes, and 
pinch off the membrane to yield vesicle like structures referred to as caveosomes which link 
with early endosomes (Khalil et al, 2006). To deduce the mechanism by which DNA 
polyplexes gain cellular access, known chemical inhibitors of each pathway were employed 
to knock out respective pathways. Quantitative analysis of fluorescent confocal localisation 
and gene expression studies were carried out.  
5.3.1 Gene expression of polyplexes within endocytic inhibitor treated CHO cells 
Gene expression of polyplexes within CHO cells, which were treated with endocytic 
inhibitors was measured (Figure 5.15). Two endocytic inhibitors were employed; 
chloropromazine (CMZ), which blocks Rab5 early endosome development of the CME 
pathway, and genistein which blocks the recruitment of dynamin-1, which is important for 
lipid raft formation of the caveolae pathway (Khalil et al, 2006). The amount of CMZ and 
genistein applied were 10µg/ml and 400µM respectively as deduced from Vercauteren et al, 
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(2010). Addition of both chemical inhibitors significantly reduced gene expression when 
compared to non-treated controls (p < 0.05). Gene expression remained topology dependent 
and despite the addition of both inhibitors the percentage of cells expressing the reporter gene 
remained >15% for SC-pDNA polyplexes (Figure 5.15). 
 
 
 
 
 
 
 
 
 
 
  
5.3.2 Confocal image analysis and quantification    
Fluorescent confocal microscopy analysis was carried out in order to quantify polyplex 
uptake in cells treated with endocytic inhibitors. Throughout the time course and regardless 
of DNA topology, the majority of DNA polyplexes were located on the cellular periphery in 
cells treated with either CMZ or genistein (Figure 5.16). By 60 minutes SC-pDNA polyplex 
Figure 5.15: Polyplex gene expression in CHO cells treated with endocytic inhibitors. 10µg 
polyplex DNA was transfected into CHO cells treated with either 10µg/ml chloropromazine (CMZ) or 
400µM genistein. The figure shows the mean and SE of 3 independent experiments. The figure shows 
the mean and SE of 3 independent experiments. One-way ANOVA was employed to deduce levels of 
statistical significance (p < 0.05) between inhibitor treated cells transfected with polyplexes and 
untreated controls. 
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nuclear association was <30% in CMZ treated cells (Figure 5.16a). In regards to cells treated 
with genistein, polyplex nuclear association was not recorded (Figure 5.16b). However by 1 
hour complexes containing OC- and SC-pDNA were predominantly located within the 
cytosol unlike that of linear-pDNA complexes (Figure 5.16b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 5.16: Quantification of polyplex uptake in CHO cells treated with endocytic inhibitors. 
Polyplex (containing 2µg pDNA) uptake in cells treated with either chloropromazine (A) and genistein 
(B). The figure shows the mean and SE of 3 independent experiments. The figure shows the mean and 
SE of 3 independent experiments. One-way ANOVA was employed to deduce levels of statistical 
significance (p < 0.05) between complexes of differing DNA topologies in different cell compartments. 
 
 
Chapter 5 Polyplex 
uptake within 
CHO cells 
 
162 
 
5.3.3 Control experiments to validate endocytic inhibitors  
The previous experiments used endocytic inhibitors to gain insight into the mechanism of 
polyplex uptake. The addition of inhibitors to cells reduced both uptake and gene expression. 
However it is important to deduce whether chemical treatment to cells could cause indirect 
effects leading to a decrease in uptake and gene expression, or specifically block the pathway 
of interest. A series of control experiments were carried out whereby CHO cells were treated 
with known characterised markers of both the CME and caveolae pathway, and whether 
uptake is reduced when the inhibitor of interest is added.   
5.3.3.1 Confocal microscopy analysis    
To deduce the specificity of CMZ in terms of only inhibiting the CME pathway, a well 
characterised marker; transferrin (Tran) (Nagabushana et al, 2010) conjugates were added to 
CHO cells. Cells were also treated with cholera toxin subunit B (CTB) conjugates which is a 
marker for the caveolae pathway. Tran is a glycoprotein that binds and delivers iron atoms 
via the CME pathway (Nagabushana et al, 2010). CTB is marker for lipid raft formation of 
the caveolae pathway (Skretting et al, 1999). Endocytic markers were added to CHO cells 
according to the protocols of Nagabushana et al, (2010) and Skretting et al, (1999) (Chapter 
2, section 2.6.6). Uptake was observed via confocal microscopy and the addition of chemical 
inhibitors reduces fluorescence corresponding to the respective endocytic marker (Figure 
5.17). Both Tran (Texas red) and CTB (FITC-green) fluorescence is reduced when the 
appropriate inhibitor is added suggesting possible knockdown of the endocytic pathway of 
interest. Importantly despite the addition of inhibitors, uptake of other markers corresponding 
to alternative pathways was not jeopardised. For example addition of CMZ (CME inhibitor) 
to cells did not hinder CTB uptake (caveolae marker) (Figure 5.17b).  
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Figure 5.17: Addition of commercial endocytic markers to CHO cells in the presence of endocytic 
pathway inhibitors. Confocal microscopy images displaying uptake of endocytic markers; Transferrin 
(Tran) (red) and cholera toxin subunit B (CTB) (FITC-green) without any inhibitors (A), in the presence 
of chloropromazine (CMZ) only (B) and genistein only (C). Endocytic markers were added at a final 
concentration of 10µg/ml. DAPI was used to stain the nuclei. Markers were added to CHO cells for 20 
minutes at 37°C. Cells were then fixed and mounted upon slides. Figure shows mid section images.    
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5.3.3.2 Flow cytometry analysis  
The fluorescent signal intensities corresponding to the endocytic markers were measured in 
cells treated with the respective inhibitor (Figure 5.18). Flow cytometry was used to measure 
this against a set of control CHO cells (with no inhibitors) that were treated with the 
respective markers. Treatment with inhibitors did reduce uptake of the respective markers as 
shown by the negative shift in fluorescent signals, and did not jeopardise uptake of markers 
exploiting differing endocytic pathways (positive fluorescent signal shift). For instance the 
addition of CMZ which inhibits the CME pathway, reduces transferrin fluorescence (marker 
for the CME pathway), while that of CTB (caveolae pathway marker) is not compromised. 
This is important in terms of validating the previous inhibition studies. 
 
 
 
 
 
Figure 5.18: Flow cytometry validation of commercial endocytic markers. Known commercial 
fluorescent endocytic markers (Transferrin - Tran, and cholera toxin subunit B - CTB) were added to 
CHO cells and analysed as to whether chemical inhibitors could reduce uptake, hence fluorescent 
intensity. CHO cells were treated with either 10µg/ml chloropromazine (CME inhibitor) or 400µM 
genistein (caveolae inhibitor) prior to addition of markers.        
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5.3.4 Tracking of polyplexes and endocytic markers         
5.3.4.1 Uptake of polyplexes and markers 
Both uptake and gene expression of DNA polyplexes were perturbed when CHO cells were 
pre-treated with either CMZ or genistein. These results suggest polyplexes regardless of 
DNA topology, may be exploiting both endocytic pathways (CME and caveolae). To further 
investigate, DNA polyplexes were transfected into CHO cells along with known endocytic 
markers to observe if uptake is parallel. DNA polyplexes were prepared whereby only the 
DNA itself was fluorescently labelled (PLL was not tagged to avoid confusion with 
fluorescently labelled markers). Figure 5.19 shows uptake of DNA polyplexes along with the 
addition of CTB and transferrin. DNA fluorescence co-localises with that of the fluorescently 
labelled markers, particularly in the case of the caveolae marker; CTB. The figure displays 
co-localisation of endocytic markers with DNA polyplexes, containing SC-pDNA, although it 
must be noted such observations were representative for other DNA topologies.  
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Figure 5.19: Co-transfection of polyplexes and endocytic markers within CHO cells. 
Polyplexes (containing 2µg pDNA) with: Transferrin - Tran (A) and cholera toxin subunit B 
- CTB (B). Both markers were added at a final concentration of 10µg/ml. DAPI was used to 
stain the nuclei. Polyplexes and endocytic markers were transfected for a period of 20 
minutes. Figure shows mid section images.   
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5.3.4.2 Caveolin-1 
To further validate the results of Figure 5.19, DNA polyplexes (of various DNA topologies) 
were transfected into CHO cells which were fluorescently stained with anti-caveolin-1 
antibodies. Caveolin-1 has been reported to play a critical role in membrane invagination 
which ultimately leads to the formation of caveosomes (Liu et al, 2002). Polyplex uptake was 
monitored over a short time course via confocal microscopy (Figure 5.20). Unlike previous 
results clear co-localisation is not observed between DNA and anti-caveolin antibody 
fluorescence at early stages of transfection. This could suggest other pathways of uptake may 
be exploited.  
 
 
 
 
 
 
 
 
 
 
 
Chapter 5 Polyplex 
uptake within 
CHO cells 
 
168 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A
B
C
Figure 5.20: Transfection of polyplexes in cells stained with fluorescent anti-caveolin-1 
antibodies. Uptake of SC- (A), OC- (B), and linear- (C) pDNA polyplexes (containing 2µg pDNA) 
within cells stained with anti-caveolin-1 antibodies. Primary caveolin-1 antibody (20µg/ml) was added 
to cells overnight at 4°C and then probed with an anti rabbit IgG (H+L) secondary FITC conjugated 
antibody. Figure shows mid section of images. 
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5.3.4.3 Rab5 early endosome tracking 
To confirm whether polyplexes exploit the CME pathway, complex uptake was studied in 
cells stained with anti-Rab5 antibodies. Rab5 is a small GTPase that mediates the fusion of 
cellular vesicles with early endosomes which is a key step of the CME pathway (Zerial and 
McBride, 2001). Figure 5.21 shows fluorescently labelled polyplexes when transfected in 
cells stained with anti-Rab5 antibodies. No clear definitive co-localisation between secondary 
anti-Rab5 and DNA fluorescence was observed. DNA polyplexes seem to be much larger 
than that of endosomes suggesting alternative routes of cellular transportation following 
initial entry. Rab5 fluorescence is very sporadic whereas polyplex DNA is quite defined and 
larger.  
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Figure 5.21: Transfection of polyplexes in cells stained with fluorescent anti-Rab5 antibodies. 
Uptake of SC- (A), OC- (B), and linear- (C) pDNA polyplexes (containing 2µg pDNA) within cells 
stained with anti-Rab5 antibodies. Primary Rab5 antibody (10µg/ml) was added to cells overnight at 
4°C and then probed with an anti   rabbit   IgG  (H+L),  F(ab’)2 fragment FITC conjugated antibody. 
Figure shows mid section images. 
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5.4 Discussion  
The present chapter focused on the potential uptake of DNA polyplexes within CHO cells 
and analysed the key factors that affect cellular uptake and gene expression. Understanding 
the key parameters that affect polyplex uptake along with the molecular mechanisms utilised 
to gain cellular entry is critical. This is important as CHO cells are widely employed for 
recombinant protein production (Liu et al, 2008). Polyplex uptake was monitored at various 
time points, qualitatively tracked, quantitatively analysed in terms of confocal image analysis 
and gene expression. Finally the mechanisms responsible for polyplex uptake are reported. If 
the detailed parameters of polyplex CHO cell uptake are understood, gene delivery for 
therapeutic purposes can be significantly enhanced. 
5.4.1 Polyplex uptake within CHO cells 
In this study PLL/DNA polyplex uptake in CHO cells was monitored qualitatively and 
quantitatively. Parameters such as DNA topology, charge ratio and uptake mechanisms were 
studied. The PLL polymer and DNA were individually labelled to track cellular uptake via 
fluorescent confocal microscopy. Polyplexes were classified on the basis of their cellular 
location as to being located within the cellular periphery, cytosol or nucleus (Figure 5.1). 
This was confirmed by identification in both mid section and stack projection images by 
fluorescent confocal microscopy in order to identify true polyplex uptake. DNA and PLL 
fluorescence remained co-localised following uptake for periods up to 1 hour (Figure 5.2). 
Following an extended time period co-localisation was not definitive (Figure 5.5). This may 
be due to polymer separation or degradation over the course of uptake. Complexes appear 
larger than initial size measurements (Chapter 3, Figure 3.5), presumably due to the cellular 
ionic environment, an observation in line with size measurements when polyplexes were 
formed in high salt solutions (Chapter 3, Figure 3.14). Therefore it is intriguing to speculate 
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how complexes of such large sizes enter the nuclei to induce gene expression. Studies have 
shown how large viral DNAs attain nuclear access through the exploitation of importin-7, 
which is a key nuclear transport receptor (Zaitseva et al, 2009). Polyplexes have been 
observed to associate with various importin proteins in a manner similar to large viral DNA 
structures (Breuzard et al, 2008).   
Although both TOTO-3 and DAPI bind to DNA, TOTO-3 labelled DNA did not stain with 
DAPI which could be due to the difference in fluorescent spectra. In this study pDNA was 
pre-stained with TOTO-3 prior to PLL binding. TOTO-3 only fluoresces when bound to 
nucleic acids and DNA condensation by PLL may restrict detection within the fluorescent 
spectra corresponding to DAPI. Furthermore TOTO-3 is a more sensitive fluorescent stain 
than DAPI which could lead to increased detection for TOTO-3 than DAPI. 
Qualitative (Figure 5.2) and quantitative (Figure 5.8) analysis of confocal microscopy images 
show topology dependent uptake whereby complexes containing SC-pDNA were most 
efficient in associating with the nuclei. Although Figure 5.8 shows approximately 60% of 
SC-pDNA polyplexes associated with the nucleus, this does not immediately correspond to 
gene expression whereby the percentage of SC-pDNA complex gene expression was <40% 
(Figure 5.12). Following nuclear association and uptake, gene expression can still be 
hindered through nuclease cleavage and DNA retention of the polycation which could restrict 
transcriptional access (Ko et al, 2011). Polyplexes containing OC- and linear-pDNA were 
often situated on the outer periphery of the cells (Figure 5.8). This uptake pattern may be due 
to a variety of reasons:  
 The increased stability of the SC-pDNA polyplex within the cytosol of the cells may 
facilitate rapid diffusion towards the nuclei (Remaut et al, 2006).  
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 This was also observed when polyplexes were transfected for extended periods 
(Figure 5.9).  
 Findings in Chapter 3 revealed how SC-pDNA polyplexes were smaller in size 
(<200nm) in comparison to OC- (>300nm) and linear-pDNA complexes (<1000nm), 
and displayed greater nuclease resistance, which collectively may enhance cellular 
uptake and subsequent in vivo passage.  
 Xie and Tsong (1993) reported the increased susceptibility of linear-pDNA towards 
cytosolic nucleases than SC-pDNA, which ultimately led to reduced gene expression.  
The observation of a rapid and efficient cellular uptake pattern for SC-pDNA polyplexes is 
consistent with that of Shen et al, (2006). In that study the authors found how DNA diffusion 
was both size and topology dependent. Complex sizes of 181nm (radius) were reported which 
may aid cellular uptake (Shen et al, 2006). The present study revealed how SC-pDNA 
polyplexes displayed the smallest diameters, greatest nuclease resistance and effective DNA 
packaging (Chapter 3) which could all contribute towards the uptake results observed. The 
small and compact size of the SC-pDNA polyplex could facilitate entry across the plasma 
membrane (Zhang et al, 2008). Few studies have analysed the effect of DNA topology on 
polyplex characterisation and uptake in mammalian cells, but those that have concluded SC-
pDNA displays beneficial characteristics that enhance uptake and gene expression which are 
summarised in Table 5.1. For example studies analysing DNA topology have reported 
smaller complex sizes for those containing SC-pDNA, which may enhance cellular uptake 
(Table 5.1). Therefore results of the current chapter strongly suggest uptake is dependent on 
DNA topology with SC-pDNA displaying characteristics that would favour non-viral gene 
delivery. 
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However when analysing lipoplex uptake, cell association was most efficient for OC-pDNA 
(Chancham and Hughes, 2001). Therefore other factors could play a role in cellular uptake 
and should not be discounted. Also DNA uptake was also found to be independent of DNA 
topology in another previous study (Hsu and Uludag, 2008). Polyplexes of differing DNA 
topologies were significantly different in terms of size and so each may exploit specific 
independent uptake mechanisms leading to different uptake patterns (Hsu and Uludag, 2008). 
5.4.2 CHO cell polyplex gene expression  
For polyplex gene delivery to be viable tool in bio-processing, complexes must induce strong 
and sustained gene expression. The current chapter analysed gene expression under a range of 
conditions and parameters to deduce the ability of DNA polyplexes to undergo gene 
transcription.  
5.4.2.1 Gene expression is dependent on DNA topology  
PLL/DNA polyplexes were transfected into CHO cells for a period of 48 hours and plasmid 
reporter gene expression was highest for complexes containing SC-pDNA (Figure 5.12). OC-
pDNA polyplex gene expression was slightly lower followed by linear-pDNA polyplexes, 
which was significantly lower than that of the SC form (p < 0.05). The topology dependent 
results provide key insights in regards to polyplex gene expression. Firstly the data indicates 
that DNA in the SC conformation is more readily transcribed than OC- or linear-pDNA. 
Secondly the ability of SC-pDNA polyplexes to be efficiently taken up in CHO cells and 
transported from cell periphery to the nucleus will enhance the likelihood of gene expression 
to occur, unlike that of linear-pDNA complexes (Figure 5.8). Thirdly, the effectiveness of 
SC-pDNA complexes to diffuse through the cell could lead to higher intracellular 
concentrations that increase the probability of attaining nuclear entry (Remaut et al, 2006). 
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Complexes containing SC-pDNA were found to be significantly smaller than OC- and linear-
pDNA polyplexes, and this may facilitate nuclear pore entry (Kreiss et al, 1999). Previous 
reports found how transient gene expression and long term integration was greater for SC-
pDNA, than linear-pDNA (Xie and Tsong, 1993). The SC and OC forms only differ by a 
nicked strand rather than a double stranded break (Remaut et al, 2006). Both SC- and OC-
pDNA complexes were quite resistant to nuclease attack (Chapter 3, Figure 3.11) which may 
ultimately aid preservation of the DNA cargo, and hence enhance gene expression (Quaak et 
al, 2009 and Shen et al, 2006). The topology dependent gene expression data reported in this 
study in addition to further uptake studies are in line with previous results and summarised in 
Table 5.1. Previous reports such as Cherng et al, (1999) reported topology dependent gene 
expression. Interestingly Hsu and Uludag (2008) reported just over 90% EGFP positive cells 
following uptake of PEI/DNA complexes. This indicates that uptake may be due to topology 
although Hsu and Uludag (2008) reported no significant difference in expression when 
transfection time increased. Therefore uptake and expression could be due to DNA dose 
which could increase the DNA concentration entering the nuclei.  
Although linear-pDNA complexes were susceptible to nuclease cleavage, its open and 
accessible structure does make it available for transcription factors to induce gene expression 
(Hsu and Uludag, 2008). This may account for the modest gene expression detected. Linear-
pDNA may also self ligate leading to formation of structures similar to OC-pDNA, which 
may improve gene expression (Cherng et al, 1999). Despite reporting superior gene 
expression for complexes containing SC-pDNA, DNA topology did not significantly affect 
complex uptake, with more emphasis placed on other factors such as size (Hsu and Uludag, 
2008).        
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To understand why the SC form is more successful at inducing gene expression, the 
degradative pathways of pDNA must be considered. Maintenance of the plasmid 
phosphodiester bond is important as cleavage of this can lead to the conversion of different 
pDNA forms (Middaugh et al, 1998).  Depurination  and  β-elimination (cleavage of nucleotide 
backbone) have been cited as the main cause of pDNA degradation in vivo causing breakage 
of the phosphodiester chain (Lindhal and Karlstrom, 1993). These events are accelerated at 
low pH environments in vivo, and so protection of the pDNA backbone is vital. It may be that 
the compact nature of the SC form coupled with PLL induced condensation protects against 
this, thereby maintaining structural integrity.  
5.4.2.2 Polyplex charge ratio  
Polyplex charge ratio (ratio of polymer to DNA) is important in terms of converting the 
negative charge of DNA to a positive charge to facilitate cellular entry. In the present study, 
polyplexes containing SC- and OC-pDNA were produced at charge ratios of +1.6. This 
particular charge ratio was recommended by previous biophysical polyplex studies (Tsai et 
al, 1999). In that study the authors reported efficient DNA condensation, reduced sizes and 
strong cationic charge for the given charge ratio, which are characteristics favourable for 
gene delivery (Tsai et al, 1999). Previous studies formulated PEI complexes at a charge ratio 
of +1.6, and reported complex sizes of only 20nm, which contributed to effective uptake and 
gene expression (Dunlap et al, 1997). Linear-pDNA required a higher charge ratio (greater 
concentration of PLL) to undergo charge neutralisation and even when the charge ratio was 
equal, gene expression remained highest for SC-pDNA polyplexes (Figure 5.14). In fact 
when the charge ratio increased to +5 for all three DNA forms, gene expression decreased by 
approximately 50%, suggesting greater amounts of PLL may jeopardise DNA uptake. 
Although experiments were identical to that of Figure 5.12, linear-pDNA polyplexes 
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displayed approximately 10% reduction in gene expression. This may highlight how such 
complexes are susceptible to degradation and unstable. Furthermore at high charge ratios it 
has been shown that increasing the amount of polymer leads to a rise in complex aggregation, 
which hinders gene expression (Christie et al, 2010). Despite displaying similar gene 
expression profiles to that of SC-pDNA, OC-pDNA polyplexes were much larger in size 
(>300nm) (Chapter 3, Figure 3.5). This indicates that other factors, along with complex size 
may contribute towards gene expression such as nuclease resistance and stability. Therefore 
when formulating DNA polyplexes it is essential to compromise between the amount of 
polymer and DNA in order to avoid hindering uptake.  
5.4.2.3 Short term gene expression 
Polyplex gene expression was rapid and was detected within 20-60 minutes (Figure 5.13). 
Although administered by pressure injection, Stechschulte et al, (2001) reported gene 
expression as early as one hour with naked pDNA. A recent study revealed how a large 
population of enhancers can be stimulated to induce gene expression programmes. These 
gene expression programmes have been found to elicit rapid sequential gene expression 
during cell development, differentiation and stress (Wang et al, 2011). Such events may be 
triggered during uptake of DNA. Furthermore studies have reported rapid gene expression 
whereby PEI/DNA polyplex gene expression was measured as early as 30 minutes post 
transfection (Koyama et al, 2010). Although the early detection could also be due to 
background   staining   for   β-galactosidase, this is unlikely to impact on studies as gene 
expression clearly shows dependence on DNA topology. Moreover staining with X-gal shows 
a  clear  difference  between  cells  positive  and  negative  for  β-galactosidase (Figure 5.10).            
5.4.2.4 Bolus transfection vs. reverse transfection 
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Polyplex uptake and gene expression were measured in CHO cells that were adherent to the 
tissue culture surface. Adherent CHO cells in culture media were supplemented with DNA 
polyplexes (referred to as bolus transfection). However CHO cells employed for recombinant 
protein production and other key primary cell lines are also non-adherent. Alternative 
transfection techniques are required. Using confocal microscopy this chapter revealed 
successful uptake of polyplexes within CHO cells suspended in culture. This occurred via 
reverse transfection (RT), which involves immobilisation of the polyplex to the culture 
surface for a given period, and supplementing with suspended cells (Bengali et al, 2009). 
Polyplexes uptake was monitored for periods of up to 1 (Figure 5.6) and 48 hours (Figure 
5.7). Uptake of complexes seemed to occur in a topology dependent manner with SC- and 
OC-pDNA complexes associating with the nuclei. RT has advantages in that direct addition 
of cells enhances uptake and reduces aggregation (Shea et al, 1999). The conventional bolus 
transfection procedure, although widely employed for reliable gene uptake studies does fall 
short in the direct delivery of polyplexes to cells (Bengali et al, 2009). RT operates by surface 
binding of complexes and therefore transfection is more controlled, which is a key parameter 
of biotechnology (Bengali et al, 2005).  
However although RT promotes immediate uptake of DNA, it does not offer superior gene 
expression to that of bolus transfection. In fact the study that compared both methods 
reported no significant differences (Bengali et al, 2009).  
5.4.2.5 Improvements to current protocols and alternative methods  
Although staining and detection by confocal microscopy allowed polyplexes to be tracked 
and in some experiments revealed co-localisation of fluorescence (PLL and DNA), 
alternative techniques to study polyplex uptake should also be considered. Fluorescence 
resonance energy transfer (FRET) is a useful tool that can detect subtle changes in 
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fluorescence. FRET detects energy transfer in the form of fluorescence between two 
fluorophores in close proximity (Haugland et al, 1969). FRET has been used to study 
polyplex dissociation kinetics. Recent studies employing FRET revealed incomplete binding 
of polymer and DNA (Ko et al, 2011). Therefore FRET can be used to improve interpretation 
and confirm DNA/polymer association.   
For polyplexes to achieve initial uptake, electrostatic interaction occurs between the 
positively charged complex and negatively charged plasma membrane (Elouahabi and 
Ruysschaert, 2005). More specifically polyplexes have been found to associate with 
negatively charged protein regions of the membrane referred to as proteoglycans. 
Proteoglycans are negatively charged membrane proteins that are involved in binding with 
cations (Kopatz et al, 2004; Tros de Ilarduya et al, 2010). Chenevier et al, (2000) reported a 
two step mechanism of cationic complex association with the cell surface. Firstly acidic 
glycoproteins within the membrane interact with cationic complexes, followed by anionic 
matrix components which facilitate complex recognition and entry (Chenevier et al, 2000). In 
regards to CHO cells, Labat-Moieur et al, (1996) revealed knock down of heparin sulphate 
proteoglycans reduced PLL complex cell binding and gene expression. Enzymatic inhibition 
confirmed such results (Mislick and Baldeschwieler, 1996). Therefore non-viral gene 
delivery vectors should be designed to target and maximise interactions with cell surface 
components to facilitate cellular entry.  
In regards to future analysis concerning complex uptake, the PLL/DNA polyplexes used in 
this study can be improved through the incorporation of components that maximise 
membrane association. Specific peptide nanoparticles have been synthesised which enhance 
cellular delivery and membrane association, particularly proteoglycan regions (Sun et al, 
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2010). Incorporation of such components could potentially enhance uptake and possibly gene 
expression.      
5.4.3 Mechanism of polyplex uptake  
Understanding the mechanisms exploited by DNA polyplexes to gain cellular access will aid 
in the design of gene delivery vehicles. Polyplex uptake in mammalian cells has been 
attributed towards endocytosis (Rejman et al, 2005). Endocytosis refers to the process of 
internalisation of extracellular material (Gould and Lippincott-Schwartz, 2009; Pinchon et al, 
2010). There are two main endocytic pathways to which polyplexes have been reported to 
exploit. The clathrin mediated endocytic (CME) pathway entails the entry of foreign 
materials via clathrin coated pits which form into vesicles that transport the internalised cargo 
(Rejman et al, 2005). The vesicles fuse with early endosomes for further trafficking. The 
second endocytic route of entry is via the caveolae pathway. This involves lipid raft 
structures that bind and dock with incoming cargo. These structures invaginate off the 
membrane transporting its contents (Khalil et al, 2006).         
5.4.3.1 Endocytic uptake of polyplexes 
Quantitative analysis was carried out to identify whether polyplexes utilise endocytosis as 
means of CHO cell entry, and any particular pathway of interest. Known chemical inhibitors 
of the CME (choloropromazine [CMZ]) and caveolae pathway (genistein) were added to 
CHO cells and the effect on gene expression was reported. Addition of CMZ and genistein 
significantly reduced gene expression (Figure 5.15). Furthermore experiments showed 
reduced uptake and nuclear association of polyplexes regardless of DNA topology in cells 
treated with endocytic inhibitors (Figure 5.16). The reduction in polyplex uptake when 
treated with chemical inhibitors is in line with that of Luhmann et al, (2008). Previous studies 
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showed caveolae pathway inhibition did reduce uptake in CHO cells by over 75% in regards 
to chitosan complexes (Douglas et al, 2008). Polyplexes have been reported to utilise various 
endocytic pathways for cellular uptake. For example PEI/DNA polyplex uptake was reported 
to occur via both the CME and caveolae pathway (Rejman et al, 2005).   
Validation of the chemical inhibitors was carried out to confirm specific pathway inhibition. 
Genistein blocks ATPase function and is involved in hormone induction (Kuiper et al, 1998) 
and such actions may limit complex uptake rather than specific pathway inhibition. To test 
whether chemical treatment leads to specific pathway inhibition, commercial markers of the 
CME and caveolae pathway were added to cells treated with the respective inhibitors. 
Confocal microscopy and flow cytometry studies revealed chemical treatment did lead to 
specific inhibition of the pathway of interest and did not jeopardise uptake of markers 
corresponding to alternative pathways (Figures 5.17 and 5.18).  
5.4.3.2 Analysis with commercial endocytic markers 
To analyse further whether PLL/DNA polyplexes may exploit both CME and caveolae 
pathways, characterised commercial markers of the CME and caveolae were co-transfected 
with DNA polyplexes. Fluorescent confocal microscopy analysis revealed co-localisation of 
polyplex DNA with transferrin (CME marker) and cholera toxin subunit (CTB) (caveolae 
marker) (Figure 5.19). However polyplexes (regardless of DNA topology) did not show 
fluorescent co-localisation when transfected in cells treated with an alternative commercial 
antibody stain specific for markers of the caveolae pathway (Figures 5.20). Furthermore no 
fluorescent co-localisation was observed in cells treated with fluorescently labelled antibodies 
specific for the CME marker (Figure 5.21). Therefore the collective results suggest that 
PLL/DNA polyplexes may exploit both CME and caveolae pathways according to gene 
expression and quantitative experiments, however antibody staining experiments suggests 
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otherwise. Therefore alternative endocytic routes may be employed. Endocytic pathways 
such as these have size criteria for their incoming cargo to which polyplexes may meet (100-
300nm) allowing the possible entry through both pathways. (Douglas et al, 2008).  
Despite uptake and gene expression studies indicating both CME and caveolae pathways of 
endocytosis could potentially be exploited by DNA polyplexes, no clear fluorescent co-
localisation was identified in transfected cells stained with anti-Rab5 (marker of CME 
pathway) antibodies (Figure 5.21). Knockdown of Rab5 through RNA gene silencing is an 
alternative method that can be used to specify polyplex CME entry. This method has recently 
been used to decipher the role of early endosomes (Kageyama-Yahara et al, 2011). In 
addition to the CME and caveolae pathway, there are alternative endocytic pathways. For 
example macropinocytosis is a form of endocytic entry which involves the formation of large 
vesicles which pinch off the membrane (Khalil et al, 2006). This form of entry could be used 
by complexes in this study particularly as macropinocytosis entails the entry of foreign cargo 
as large as 5µm (Khalil et al, 2006). Recent studies have developed new methods to track 
internalised cargo (labelled with MRI agents), in which endosome internalisation corresponds 
to photochemical activation allowing researchers to identify the location of transfected cargo 
(Gianolio et al, 2011).   
5.4.3.3 Enhancing endocytic uptake 
Understanding the mechanism of polyplex uptake will lead to improvements in the 
transportation of DNA, which will ultimately serve to enhance gene expression for 
therapeutic purposes. The present study revealed how PLL/DNA polyplexes may exploit both 
the CME and caveolae pathways. This could allow for optimisation. A recent study 
incorporated transmembrane receptor domains within PEI polyplexes which significantly 
enhanced cellular uptake and endosomal transportation within CHO cells (Kakimoto et al, 
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2010). Improved cellular uptake and endosomal trafficking also led to increased gene 
expression (Kakimoto et al, 2010). Knowledge of the CME pathway and the role of 
endosomes as trafficking vesicles, led to Kulkarni et al, (2006) to emphasise the importance 
of the microtubule network for endosomal transport. In that particular study biophysical 
analysis revealed how motor proteins mediate the active transport of polyplex loaded 
endosomes towards the nucleus (Kulkarni et al, 2006). 
Although generally regarded to occur via endocytosis, polyplex uptake varies, depends on 
various parameters and is very specific. Douglas et al, (2008) reported nanoparticle vector 
uptake is dependent upon the cell line. Qi et al, (2010) reported how dendrimer non-viral 
gene delivery does not occur via the caveolae pathway whereas others report PEI based 
complexes use the CME pathway (Ma and Lim, 2003). Moreover there are reports that show 
utilisation of both endocytic pathways by polyplexes (Luhmann et al, 2008; Sahay et al, 
2010). Alternatively pathways independent to that of the CME and caveolae have been used 
by PEI polyplexes (Hufnagel et al, 2009). Therefore from these reports and the findings of 
the present chapter, endocytosis could be utilised by DNA polyplexes, however antibody 
staining for specific markers suggest otherwise and factors such as vector type, size and cell 
type seem to determine pathway of entry. 
In this chapter uptake and gene expression of PLL/DNA polyplexes showed dependence on 
DNA topology. These two parameters were greatest for SC-pDNA polyplexes. Regardless of 
DNA topology polyplex gene expression was reduced when transfected into cells treated with 
endocytic inhibitors suggesting possible exploitation of endocytic pathways. Modification or 
incorporation of elements that target these pathways within complexes, could potentially 
improve cell uptake. However antibody staining for endocytic markers showed no fluorescent 
co-localisation indicating other routes of cellular entry may be exploited by DNA polyplexes.  
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5.5 Chapter Summary  
 Polyplex uptake showed dependence on DNA topology whereby approximately 60% 
of complexes containing SC-pDNA associated with the nuclei by one hour. 
 PLL and DNA exhibited close association following uptake as shown by co-
localisation in fluorescent confocal microscopy studies. However co-localisation 
decreased at extended time periods in which PLL may be separated from DNA or 
degraded. 
 CHO cell polyplex gene expression (lacZ plasmid reporter gene) was dependent on 
DNA topology, which was highest for SC-pDNA polyplexes at >40%. This occurred 
regardless of charge ratio. 
 PLL/DNA polyplexes can also be transfected into CHO cells via reverse transfection 
(RT) as shown by fluorescent confocal microscopy.   
 Polyplex (regardless of DNA topology) gene expression was reduced in cells treated 
with endocytic inhibitors and showed co-localisation when transfected with markers 
of the caveolae and CME pathways. 
 However no fluorescent co-localisation was observed between DNA polyplexes and 
fluorescently labelled antibodies specific for alternative endocytic markers.   
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6. Polyplex uptake within dendritic cells  
 
Dendritic cells (DCs) are key components of the immune system which function by binding 
and collecting antigens. They bridge both arms of immunity; the innate and adaptive 
response. The innate response refers to the recognition of microbial agents, foreign antigens 
and pathogens via pathogen recognition receptors (PRRs) (Stevenson et al, 2010). The 
adaptive arm of immunity is primed into response when exposed to a foreign antigen leading 
to recognition and targeting of the antigen culminating in immunological memory for future 
attacks (Marieb, 2004). To achieve this DCs present the antigen of interest through selective 
surface markers to T cells (Ueno et al, 2011; Stevenson et al, 2010). T-cells are blood cells 
which recognise antigens presented by DC surface markers and become activated. When 
activated, T-cells function by releasing small proteins referred to as cytokines which aid in 
the immune response (Ueno et al, 2011). Following antigen presentation T-cells differentiate 
into effector cells (Finkleman et al, 1996). It is these functions that researchers aim to exploit 
and why polyplex gene delivery to DCs is a key area of study for the design of DNA 
vaccines.   
The chapter investigated non-viral gene delivery within human monocyte derived DCs. 
Polyplex uptake (defined as the intake of materials by a cell or tissue leading to its permanent 
or temporary retention) and gene expression (transcription of pDNA reporter gene) is 
reported. DCs express various cell surface markers which contribute towards antigen 
presentation (Stevenson et al, 2010). In this study polyplex gene expression was measured 
and whether this impacts on DC surface marker expression and hence activation of DCs.  
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6.1 Observation of polyplex uptake in DCs 
6.1.1 Classification of polyplex location 
Polyplexes were transfected into DCs (Chapter 2, section 2.6.2). Polyplexes were dual 
labelled whereby DNA was fluorescently labelled red, while PLL was tagged green. Dual 
staining was maintained indicating both DNA and PLL remained associated following uptake 
(Figure 6.1). DC cytosol was also stained light grey to highlight uptake and location of 
polyplexes. Polyplexes in each cell were then classified as being at the periphery (Figure 
6.1a), in the cytosol (Figure 6.1b) or inside the nucleus (Figure 6.1c). This criterion is applied 
throughout the chapter as in Chapter 5 (refer to Chapter 5, Figure 5.1). As in Chapter 5, 3-D 
images were taken (as sections) to confirm polyplex uptake when analysing via fluorescent 
confocal microscopy. Ten sections of each image, each of 0.2µm in thickness were taken. 
Mid section images were taken to confirm true polyplex uptake along with projection images 
of all sections (referred to as z-stack projection images). Details are provided in Chapter 2, 
section 2.6.7.1. 
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Figure 6.1: Classification of polyplex cellular location in DCs. Mid section (A) and stack projection 
images (B). Confocal microscopy analysis showing the location of polyplexes; cell periphery (linear-pDNA 
polyplexes) (i), cytosol (OC-pDNA polyplexes) (ii) and nucleus (SC-pDNA polyplexes) (iii). Complexes 
were prepared at charge ratios (ratio of PLL to DNA) of +1.6 (for SC- and OC-pDNA) and +5 for linear-
pDNA.  Scale bar represents 5µm. DCs were fixed with paraformaldehyde, stained and coverslips were 
mounted on slides.       
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6.1.2 Short time course 
Polyplexes containing 2µg pDNA were transfected into approximately 1x106 DCs and 
analysed via fluorescent confocal microscopy. Complexes were often located on the cell 
periphery and in the case of SC-pDNA polyplexes, migrated to the cytosol by 30-60 minutes 
(Figure 6.2). Complexes containing OC- and linear-pDNA were predominately located on the 
periphery of the cell between 10-30 minutes and cytosol by 60 minutes.     
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Figure 6.2: Time course of polyplex uptake in DCs as observed via confocal microscopy. Polyplexes 
containing linear- (A), OC- (B), and SC- (C) pDNA (2µg). Polyplexes were prepared at charge ratios of +1.6 
(for SC- and OC-pDNA) and +5 for linear pDNA. Polyplexes were spotted onto PLL coated coverslips for 1 
hour at room temperature (protected from light). DCs were then added to complexes and incubated at 37°C 
for the desired period. Figure shows mid section images. 
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Naked DNA displayed no fluorescence, throughout the time course, presumably requiring 
PLL to enter cells (Figure 6.3).     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3: Transfection of naked pDNA in DCs as observed via confocal microscopy. Naked linear- 
(A), OC- (B), and SC- (C) pDNA (2µg).        
 
Chapter 6 Polyplex 
uptake within 
dendritic cells 
 
193 
 
6.1.3 Extended time course 
Polyplex uptake was studied at an extended time period of 48 hours (Figure 6.4). Polyplexes 
were often situated within the periphery (linear-pDNA) or the cytosol (SC- and OC-pDNA) 
of the cell, with low nuclear association. Unlike what was observed for CHO cells (Chapter 5, 
5.1.3) the polyplexes exhibited dual staining. No dissociation of DNA from PLL was noted 
which may be due to differing uptake mechanisms within the two cell lines.    
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 6.4: Extended time course of polyplex uptake in DCs as observed via confocal microscopy. 
Polyplexes containing linear- (A), OC- (B), and SC- (C) pDNA (2µg). Polyplexes were prepared at 
charge ratios of +1.6 (for SC- and OC-pDNA) and +5 for linear pDNA. Figure shows mid stack images. 
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6.2 Quantification of polyplex uptake and gene expression within DCs 
Confocal image quantification of polyplex uptake was carried out along with gene expression 
measurements. As in Chapter 5 (Figure 5.8) polyplexes were classified on the basis of their 
intracellular location. 
6.2.1 Efficiency of polyplex uptake within DCs 
The number of cell associated polyplexes was counted and classified according to the basis of 
their location (as in Figure 6.1). By 10-30 minutes, the majority of polyplexes regardless of 
DNA topology were often situated within the periphery of DCs (Figure 6.5). However by 1 
hour 15% of SC-pDNA complexes associated with the nuclei (complete overlap between 
polyplex fluorescence and nuclear stain). In contrast, no nuclear association was observed for 
OC- and linear-pDNA polyplexes, emphasising topology dependent uptake.  
Polyplexes were transfected in DCs for an extended period of 48 hours and were also 
quantified (Figure 6.6). Uptake was topology dependent whereby 30% of SC-pDNA 
polyplexes associated with the DC nuclei, which was greater than OC- and linear-pDNA 
polyplexes. Therefore SC-pDNA polyplexes seem more efficient in terms of attaining nuclear 
association within DCs than its counterparts. It is important to note that while compartment 
association is a useful indicator for polyplex uptake, nuclear association does not directly 
correspond to gene expression due to various molecular barriers and presence of nucleases 
within the nucleus. Details of quantification methodology are provided in Chapter 2, section 
2.6.7.3.       
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Figure 6.5: Quantification of polyplex uptake in DCs for up to 1 hour. Polyplexes (containing 2µg 
DNA) were prepared at charge ratios of +1.6 (for SC- and OC-pDNA) and +5 for linear pDNA. The 
figure shows the mean and standard error (SE) of 3 independent experiments. One-way ANOVA was 
employed to deduce levels of statistical significance (p < 0.05) between complexes of differing DNA 
topologies in different cell compartments. 
Figure 6.6: Quantification of polyplex uptake in DCs at 48 hours. Polyplexes (containing 2µg DNA) 
were prepared at charge ratios of +1.6 (for SC- and OC-pDNA) and +5 for linear pDNA. The figure 
shows the mean and SE of 3 independent experiments. One-way ANOVA was employed to deduce levels 
of statistical significance (p < 0.05) between complexes of differing DNA topologies in different cell 
compartments. 
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6.2.2 DC polyplex gene expression studies  
In this study PLL/DNA polyplex uptake and gene expression was measured in human 
monocyte derived DCs. The pDNA encodes a lacZ reporter gene for β-galactosidase which 
was measured by X-Gal staining via light microscopy (refer to Chapter 2, section 2.6.3 for 
details and also shown in Chapter 5, Figure 5.10). Gene expression measurements are 
important in terms of deducing the efficiency of polyplex uptake and the ability of polyplexes 
to gain nuclear access and undergo gene transcription. In this study complexes containing 
20µg pDNA were transfected into DCs to induce gene expression. This is important in 
regards to gene expression within DCs as such cells express nucleases (Chain, 2003). 
Although 2µg pDNA was used for confocal image uptake studies, there was no significant 
difference between uptake profiles of complexes containing 2 and 20µg.        
6.2.2.1 48 hour time course 
DCs were transfected for a period of 48 hours. This time period was selected due to optimal 
expression of the lacZ reporter gene identified from previous studies regarding DCs 
(Nakamura et al, 2002). Gene expression showed dependence on DNA topology which was 
highest for SC-pDNA polyplexes at 14% when the charge for all three complexes are similar; 
+1.6 for SC- and OC-pDNA, and +5 for linear-pDNA (Figure 6.7). This was significantly 
greater than OC- and linear-pDNA polyplexes (p < 0.05). OC- and linear-pDNA complex 
gene expressions were not significantly different to naked pDNA controls (with the exception 
of naked linear-pDNA) (Figure 6.7).  
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6.2.2.2 Polyplex gene expression at an equal charge ratio   
Polyplex charge ratio (ratio of PLL to DNA) is important in terms of converting the negative 
charge of DNA to a positive charge to facilitate cellular entry (across negatively charged 
membrane). In the present study, polyplexes containing SC- and OC-pDNA were produced at 
charge ratios of +1.6. This was due to the equal positive surface charge displayed (zeta 
potentials). This particular charge ratio was recommended for future gene delivery analysis 
by previous biophysical polyplex studies (Tsai et al, 1999). 
The previous figure showed the transfection efficiency when the charge of all three 
polyplexes was similar (although at differing charge ratios). When DCs were transfected at 
Figure 6.7: Polyplex gene expression within DCs. 20µg polyplex DNA was transfected into DCs. 
Polyplexes were prepared at charge ratios of +1.6 for SC- and OC-pDNA polyplexes and +5 for linear-
pDNA polyplexes (1mM HEPES [pH 7.5]). The figure shows the mean and SE of 3 independent 
experiments. One-way ANOVA was employed to deduce levels of statistical significance (p < 0.05) 
between complexes of differing DNA topologies.  
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equal charge ratios, gene expression still remained highest for the SC-form (Figure 6.8). 
When the charge ratio increased to +5, transfection efficiency was not significantly different, 
however gene expression decreased slightly. This observation is consistent with that of CHO 
cells (Chapter 5, Figure 5.14), suggesting greater concentrations of PLL may jeopardise 
uptake. When the charge ratio increased polyplex sizes have also been measured to rise (with 
the exception of SC-pDNA) (Chapter 3, section 3.2.4) and the increase in size may hinder 
uptake and gene expression for complexes formulated at charge ratios of +5. Furthermore at 
high charge ratios it has been shown that increasing the amount of polymer leads to a rise in 
complex aggregation, which hinders gene expression (Christie et al, 2010).   
 
 
 
Figure 6.8:  Polyplex gene expression within DCs when the charge ratio is equal. 20µg polyplex 
DNA was transfected into DCs. Polyplexes were produced at charge ratios of +1.6 and +5 (1mM 
HEPES [pH 7.5]). The figure shows the mean and SE of 3 independent experiments. One-way ANOVA 
was employed to deduce levels of statistical significance (p < 0.05) between complexes of differing 
DNA topologies at different charge ratios. 
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6.3 Impact of polyplex gene expression on DC phenotype    
DCs express various cell surface markers which generally function by presenting foreign 
antigens to T cells (summarised in Table 6.1). DC surface marker expression has been 
reported to be upregulated when cells are exposed to chemical allergens. Therefore changes 
in DC surface marker expression provide a measure of DC activation (Hulette et al, 2002). In 
this study DNA polyplexes were transfected into DCs (approximately 1.9 x106 cells) to 
analyse whether polyplex gene expression activates DCs. Polyplex gene expression and the 
level of DC surface marker expression was measured by flow cytometry. 
Unlike previous gene expression studies which entailed X-Gal staining and detection via light 
microscopy, β-galactosidase activity was probed by a fluorescein stained substrate which 
allowed for flow cytometric analysis (Chapter 2, section 2.8). Following uptake cells were 
exposed to fluorescently labelled antibodies specific for various DC surface markers. These 
antibodies were labelled with far red fluorophores (to distinguish from the green labelled 
transfected cell population positive for β-galactosidase). Cells were analysed by flow 
cytometry, whereby fluorescein was measured under the FL-1 filter, while the far red 
antibody stains were detected under FL-2 or FL-4 filters.       
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CD1a 
DC-SIGN 
CD11c 
MHC-I 
MHC-II 
CD40 
CD80 
CD83 
CD86 
Surface Marker Function Reference 
CD1a 
 Recognises foreign lipid antigens and presents to T cells for 
specific recognition         Hulette et al, 2001 
- I  C-type lectin which regulates activation of CD4+ T cells   Curtis et al, 1992 
CD11c 
 
Expressed on DCs and involved in a variety of roles 
including phagocytosis and T cell proliferation.  Sadhu et al, 2007 
MHC-I 
Presents peptides generated by the proteosome. The MHC-I-
peptide complex is positioned within the plasma membrane 
to present the peptide to T cells.  Ueno et al, 2011 
MHC-II 
Complexes which present extracellular derived peptides. 
MHC-II complex recognises foreign pathogens and bacteria, 
and presents to CD4+ T cells Stvenson et al, 2010 
CD40 
Member of the tumour necrosis factor receptor family which 
is involved in IL-12 synthesis in DCs. Tone et al, 2001 
CD80 Expressed on B cells and upregulated during infection.  Suvas et al, 2006 
CD83 
Expressed on mature DCs and expression coincides with 
MHC-II antigen expression. Prazma andTedder, 2002 
CD86 
Widely expressed on DCs and an important costimulator of 
T cell activation.   Zheng et al, 2004 
 
Table 6.1: A selection of the key DC surface markers that play an important role in induction of 
immunity. These surface markers were studied in subsequent flow cytometry studies.  
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6.3.1 Flow cytometry analysis 
Figure 6.9 shows scatter plots which display the population of DCs and the level of 
expression of the 9 surface markers following uptake of DNA polyplexes. SC-pDNA 
polyplexes were analysed, as these gave clear distinguishable population of cells positive for 
β-galactosidase expression as detected by flow cytometry. Isotype controls (IgG1 and IgG2b) 
were employed to compensate for non-specific antibody binding. A comparison of the bulk 
transfected and nontransfected populations showed no evidence of increased expression of 
any of the markers. DCs expressing β-galactosidase (FL-1 filter) displayed a negative 
fluorescent shift for surface marker expression detected in the FL-2 or FL-4 filter (such as 
DC-SIGN [dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin]) 
(Figure 6.9).      
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polyplex gene  
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6.3.2 The effect of gene expression on DC surface marker expression 
Healthy DC populations were gated in order to avoid analysis of debris and dead cells (Figure 
6.10a). The level of polyplex gene expression within DCs was measured (in the fluorescein, 
FL-1 filter) (Figure 6.10b) and its effect on surface marker expression was compared with 
untransfected controls (Figure 10c). Gene expression within DCs was detected with a slight 
positive shift for transfected cells. The level of DC surface marker expression in transfected 
cells did not change and in some cases was less (e.g. CD80 and CD83) than untransfected 
controls (Figure 6.10c). These findings are consistent with Figure 6.9 whereby polyplex DNA 
uptake did not activate DCs through surface marker expression.    
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Figure 6.10: Histogram analysis displaying effect of polyplex gene expression on DC surface marker 
expression. DCs were analysed by flow cytometry. Polyplex (containing 20µg DNA) gene expression was 
measured under the FL-1 filter, while DC surface marker expression was measured under the FL-2 or FL-4 
filters. Healthy DCs were gated and selected for analysis (A). DC polyplex gene expression was measured (B) 
and the effect on surface marker expression was recorded (C).  
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6.4 Discussion  
The current chapter investigated polyplex uptake within dendritic cells (DCs). DCs are 
important components of the immune system, which function by binding and presenting 
antigens to T-cells (Ueno et al, 2011). DCs express various cell surface markers which 
contribute towards antigen presentation to T-cells (Landi et al, 2007). T-cells are blood cells 
which recognise antigens presented by DC surface markers and become activated. When 
activated, T-cells function by releasing small proteins referred to as cytokines which aid in 
the immune response (Ueno et al, 2011). Such cells are unique in that they bridge both arms 
of immunity; innate and adaptive responses. The innate response refers to the recognition of 
microbial agents and pathogens via pathogen recognition receptors (PRRs) (Stevenson et al, 
2010). The adaptive response entails the activation of T cells to trigger antigen specific 
responses, brought about by the release of specific antibodies (Marieb, 2004). 
DCs have important therapeutic applications. One DC based immunotherapy product has 
gained FDA approval (April 2010) and is available on the market. This refers to the cancer 
vaccine Sipuleucel-T by the company Dendreon for the treatment of prostate cancer. The 
vaccine is prepared specifically using patient’s  own DCs which are then fused with a protein 
termed; antigen prostatic acid phosphatase (PAP) which is present in approximately over 
90% of prostate cancer cells. Patients are treated with the vaccine which is designed to 
stimulate an immune response towards cancer cells harbouring the antigen.   
In this study PLL/DNA complexes were transfected into monocyte-derived human DCs. 
Polyplex uptake was monitored qualitatively and quantified through confocal image analysis 
and gene expression studies. Additionally, the effect of polyplex gene expression on DC 
surface marker expression was studied. This is important in terms of analysing whether 
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PLL/DNA polyplexes stimulate expression of surface markers involved in antigen 
presentation, which is a key function of DCs.    
6.4.1 DC polyplex uptake 
Polyplexes containing different DNA topologies (SC, OC, and linear-pDNA) were 
transfected into DCs and uptake was monitored qualitatively by confocal microscopy. 
Polyplex uptake was classified on the basis of intracellular location (periphery, cytosol or 
nucleus) (Figure 6.1). This was confirmed by identification in both mid section and stack 
projection images by fluorescent confocal microscopy in order to identify true polyplex 
uptake. Unlike that of CHO cells (Chapter 5, Figure 5.2), polyplex uptake in DCs was 
gradual with low nuclear association (Figure 6.2). Regardless of topology, DNA showed co-
localisation with PLL (Figure 6.2). By one hour SC-pDNA polyplexes were located in the 
cytosol (polyplex fluorescence overlaid with cytosol stain) which continued by 48 hours 
(Figure 6.4). OC- and linear-pDNA polyplexes were observed to be within the cytosol and 
periphery of the cell respectively. Confocal image quantification studies revealed uptake of 
complexes was progressive and topology dependent (Figures 6.5 and 6.6). SC-pDNA 
complexes associated most efficiently and rapidly with the nuclei whereby 15% of complexes 
associated with the nucleus by 1 hour in comparison to 0% for OC- and linear-pDNA. This 
may be due to various biophysical factors such as polyplex charge. Moffatt and Cristiano 
(2006) formulated PEI complexes displaying charges of approximately +45mv and recorded 
reduced gene expression within DCs. In this study SC- and OC-pDNA complexes displayed 
zeta potentials of +13.7 and +23mv respectively (Chapter 3, Figure 3.2) and displayed 
markedly higher percentage nuclear association than linear-pDNA complexes (Table 6.2), 
which displayed a greater cationic charge of +27mv when formulated at a greater charge ratio 
(ratio of PLL to DNA) of +5. This suggests increased zeta potentials of strong cationic  
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charges may not necessarily correspond with enhanced DC uptake. The increased cationic 
charges could lead to non specific binding with protein components culminating in reduced 
cell uptake (Moffatt and Cristiano, 2006). 
DCs are key sentinels of the immune system in which foreign components are recognised and 
engulfed in a process referred to as phagocytosis (Ishimoto et al, 2008). DCs represent the 
first line of defence of the immune system and so recognition of foreign materials is 
important. Polyplexes are likely to be engulfed, as they display similar sizes to readily up 
taken molecules by DCs (Thiele et al, 2001; Moffatt and Cristiano, 2006; Jilek et al, 2004). 
Polyplex size is a key parameter that affects uptake and subsequent gene expression. SC-
pDNA polyplexes were found to display the smallest mean diameters at <200nm which may 
facilitate cellular uptake. In contrast OC-pDNA polyplexes were larger at just over 300nm, 
while linear-pDNA complexes had diameters of approximately 840nm (Chapter 3, Figure 
3.14). One study revealed how PEI/DNA complexes with sizes of up to 11µm were engulfed 
by DCs. However gene expression for these particular complexes was very low which may 
be due to the large size which may hinder nuclear uptake (Table 6.2) (Jilek et al, 2004). 
These reports along with the findings of the present study indicate smaller complexes favour 
potential gene expression.       
Although DCs are key cells of the immune system their ability to recognise foreign 
components can lead to unspecific binding. To counter this polyplex cationic charge can be 
masked and this can be brought about by polyethylene glycol (PEG) which has been found to 
enhance cellular uptake and gene expression (Ulasov et al, 2011). PEG operates by forming a 
hydrophilic shield around the polycation/DNA complex which masks the cationic charge 
(Ulasov et al, 2011). Further improvements regarding polyplex uptake include the 
conjugation of DC-specific antibodies which enhance cellular recognition and uptake (Reddy 
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et al, 2006). One study employed anti-Dec205 antibodies bound to conjugates which 
significantly increased DC uptake. The antibody bound conjugate was recorded to be <1µm 
in size which facilitated recognition by DCs (Kwon et al, 2005).          
6.4.2 DC polyplex gene expression 
In this study complexes containing 20µg pDNA were transfected into DCs to induce gene 
expression. This is important in regards to gene expression within DCs as such cells express 
nuclear nucleases (Chain, 2003). Although 2µg pDNA was used for confocal image 
qualitative and quantitative studies, there was no significant difference between uptake 
profiles of complexes containing 2 and 20µg (data not shown). Non-viral gene expression 
within DCs is notoriously sensitive. Poor gene transfer has led to reduced gene expression 
(Landi et al, 2007). To date, comparison of PLL/DNA polyplex (containing differing pDNA 
forms) gene expression within DCs has not been reported. Gene expression (lacZ reporter 
gene encoding   β-galactosidase) was highest for SC-pDNA polyplexes at 14% when the 
charge for all three complexes was similar, (when the charge ratio was +1.6 for SC- and OC-
pDNA and +5 for linear-pDNA) (Figure 6.7). This was significantly greater than OC- and 
linear-pDNA polyplexes. When the charge ratio was equal DC polyplex gene expression still 
showed dependence on DNA topology (Figure 6.8). The ability of SC-pDNA polyplexes to 
diffuse through cells more efficiently than the other pDNA forms may contribute towards 
higher gene expression. As mentioned previously SC-pDNA polyplexes displayed smaller 
sizes which may facilitate nuclear entry and expression. Importantly this study showed that 
SC-pDNA polyplexes displayed greater nuclease resistance than other DNA forms which 
were more susceptible towards nuclease degradation (Chapter 3, Figure 3.11). This is pivotal 
as DCs have been found to express various nucleases (Chain, 2003). Modest polyplex gene 
expression has been reported previously and summarised in Table 6.2 in conjunction with the 
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findings of the current study (Landi et al, 2007; Van Tendeloo et al, 1998; Moffatt and 
Cristiano, 2006). With the exception of Landi et al, (2007) and Faham et al, (2011), findings 
from Table 6.2 indicate non-viral gene expression is dependent on DNA dose and complex 
size. Although Jilek et al (2004) employed pDNA doses of up to 10µg gene expression was 
only 0.005%. This may be due to the size of such complexes which ranged between 7-
11.6µm (Table 6.2). Despite polyplexes displaying similar sizes to the present study 
Kanazawa et al, (2009) employed pDNA doses of >5µg and reported <0.05% unlike the 
present study whereby a dose of 20µg led to up to 14% gene expression. Therefore size and 
dosage are key parameters. Zeta potentials of SC-pDNA complexes were low in comparison 
to previous results but displayed greater expression which may be due to a reduction in non-
specific binding (Moffatt and Cristiano, 2006) (Table 6.2). As shown in this study DNA 
topology is a key factor in regards to polyplex DC uptake. Polyplexes containing pDNA in 
the SC form display smaller sizes, greater nuclease resistance, enhanced nuclear association 
and greater gene expression than other topologies which is critical for gene delivery to 
immune cells. Overall DC gene expression was quite low and so techniques to enhance gene 
expression should be considered (mentioned further in this section).  
6.4.3 The effect of polyplex gene expression on DC phenotype 
DCs are characteristic through the expression of various cell surface markers. These markers 
generally contribute towards antigen presentation and changes in expression are a hallmark of 
DC activation (Stevenson et al, 2010). In this study DCs were transfected with DNA 
polyplexes to observe whether gene expression affects DC phenotype through changes in 
surface marker expression. Flow cytometry studies (Figures 6.9 and 6.10) revealed no change 
in DC surface marker expression following uptake of SC-pDNA polyplexes. This may be due 
to the low DNA dose transfected into DCs, which may not be enough to pass a specific 
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threshold to elicit phenotypic changes. Table 6.2 summarises how the majority of non-viral 
gene delivery studies employed doses ranging from 5-20µg pDNA, failed to induce DC 
phenotypic changes. Plasmid DNA vaccine clinical trials which aim to stimulate immune 
cells through phenotypic changes employed greater doses. One study administered pDNA 
doses as high as 1mg/ml, whereas another employed doses of up to 0.5mg (Doukas et al, 
2011; ClinicalTrials.gov Identifier: NCT00709800; Cebere et al, 2006; ClinicalTrials.gov 
Identifier: NCT00301184). The dose employed in this study (20µg or 0.02mg pDNA) may be 
insufficient to alter DC phenotype which is in line with previous reports employing similar 
does, with the exception of Faham et al, (2011) who identified DC phenotypic changes 
following administration of 200µg DNA (Table 6.2). An increased DNA dosage may be 
required to induce phenotypic changes as DCs predominantly express nucleases (Chain, 
2003). Expression of surface markers such as DC-SIGN (dendritic cell-specific intercellular 
adhesion molecule-3-grabbing non-integrin), which mediates T-cell activation (Curtis et al, 
1992) did not change with polyplex gene expression (Figure 6.10).  
Measuring such parameters is important in regards to clinical applications. Vaccines targeting 
DCs  incorporate  adjuvants  (enhances  recipient’s  immune  response)  that  are  designed  to  elicit  
phenotypic changes that activate DCs to induce antigen specific T-cell responses (Tang et al, 
2010). Therefore the findings from Figures 6.9 and 6.10 reveal how PLL/DNA complexes 
containing greater DNA dosage (>0.2mg) must incorporate components (adjuvants) to induce 
DC activation. This is important as DCs predominately express nucleases which are likely to 
degrade the DNA, thereby preventing DC phenotypic changes. Alternatively by not 
activating DCs, PLL/DNA polyplexes display biocompatibility allowing safe and effective 
nucleic acid delivery (Tang et al, 2010).  
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Knowledge of DC surface markers has led researchers to exploit such receptors for targeted 
delivery. Anderson et al, (2010) developed a polyacridine glycopeptide as means of targeted 
gene delivery. The glycopeptide DNA polyplex consisted of a mannose-glycan that allows 
recognition by DC-SIGN and led to improved gene expression (Anderson et al, 2010). 
Although flow cytometry does provide benefits of rapid high throughput analysis, alternative 
techniques can be used to measure minute changes in DC surface marker expression. 
Quantitative polymerase chain reaction (Q-PCR) can be used to measure subtle changes in 
DC surface marker gene expression following transfection. DC activation through changes in 
DC surface marker gene expression following allergen exposure was recorded by Ryan et al, 
(2004).  
6.4.4 Improvement of current protocols to enhance DC polyplex gene 
expression 
In this study DCs were transiently transfected with PLL/DNA polyplexes. However it is 
important to consider alternative methods to the current protocol which have been shown to 
enhance DC gene expression. Various groups have attempted techniques to shield the DNA 
and protect against unspecific binding. One study revealed significantly improved gene 
expression when immature DCs (iDCs) were used (Landi et al, 2007). Monocyte-derived 
DCs are a common source of DCs which are generated within 5 days. However Landi et al, 
(2007) used iDCs (generated after only 3 days) for transfection studies and revealed 
improved gene expression of up to 20% (Table 6.2). This was attributed towards higher cell 
viability allowing gene expression to increase when induced via electroporation (Landi et al, 
2007).  
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DCs incorporate mannose cell surface receptors, and uptake of lipid/DNA complexes 
increased when complexes were mannosylated (Un et al, 2010). This increased DC 
interaction and bypassed non-specific protein binding. The authors reported enhanced gene 
expression when the DNA dose increased (500µg/200µl). Gene expression corresponding to 
approximately >1ng/mg protein within DCs was recorded which was not significantly 
different to commercial gene delivery systems (Un et al, 2010). In this study 20µg DNA was 
used for gene expressions studies which lead to 14% expression for SC-pDNA polyplexes. 
Therefore an increase in dose could enhance gene expression.  
Block copolymer systems consisting of a polycation (for DNA binding) and PEG (steric 
stabilisation) lead to improved DC uptake and gene expression particularly for long chain 
polymers. The long polymer chain coupled with an endosomolytic compound 
(hydroxychloroquine) allowed endosomal escape and reduced clearance (Tang et al, 2010). 
However drawbacks of copolymers include polydispersity and have been found to be quite 
cytotoxic for primary cell lines. 
Overall it is clear that uptake and gene expression of PLL/DNA polyplexes is dependent on 
DNA topology. Complexes containing SC-pDNA were most efficient in associating with the 
nucleus as observed by confocal microscopy studies. Complexes containing SC-pDNA 
displayed significantly higher gene expression than other topological forms, although 
expression was modest at approximately 14% in comparison to that reported for CHO cells 
(Chapter 5, section 5.2.2.2). This may be due to DCs predominately expressing nucleases 
which restrict uptake and gene expression. The modest gene expression and low dose may 
also explain the inability of complexes to activate DCs through changes in surface marker 
expression. In terms of bio-processing and vaccine production, the application of SC-pDNA 
is a key pre-requisite. The findings of this study show how pDNA in the SC conformation is 
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more efficient in terms of both uptake and gene expression than OC- and linear-pDNA. This 
is important as very few studies have systematically compared plasmids of different DNA 
topologies in regards to biophysical characterisation, mammalian cell uptake and potential 
nuclear import. Therefore DNA topology does impact on processing and vaccine 
manufacture. This is in agreement with current regulatory bodies such as the FDA which 
require 80% SC content (Guidance for Industry: Considerations for Plasmid DNA Vaccines 
for Infectious Disease Indications – FDA, 2007). 
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6.5 Chapter Summary  
 Polyplex uptake in DCs showed dependence on DNA topology. 
o SC-pDNA polyplexes displayed efficient uptake within 60 minutes. 
o SC-pDNA polyplexes associated most with nucleus as shown by confocal 
microscopy. 15% of SC-pDNA polyplexes associated with the nuclei at 60 
minutes. 
o No nuclear association was recorded for OC- and linear-pDNA polyplexes 
which remained within the cytosol and periphery of cells by 60 minutes.  
o DNA and PLL displayed dual labelling indicating plasmid and polymer 
remain closely associated. 
 DC polyplex gene expression showed dependence on DNA topology, size and dose. 
Gene expression was highest for SC-pDNA polyplexes at approximately 14%, which 
was independent of charge ratio (ratio of PLL to DNA). 
 OC-pDNA and linear-pDNA polyplex gene expression was not significantly different 
to each other. Gene expression was not significantly different to naked DNA controls 
(with the exception of naked linear-pDNA). This may be due to lack of uptake and/or 
nuclease degradation.  
 Transfection of SC-pDNA polyplexes did not alter DC phenotype as shown through 
flow cytometry analysis. Gene expression did not activate DCs to express key cell 
surface markers that are involved in antigen presentation. A pDNA dosage of 20µg 
failed to elicit phenotypic changes unlike previous clinical trials which used in excess 
of 1mg pDNA (Doukas et al, 2011).  
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7. Role of importin-7 in nuclear import of polyplex 
molecules by HeLa cells  
 
Over the course of this investigation polyplex uptake and gene expression have been 
extensively studied in CHO cells and DCs. Polyplex uptake was analysed in both CHO cells 
(Chapter 5) and DCs (Chapter 6). However if DNA polyplexes are to be employed for 
therapeutic purposes, understanding nuclear uptake is important. The following chapter 
addressed the mechanism of polyplex nuclear import (defined as the transportation of foreign 
material into the nucleus) and the factors involved. Very little has been reported on the 
detailed mechanism of nuclear import of DNA polyplexes. DNA polyplex uptake was 
analysed in cells deficient in importin-7 (Imp7). Imp7 is a key nucleocytoplasmic transport 
protein which has been identified to facilitate nuclear import of viral DNA (Zaitseva et al, 
2009).  
To observe whether DNA polyplexes exploit Imp7 and enter the nuclei in a manner similar to 
viral DNA, complexes were transfected within HeLa cells deficient (knockdown [KD]) in 
Imp7 and analysed with the appropriate controls. Qualitative and quantitative analysis was 
carried out. Finally to observe whether DNA polyplexes are taken up in a similar manner to 
viral DNA, anti-viral innate immune responses was measured and whether Imp7 KD has an 
effect. 
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7.1 Qualitative and quantitative analysis of polyplex nuclear import 
7.1.1 Confocal microscopy analysis  
Polyplex nuclear import was monitored in HeLa cells with a stable Imp7 KD (generated via 
shRNA [small hairpin RNA] gene silencing) for which two clones were available; clone 2 
(Cl2) and clone 4 (Cl4). Control cells containing an shRNA targeting a different mRNA 
sequence (Discosoma corallimorpharian DsRed [DxR]) was used along with cells that were 
previously Imp7 KD, but were back complemented with an Imp7 cDNA containing two 
mutations that confer resistance towards gene silencing, thereby restoring Imp7 function 
(Back Imp7) (Chapter 2, section 2.5.3). Cells were kindly provided by Dr Ari Fassati (Wohl 
Virion Centre, UCL). Stable KD of cells was via puromycin (1µg/ml) selection (Chapter 2, 
section 2.5.3). Polyplex uptake was monitored for a period of 1 hour, as uptake and nuclear 
association has been found to occur quite rapidly. Analysis was carried out by fluorescent 
confocal microscopy (Figure 7.1). As in previous chapters, mid section images were taken to 
confirm true polyplex uptake along with projection images of all sections (referred to as z-
stack projection images). Polyplex nuclear association (polyplex fluorescence completely 
overlaid with nuclear stain) did not occur in KD cells. The majority of polyplexes were 
situated on the outer periphery of the cell or in the cytosol. In contrast nuclear association did 
occur in the DxR and Back Imp7 controls as in the case of SC-pDNA polyplexes.  
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Figure 7.1:  Observation of polyplex uptake in HeLa cells. Confocal microscopy mid section (A) and 
stack projection images (B).  Figure shows polyplex (containing 2µg DNA) uptake at 1 hour post 
transfection in HeLa cells whose importin-7 (Imp7) function is knocked down through gene silencing. Two 
Imp7 KD clones were studied; clone 2 (Cl2) and clone 4 (Cl4). Uptake was also analysed in the 
appropriate controls; control HeLa cells containing a DxR mRNA target and KD cells whose Imp7 
function is restored (Back Imp7).    
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7.1.2 Quantification of confocal analysis      
To quantify the results of Figure 7.1 the number of cell associated polyplexes was counted 
and classed according to the respective cellular compartment (Figure 7.2). Polyplexes were 
counted in the DAPI (blue) filter to avoid bias selection of fluorescently labelled complexes 
(i.e. not selecting complexes in far red or green fluorescent channels). Furthermore sample 
slides were blinded before analysis. The percentage of nuclear associated polyplexes is 
significantly reduced in Imp7 KD cells and uptake shows dependence on DNA topology. 
Polyplexes were often situated and accumulated within the periphery of the cell. However the 
percentage of nuclear associated polyplexes in control cells (which was greatest for SC-
pDNA polyplexes at >20%), where Imp7 function was not hindered, was almost 3 fold 
greater than KD cells with polyplexes gradually migrating from the periphery through the 
cytosol, culminating in nuclear access. Details of quantification methodology are provided in 
Chapter 2, section 2.6.7.3.   
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7.1.3 The effect of Imp7 KD on polyplex gene expression  
Polyplex gene expression was measured in Imp7 KD and control cells according to optimal 
conditions of preliminary studies (Figure 7.3a). Gene expression is significantly reduced in 
Imp7 KD cells, whereas those of the controls (DxR and Back Imp7) are more than 2 fold 
greater (SC and OC forms) (Figure 7.3b). Polyplex gene expression was not significantly 
different (p < 0.05) between the controls and was highest for SC-pDNA polyplexes in a 
topology dependent manner.  
 
 
Figure 7.2: Quantification of polyplex uptake in HeLa cells at 1 hour. Polyplexes (containing 2µg 
DNA) were prepared at charge ratios of +1.6 (for SC- and OC-pDNA) and +5 for linear pDNA. The 
figure shows the mean and standard error (SE) of 3 independent experiments. One-way ANOVA was 
employed to deduce levels of statistical significance (p < 0.05) of the percentage uptake of complexes 
within each cellular location between those of the control cells and Imp7 KD cells.  
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Figure 7.3: The effect of Imp7 KD on polyplex gene expression. Time and dose dependent polyplex 
gene expression within control DxR HeLa cells (A). Polyplex gene expression at optimal conditions (48 
hours, 20µg DNA) (B). Polyplexes were prepared at charge ratios of; +1.6 for SC- and OC-pDNA, and 
+5 for linear-pDNA. The figure shows the mean and SE of 3 independent experiments. One-way 
ANOVA was employed to deduce levels of statistical significance (p < 0.05) of polyplex gene expression 
between those of the control cells and Imp7 KD cells.  
 
  
 
 
Chapter 7 Role of 
importin-7 in 
nuclear import 
of polyplex 
molecules by 
HeLa cells 
 
223 
 
7.2 Live cell confocal microscopy analysis of nuclear uptake 
For the first time PLL/DNA polyplex (of differing DNA topologies) uptake was monitored in 
real time in Imp7 KD cells via live cell confocal microscopy. HeLa cells were seeded 
(approximately 500,000 cells per well) into chambered glass coverslips and stained for 
nuclei. Cells were transfected with fluorescently labelled polyplexes (containing 2µg of 
pDNA) in a chambered confocal microscope (37°C) and immediately imaged. Images were 
attained as a projection of slices, taken every 2 minutes for 1 hour. A total of 10 slices (each 
of 0.2µm in thickness) were taken. To accurately deduce whether DNA is truly associated 
with the nuclei (fluorescence overlay) and gaining nuclear access, individual image slices 
from the total stack were analysed. Images from the middle of the slice stack (slice number 5 
out of 10) were used for image analysis from each time point to deduce if co-localisation of 
fluorescence, if any, occurs corresponding to DNA nuclear entry. Details of analysis are 
provided in Chapter 2, section 2.6.7.2.    
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7.2.1 SC-pDNA polyplex nuclear import        
Live cell imaging was used to analyse whether DNA polyplexes utilise Imp7 for nuclear 
import. The advantage of live cell imaging is that uptake can be monitored in real time in vivo 
and therefore bypasses fixation and probing. In these experiments the polyplex DNA (red) 
and nuclei (blue) were stained to highlight any possible entry. Uptake of SC-pDNA 
polyplexes in HeLa DxR control cells (Figure 7.4a) was compared with that of Imp7 KD 
cells. By 2 minutes, red fluorescence begins to overlay with the blue nuclei. This continues 
for the remainder of the time course (Figure 7.4a).  
In contrast when the experiment was repeated with Imp7 KD cells no fluorescence overlay 
occurred. Fluorescence corresponding to polyplex DNA was situated on the outside of the 
nuclei (Figure 7.4b). By residing on the outside of the nucleus, nuclear association seems to 
be blocked. This is shown in Figure 7.4b by the accumulation of DNA around the nuclei 
which continues throughout the time course. Imp7 functions by shuttling foreign cargo 
between the cytosol and nucleus (Fassati et al, 2003) and inhibition of this clearly affects 
polyplex nuclear import.  
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Figure 7.4: Live cell fluorescent confocal microscopy analysis of SC-pDNA polyplexes in control DxR and 
Imp7 KD cells. Images show polyplex (2µg DNA) uptake within control DxR HeLa cells (A) and Imp7 KD 
cells (Importin-7 function is rendered) (B). Microscope images were collected as a stack of ten image slices. The 
figure shows the middle slice (slice number 5) spanning a time course of 60 minutes. HeLa cells were stained 
with Hoechst 34580 and immediately imaged in real time. 
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7.2.2 OC-pDNA polyplex nuclear import 
Polyplexes containing OC-pDNA did show fluorescence overlay with the DxR control cell 
nuclei by 6 minutes (Figure 7.5a) which continued throughout the time course. DNA 
fluorescence was also detected in Imp7 KD cells which could be due to residual DNA, 
although this was much lower than that of the control (Figure 7.5b).  
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Figure 7.5: Live cell fluorescent confocal microscopy analysis of OC-pDNA polyplexes in control DxR 
and Imp7 KD cells. Images show polyplex (2µg DNA) uptake within control DxR HeLa cells (A) and Imp7 
KD cells (Importin-7 function is rendered) (B). Microscope images were collected as a stack of ten image 
slices. The figure shows the middle slice (slice number 5) spanning a time course of 60 minutes. HeLa cells 
were stained with Hoechst 34580 and immediately imaged in real time. 
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7.2.3 Linear-pDNA polyplex nuclear import 
Linear-pDNA polyplexes showed fluorescence overlay with the DxR cell nuclei (Figure 7.6a) 
in contrast to that of the Imp7 KD cell (Figure 7.6b). This could indicate potential use of 
Imp7 for nuclear access.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 7 Role of 
importin-7 in 
nuclear import 
of polyplex 
molecules by 
HeLa cells 
 
229 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.6: Live cell fluorescent confocal microscopy analysis of linear-pDNA polyplexes in control 
DxR and Imp7 KD cells. Images show polyplex (2µg DNA) uptake within control DxR HeLa cells (A) and 
Imp7 KD cells (Importin-7 function is rendered) (B). Microscope images were collected as a stack of ten 
image slices. The figure shows the middle slice (slice number 5) spanning a time course of 60 minutes. HeLa 
cells were stained with Hoechst 34580 and immediately imaged in real time. 
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7.2.4 Naked DNA controls 
To show uptake of DNA was due to association with PLL, fluorescently labelled naked 
pDNA was transfected into the DxR control cell line.  
7.2.4.1 Naked SC-pDNA 
SC- (2µg naked DNA) was transfected into DxR control cell line. Throughout the time course 
of up to 1 hour, no fluorescence is observed. This could be due to DNA degradation by 
nucleases and also the nucleic acid requiring PLL to enter cells (Figure 7.7) 
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7.2.4.2 Naked OC-pDNA 
Naked OC-pDNA was transfected in the DxR control cell line and like Figure 7.7 no 
fluorescence corresponding to DNA is observed (Figure 7.8). Again this could be due to 
nucleic acids requiring PLL to enter cells.  
 
 
 
Figure 7.7: Live cell fluorescent confocal microscopy analysis of naked SC-pDNA (2µg). Images 
show uptake within control DxR HeLa cells. Microscope images were collected as a stack of ten image 
slices. The figure shows the middle slice (slice number 5) spanning a time course of 60 minutes.   
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7.2.4.3 Naked linear-pDNA 
Naked linear-pDNA was transfected into the DxR control cell line and no DNA fluorescence 
is observed within the nuclei or outside of it (Figure 7.9). This could be due to the pDNA 
requiring PLL to enter cells. Alternatively DNA may have entered cells but could be readily 
degraded by host cell nucleases due to lack of protection that is offered by PLL (due to DNA 
condensation). 
 
 
 
Figure 7.8: Live cell fluorescent confocal microscopy analysis of naked OC-pDNA (2µg). Images 
show uptake within control DxR HeLa cells. Microscope images were collected as a stack of ten image 
slices. The figure shows the middle slice (slice number 5) spanning a time course of 60 minutes.   
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Therefore the data provided by the live cell imaging studies highlight how: 
 DNA polyplex fluorescent (regardless of DNA topology) co-localisation with host 
cell nuclei was reduced in Imp7 KD cells. 
 Although DNA fluorescent co-localisation with the nuclei occurred in Imp7 KD cells, 
this was much more pronounced in control cells suggesting a possible role of Imp7 
regarding nuclear import. However alternative import mechanism may be utilised.    
 Imp7 KD inhibits nuclear import, as shown by the accumulation of DNA fluorescence 
surrounding the nuclei (Figure 7.4b). This is a key function of Imp7 (Fassati et al, 
2003).  
Figure 7.9: Live cell fluorescent confocal microscopy analysis of naked linear-pDNA (2µg). Images 
show uptake within control DxR HeLa cells. Microscope images were collected as a stack of ten image 
slices. The figure shows the middle slice (slice number 5) spanning a time course of 60 minutes.   
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7.3 DNA polyplexes trigger anti-viral innate immune responses 
Imp7 has been found to facilitate viral DNA nuclear import (Zaitseva et al, 2009). To observe 
whether DNA polyplexes are taken up in a similar manner to viral DNA, anti-viral innate 
immune responses was measured and whether Imp7 KD has an effect. Polyplexes were 
transfected into HeLa cells for 4 hours (time required to stimulate innate response) and 
interferon-β  (IFN-β) activity was measured. IFN-β is a cytokine protein synthesized by host 
cells and secreted in response to viral or pathogen infection. They are important in terms of 
facilitating immune responses to protect against pathogens (Li et al, 2010). IFN-β stimulates 
the production of various proteins in response to viral infection, such as interferon-induced 
protein with tetratricopeptide repeats-2 (IFIT2). To deduce whether uptake of DNA 
polyplexes triggers an innate immune response similar to that of viruses, IFIT2 gene 
expression was measured via quantitative polymerase chain reaction (Q-PCR) (Chapter 2, 
section 2.7).      
7.3.1 Q-PCR analysis of IFIT2 gene expression 
Q-PCR was used to measure IFIT2 gene expression following uptake of DNA polyplexes in 
Imp7 KD and control cells (Figure 7.10). Q-PCR is based on the fluorescent detection of the 
target nucleic acid sample. The figure displays Ct (cycle threshold) values for each 
component. The Ct value refers to the number of cycles required for the fluorescent signal to 
cross the threshold (beyond background fluorescence). Ct values are inversely proportional to 
the amount of target DNA sample present, hence high Ct values equate to low gene 
expression. Figure 7.10 shows the Ct values of triplicate data. The highest Ct value regardless 
of Imp7 KD was that of untransfected cells (lowest IFIT2 gene expression) (Figure 7.10a). 
IFIT2 gene upregulation was greatest in cells transfected with SC-pDNA polyplexes. 
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However no significant difference in expression was observed between polyplexes of 
differing DNA topologies (p < 0.05). 
To confirm the results of Figure 7.10a, the Ct values were normalized with those of a 
housekeeping gene (whose expression remains constant) GAPDH (glyceraldehyde 3-
phosphate dehydrogenase) to yield delta Ct (dCt) values (Figure 7.10b). Like the Ct 
component, dCt values are inversely proportional to IFIT2 gene expression (low dCt values 
correspond to high gene expression). Uptake of DNA polyplexes causes upregulation of 
IFIT2 gene expression, which was greater than untransfected cells.  
 
 
 
 
 
 
 
 
 
 
 
Figure 7.10: DNA polyplexes stimulated upregulation of IFIT2 gene expression. Gene expression 
profiles before (A) and after (B) normalization with GAPDH housekeeping gene. Polyplexes were prepared 
at charge ratios of; +1.6 for SC- and OC-pDNA, and +5 for linear-pDNA. Error bars represent the SE of 
triplicate readings. QPCR experiments were performed twice independently. Bonferroni’s   Multiple  
Comparison’s  Test was used to deduce levels of statistical significance (p < 0.05) of IFIT2 gene expression 
between control cells and Imp7 KD cells transfected with polyplexes of differing DNA topologies.   
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7.3.2 IFIT2 gene upregulation showed dependence on polyplex DNA topology 
Figure 7.10 shows uptake of PLL/DNA polyplexes induces IFIT2 gene expression. However 
these polyplexes were transfected at a high DNA dose (20µg pDNA) which may mask subtle 
changes in IFIT2 expression between differing DNA topologies. Polyplexes were transfected 
at a lower dose of 0.2µg pDNA (Figure 7.11). IFIT2 gene expression (normalised against 
GAPDH) was highest for cells transfected with SC- and OC-pDNA polyplexes, which were 
not significantly different to each other, but were significantly different to cells transfected 
with linear-pDNA polyplexes (p < 0.05). More specifically IFIT2 upregulation was not 
significantly different between Imp7 KD Cl2 and Cl4 cells transfected with SC-pDNA (p < 
0.05). IFIT2 gene expression was highest in Imp7 KD cells transfected with SC-pDNA which 
may be due to the accumulation of polyplex DNA in the cytosol triggering cytosolic DNA 
sensing agents. IFIT2 gene expression was slightly lower for cells transfected with linear-
pDNA polyplexes. Untransfected cells displayed significantly higher dCt values 
corresponding to low gene expression, hence no anti-viral response. To deduce whether 
IFIT2 gene expression was due to DNA and not the transfection process, uncomplexed PLL 
(at  amounts  corresponding  to  a  charge  ratio  of  +1.6  and  +5)  were  ‘mock  transfected’  within  
cells and gene expression was measured. The dCt values for these samples were quite high 
indicating that only transfected DNA caused an innate response through IFN-β induced IFIT2 
synthesis (Figure 7.11). Therefore innate immune response in the form of IFIT2 increased in 
cells transfected with SC-pDNA polyplexes (topology dependent), particularly Imp7 KD 
cells. This could be due to the efficiency of SC-pDNA polyplexes gaining cellular access 
unlike its topological counterparts and activating cytosolic DNA receptors that can trigger 
innate immune responses due to nuclear access being blocked (Hornung and Latz, 2010).      
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Details of the significant difference  provided  by  the  Bonferroni’s  Multiple  Comparison’s  Test 
to deduce levels of statistical significance (p < 0.05) of IFIT2 gene expression between control cells 
and Imp7 KD cells transfected with polyplexes of differing DNA topologies, are provided in Table 
7.1 
Figure 7.11: IFIT2 gene upregulation showed dependence on DNA topology. DNA polyplexes 
(containing 0.2µg pDNA) were transfected into HeLa cells. Uncomplexed   PLL   was   ‘mock  
transfected’  at  amounts  corresponding   to  charge ratios of +1.6 and +5. Polyplexes were prepared at 
charge ratios of; +1.6 for SC- and OC-pDNA, and +5 for linear-pDNA. Error bars represent the SE of 
triplicate readings. QPCR experiments were performed twice independently. Bonferroni’s  Multiple  
Comparison’s   Test   was used to deduce levels of statistical significance (p < 0.05) of IFIT2 gene 
expression between control cells and Imp7 KD cells transfected with polyplexes of differing DNA 
topologies.     
 
Figure 7.11: IFIT2 gene upregulation showed dependence on DNA topology. DNA polyplexes 
(containing  0.2µg  pDNA)  were   transfected   into  HeLa  cells.  Uncomplexed  PLL  was   ‘mock   transfected’  at  
amounts corresponding to charge ratios of +1.6 and +5. Polyplexes were prepared at charge ratios of; +1.6 
for SC- and OC-pDNA, and +5 for linear-pDNA. Error bars represent the SE of triplicate readings. QPCR 
experiments were performed twice independently. Bonferroni’s  Multiple   Comparison’s   Test   was   used   to  
deduce levels of statistical significance (p < 0.05) of IFIT2 gene expression between control cells and Imp7 
KD cells transfected with polyplexes of differing DNA topologies. 
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7.4 Discussion  
Knowledge of polyplex nuclear import is pivotal if non-viral gene delivery is to be applied 
therapeutically. Few studies have reported detailed mechanisms of polyplex nuclear entry. 
Importin-7 (Imp7) is part of a large family of factors involved in the continuous shuttling of 
cargo between the cytosol and nucleus, and has been specifically implicated in the nuclear 
import of viral DNA; HIV-I (Zaitseva et al, 2009). This could provide some insight into 
pDNA uptake and expression.  
7.4.1 Polyplex nuclear import: qualitative and quantitative analysis 
The findings from Chapter 5 revealed PLL/DNA polyplex uptake in CHO cells and how 
complexes are also taken up by DCs (Chapter 6). However polyplex nuclear import and the 
mechanisms responsible have not been reported in great depth. The current chapter attempted 
to address this whereby polyplex uptake in cells lacking importin-7 (Imp7) was studied. Imp7 
is a key receptor transport protein reported to aid nuclear import of viral DNA. Uptake of 
polyplexes within Imp7 knockdown (KD) (which was brought about via shRNA [small 
hairpin RNA] gene silencing) cells was monitored by confocal microscopy and gene 
expression studies. Uptake and gene expression was compared with control cells that 
contained functioning Imp7. 
7.4.1.1 Imp7 KD reduces polyplex nuclear association as revealed by confocal 
microscopy 
Imp7 has been reported to facilitate HIV-I viral DNA nuclear import (Zaitseva et al, 2009; 
Fassati et al, 2003). To observe whether PLL/DNA complexes exploit such a mechanism, 
polyplex uptake was studied in HeLa cells containing a stable Imp7 KD via puromycin 
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selection (two clone cells were used; clone 2 [Cl2] and clone 4 [Cl4]). Uptake was also 
studied within control HeLa cells containing a shRNA targeting an alternative mRNA 
sequence (DxR), along with KD cells that had Imp7 function restored (Back Imp7). Confocal 
microscopy analysis revealed polyplex nuclear association (defined when polyplex 
fluorescence completely overlaid with nuclear stain) was hindered in Imp7 KD cells (Figure 
7.1). This was confirmed in both mid section and stack confocal images. The percentage of 
nuclear associated polyplexes, which was greatest for SC-pDNA polyplexes at >20%, 
reduced dramatically when Imp7 function was abolished (<5%) (Figure 7.2). Although 
infected with viral DNA, Imp7 KD led to DNA accumulation within the cytosol (Zaitseva et 
al, 2009; Miller et al, 2009). Imp7 works in conjunction with protein factors and 
nucleoporins which constitute the nuclear pore complex (NPC) (Gorlich and Kutay, 1999). 
The nuclear pore import receptor (NIR) in the cytosol has been found to recognise viral 
DNA. The NIR/DNA complex then interacts with the NPC to gain access within the 
nucleoplasm (Fassati et al, 2003). This mechanism could be responsible for polyplex nuclear 
import. 
7.4.1.2 Imp7 KD decreases polyplex gene expression  
Polyplex gene expression was measured to record the effect of Imp7 KD. Gene expression 
significantly decreased when Imp7 function was silenced. Gene expression reduced by 50% 
for SC-pDNA polyplexes (Figure 7.3). HIV-I plasmid gene expression was also found to be 
hindered when Imp7 function was inhibited (Zaitseva et al, 2009). However this is the first 
reported case of Imp7 inhibition affecting PLL/DNA complex gene expression. Fluorescence 
resonance energy transfer (FRET) has revealed how DNA polyplex nuclear entry occurs via 
the NPC and binds to various importin proteins (Breuzard et al, 2008; Lam and Dean, 2010). 
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The present study identified DNA topology dependent gene expression for polyplexes within 
CHO cells, DCs and HeLa cells. Although displaying larger sizes (<1000nm) and 
susceptibility towards nucleases, linear-pDNA polyplexes still managed to induce gene 
expression. This may occur via Imp7 mediated NPC nuclear delivery, which readily occurs 
for large viral DNAs which share the same topological form as linear-pDNA. 
7.4.2 Live cell imaging studies 
PLL/DNA polyplex (containing different DNA topological forms) uptake in Imp7 KD cells 
was monitored in real time via live cell confocal microscopy (Figure 7.4). These experiments 
provided some key insights:  
 Polyplex DNA fluorescence and host cell nuclei (of control) fluorescence co-
localised.  
 However DNA fluorescence also co-localised with host cell nuclei in Imp7 KD cells 
(Figure 7.5b) indicating alternative import mechanisms may be utilised, although this 
was much more pronounced in control cells indicating Imp7 may be used by DNA 
complexes.   
 This is important as nuclear import of cargo is a key function of Imp7 (Fassati et al, 
2003; Nagasaki et al, 2005).  
 Nuclear import of SC- and OC-pDNA polyplexes is rapid occurring in less than 10 
minutes.    
However it is clear there is significantly more polyplex DNA in the control cells (Figure 
7.4a), than Imp7 KD cells (Figure 7.4b). A possible reason could be due to a reduction in 
cytoplasmic transport as a result of Imp7 KD. Imp7 is a key nucleocytoplasmic complex that 
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shuttles foreign components to the nucleus. As Imp7 function is reduced, it is unable to bind 
to cytoplasmic protein complexes such as Impβ which constitutes a protein complex that 
hauls foreign components from the cytosol (Ao et al, 2007; Zaitseva et al, 2009). Therefore 
Imp7 KD reduces Impβ interaction which could potentially hinder polyplex uptake and 
transport in the cytosol towards the nuclei. This could account for the reduced DNA 
fluorescence in Figure 7.4b).  
To optimise this strategy and further confirm the role Imp7 in polyplex nuclear import, live 
cell imaging studies could incorporate fluorescent staining of NPC components. Although 
Imp7 KD specifically inhibited nuclear import, Imp7 operates in conjunction with various 
other protein factors which constitute the NPC, and so it would be interesting to analyse how 
other factors may contribute towards nuclear entry (such as Impβ).   
7.4.3 Polyplex uptake triggers anti-viral innate immune responses  
To confirm whether DNA polyplexes utilise viral uptake mechanisms such as Imp7, anti-viral 
responses were measured. Interferon-β   (IFN-β) cytokine activity was measured following 
polyplex uptake. IFN-β is secreted in response to viral or pathogen infection and stimulates 
the synthesis of interferon-induced protein with tetratricopeptide repeats-2 (IFIT2) 
(Katsoulidis et al, 2008; Li et al, 2010).  
Following polyplex uptake, IFIT2 gene upregulation was measured by Q-PCR. The 
protective attributes of IFIT2 as an antiviral protein was reported previously whereby 
transformation of BCR-ABL (breakpoint cluster region Abelson leukaemia fusion protein) 
within host cells abolished IFIT2 antileukaemic pathways (Katsoulidis et al, 2008). HeLa 
cells transfected with PLL/DNA polyplexes led to higher IFIT2 gene expression (lower cycle 
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threshold [Ct]) than untransfected cells (Figure 7.10). Despite normalization with 
housekeeping genes, the addition of polyplex DNA (regardless of topology) clearly induced 
an anti-viral response (Figure 7.10b). 
Figure 7.10 shows upregulation of IFIT2 following uptake of polyplexes containing 20µg 
pDNA. The experiment was repeated with polyplexes containing 0.2µg pDNA as a high dose 
may mask subtle changes in IFIT2 expression between differing DNA topologies. 
Upregulation of IFIT2 showed dependence on DNA topology which was greatest for Imp7 
KD cells transfected with SC-pDNA polyplexes (Figure 7.11). SC-pDNA polyplexes are 
more efficient than its topological counterparts in regards to gaining cellular access, and 
cytosolic accumulation of these complexes in Imp7 KD cells (as a result of nuclear import 
being blocked) may activate cytosolic DNA sensing agents (Hornung and Latz, 2010). IFIT2 
gene upregulation was exclusive to transfected DNA as native PLL induced a very low 
response (presumably protein could not enter the cell) as well as untransfected cells. 
Innate responses such as IFN-β upregulation of IFIT2 and cytokine production can occur 
through various detection pathways which are often located in the cytosol. Kobiyama et al, 
(2010) revealed how histone H2B stimulates innate antiviral immune responses within human 
cells. Foreign DNA stimulates H2B to interact with interferon-β  promoter stimulator 1 (IPS-
1) via the adapter protein; CIAO (COOH terminal importin-9 related adaptor organising 
histone H2B and IPS-1) (Kobiyama et al, 2010). The IPS-1/CIAO interaction transmits a 
signal specifically for dsDNA leading to IFN-β response (Kobiyama et al, 2010). Other DNA 
sensing agents include toll-like receptors (TLRs), which are pathogen recognition receptors 
(PRRs) that offer immediate protection against viral infection. TLR9 is an example of a PRR 
that specifically detects DNA (Vilaysane and Muruve, 2009). TLR-9 was shown to recognise 
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DNA which led to the recruitment of the adaptor protein MyD88 to induce cytokine 
production (Hemmi et al, 2000). DNA detecting agents such as TLR-9 have been found to 
induce IFN-β transcription (Uematsu et al, 2005). Other DNA sensors also include Z-DNA 
binding protein-1 (ZBP1) which binds to DNA and elicits IFN responses through the 
recruitment of interferon regulatory factors (IRFs) (Takaoka et al, 2007). Absent in 
melanoma 2 (AIM2) are a family of PRRs that detects cytoplasmic dsDNA which in turn 
triggers inflammatory responses as well as programmed cell death referred to as pyroptosis 
(Shao et al, 2007; Fernandes-Alnemri et al, 2007, Vilaysane and Muruve, 2009). Therefore 
the induction of IFN-β induced IFIT2 activity can take place through a variety of mechanisms 
due to the multiple DNA sensing agents available. 
7.4.4 Improvements and future analyses 
In order to improve the current protocol, fluorescent staining/probing of Imp7 could be 
applied and co-localisation between the receptor and cargo could be used to confirm 
interaction (Jäkel et al, 1999). Imp7 nuclear shuttling is mediated by GTPases; enzymes 
which bind to guanosine triphosphate (GTP) and reversibly hydrolyse this to produce 
guanosine diphosphate (GDP). Conversion of GDP to GTP is mediated by guanine nucleotide 
exchange factor in which GTP production activates the cell (through conformational changes 
to the Imp7/cargo complex) to allow nuclear entry and release of the foreign cargo (Zatiseva 
et al, 2009; Ao et al, 2007). Specific knockdown of this GTP/GDP hydrolysis mechanism in 
regards to nuclear shuttling, could also potentially confirm the role of Imp7 towards the 
nuclear import of polyplex DNA.      
Improvements for future analysis could include the incorporation of nuclear localisation 
signal (NLS) peptides which interact with importin proteins, and has proven successful with 
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polymers such as PEI and PLL whereby improved gene expression has been reported (Kim et 
al, 2009).  
This chapter focused on the potential exploitation of Imp7 for nuclear import by DNA 
polyplexes. Confocal qualitative and quantitative studies showed reduced nuclear association 
in Imp7 KD cells than in control cells with functioning Imp7. Furthermore experiments 
showed reduced gene expression profiles in Imp7 KD cells. However whilst live cell imaging 
did show fluorescent co-localisation between DNA and nuclei in Imp7 KD cells, co-
localisation was more pronounced in control cells with functioning Imp7. Q-PCR studies 
revealed higher antiviral responses detected in Imp7 KD cells when transfected with SC-
pDNA. Therefore in regards to future therapeutic studies design of polyplexes could 
incorporate components that could potentially enhance Imp7 interaction and nuclear import.    
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7.5 Chapter Summary  
 PLL/DNA polyplex uptake and gene expression in HeLa cells showed dependence on 
DNA topology (greatest for SC-pDNA complexes). 
 Regardless of DNA topology: 
o Qualitative confocal microscopy analysis showed Imp7 KD reduced nuclear 
association of complexes. 
o Quantitative confocal image analysis revealed a decrease in the percentage of 
polyplex nuclear association in Imp 7 KD cells. SC-pDNA polyplexes 
displayed highest complex nuclear association at >20% in control cells which 
decreased to <5% in Imp7 KD cells.   
o Reduction in gene expression in Imp7 KD cells. Gene expression (particularly 
for SC- and OC-pDNA polyplexes) decreased from approximately >20% in 
DxR and Back Imp7 control cells to >8% in Imp7 KD cells.  
 Live cell imaging showed co-localisation of DNA and nucleus in Imp7 KD cells; 
however co-localisation was more pronounced in cells with functioning Imp7.  
 DNA polyplexes stimulate anti-viral responses as shown by the upregulation of IFIT2 
(protein synthesised in response to viral infection). 
o Upregulation of IFIT2 showed dependence on DNA topology. IFIT2 gene 
expression was greatest for Imp7 KD cells transfected with SC-pDNA 
polyplexes presumably due to cytosolic accumulation of DNA which could 
activate DNA sensing agents. Responses were exclusive to transfected cells. 
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8. Conclusions and Future Work 
 
In this study plasmid DNA (pDNA) was complexed with poly-L-lysine (PLL) to form DNA 
complexes (polyplexes). Biophysical analysis revealed how parameters such as DNA 
topology affect polyplex characterisation (charge, size, nuclease resistance and DNA 
condensation by PLL). To deduce whether topology and biophysical characteristics impact on 
cellular uptake (defined as the intake of materials by a cell or tissue leading to its permanent 
or temporary retention), polyplexes were transiently transfected into mammalian cells. This 
refers to the process of introducing foreign nucleic acids into host cells, often with the aim of 
expressing a desired protein product (Liu et al, 2008). Polyplexes containing plasmids in the 
supercoiled (SC) form displayed greatest gene expression (expression of encoded plasmid 
reporter lacZ gene) within Chinese hamster ovary (CHO), HeLa and dendritic cells (DCs). 
Polyplex uptake was analysed in CHO cells and possible nuclear import by importin-7 
(Imp7) in a manner similar to viral DNA was also studied. Polyplexes were found to 
stimulate anti-viral innate immune responses.  
Key points encountered in this study were: 
 DNA topology affected polyplex biophysical characteristics which included 
parameters such as size, surface charge, ability to be condensed by PLL and nuclease 
resistance amongst others. SC-pDNA polyplexes were smaller and displayed greater 
nuclease resistance than OC (open circular) - and linear-pDNA complexes. 
Furthermore linear-pDNA required greater amounts of PLL to neutralise the anionic 
pDNA charge.  
Chapter 8 Conclusions 
and future 
work 
 
249 
 
 Plasmid vector size was found to affect polyplex characterisation. A bacterial artificial 
chromosome (BAC, 56.5kb) was studied in conjunction with a 3.8kb plasmid. The 
large size of the BAC restricted charge neutralisation and condensation by PLL unlike 
that of the smaller 3.8kb plasmid.    
 Mammalian cell uptake of complexes was monitored qualitatively and quantitatively 
via fluorescent confocal microscopy. Uptake (which was confirmed by both mid 
section and stack confocal microscopy images) of SC-pDNA polyplexes was the most 
efficient in all three cell types studied. A greater percentage of SC-pDNA polyplexes 
associated with the nuclei (fluorescent co-localisation of polyplex and nuclear stain).   
 Confocal microscopy studies revealed plasmids remain associated with PLL post 
transfection as shown by fluorescent overlay between the individual components.   
 SC-pDNA polyplexes displayed highest gene expression in mammalian cells. Gene 
expression showed dependence on DNA topology regardless of charge ratio (ratio of 
PLL to DNA). 
 PLL/DNA nuclear import (defined as the transportation of foreign material into the 
nuclei) was studied in importin-7 (Imp7) knockdown (KD) cells. Confocal image 
qualitative and quantitative analysis showed nuclear association decreased in Imp7 
KD cells. Polyplex gene expression decreased in Imp7 KD cells in comparison to 
control cells with functioning Imp7. However live cell imaging analysis did show co-
localisation between DNA and nuclei in Imp7 KD cells suggesting other possible 
nuclear import mechanisms.    
 Uptake of DNA polyplexes stimulated anti-viral innate immune responses. 
Upregulation of IFIT2 (interferon induced protein with tetratricopeptide repeats-2) 
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which is produced by IFN-β in response to viral infection was measured. 
Upregulation of IFIT2 increased in Imp7 KD cells transfected with SC-pDNA 
indicating possible cytoplasmic accumulation of polyplex DNA stimulates DNA 
sensing agents that trigger innate responses.  
8.1 Biophysical characteristic study of PLL/DNA polyplexes 
Biophysical studies were performed on DNA polyplexes. The findings revealed in Chapter 3 
show that key parameters such as DNA topology influence polyplex characteristics such as 
polyplex size, charge, ability of DNA to be condensed by PLL, nuclease resistance, ionic 
strength and plasmid vector size.  
Data from Chapter 3 showed that SC- and OC-pDNA underwent rapid charge neutralisation 
unlike that of linear-pDNA, which required greater amounts of PLL (Figure 3.2). PLL/DNA 
complexes containing pDNA in its SC form were the smallest (Figure 3.5), most efficiently 
condensed by PLL (Figure 3.6) and resistant towards nuclease attack (Figure 3.11). Therefore 
based on the biophysical data the study highly recommends the use of SC-pDNA for polyplex 
mediated gene delivery.  
Plasmid size is an important consideration for gene delivery as insert size can have important 
therapeutic implications. This study analysed a 3.8kb plasmid along with a bacterial artificial 
chromosome (BAC) of 56.5kb in size, when complexed with PLL. The smaller plasmid 
yielded more favourable characteristics in regards to future gene delivery applications. When 
bound to PLL, the 3.8kb pDNA complex was much smaller, underwent rapid charge 
neutralisation and packaged (condensed by PLL) effectively. Despite offering larger gene 
insert the BAC was much larger and displayed neutral charge (even when formulated at an 
extremely high charge ratio) unworthy of uptake through the negatively charged mammalian 
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cell membrane. However it is important to note whether there is a threshold for plasmid 
vector size whereby binding with polycations is restricted which in turn limits gene delivery. 
In this study 3.8kb and 6.9kb plasmids complexed efficiently with PLL. The size threshold at 
which binding and cell uptake is reduced has been found to be approximately 12kb when 
bound to PEI (Campeau et al, 2001). Therefore smaller vector sizes in the SC conformation 
are recommended for gene delivery studies.            
Ionic strength similar to that of the microcellular environment was found to be disruptive of 
PLL/DNA complexes. When polyplexes were produced in high salt concentration (>150mM 
NaCl), size, surface charge, and DNA condensation were perturbed. This provides important 
insights towards the limitations of PLL/DNA interaction and susceptibility of the DNA cargo 
under such conditions. 
8.2 Mechanism of polyplex uptake and nuclear entry 
Mammalian cell experiments indicated possible endocytosis of polyplexes in CHO cells. 
However whilst this was indicative in endocytic inhibitor experiments, co-localisation 
between DNA fluorescence and antibody fluorescence corresponding to specific endocytic 
markers were inconclusive. SC-pDNA polyplexes displayed the greatest gene expression 
within CHO, HeLa, and dendritic cells which may be due to the advantageous biophysical 
characteristics of this particular DNA topology recorded in Chapter 3. Greater percentage of 
SC-pDNA associated with the nucleus than complexes containing other DNA forms. 
Therefore in conjunction with the biophysical data the results of mammalian cell studies 
show that DNA topology clearly effects polyplex uptake with SC-pDNA being a key pre-
requisite 
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DCs are key cells of the immune system and their targeting and exploitation for therapeutic 
application is of immense interest. Polyplex uptake within DCs can be restricted due to DCs 
predominately expressing nucleases. Confocal microscopy analysis revealed the majority of 
DNA polyplexes were found to be on the cell periphery (no overlay of polyplex fluorescence 
and cell), with a small percentage of SC-pDNA complexes associated with the nuclei (Figure 
6.4). Gene expression was highest for SC-pDNA complexes which may be due to its small 
size and ability to evade nuclease attack. DCs can trigger antibody responses and so the 
ability of SC-pDNA polyplexes to induce substantial gene expression over its counterparts is 
important for further therapeutic applications. However despite uptake of polyplexes 
containing 20µg SC-pDNA, complexes failed to activate DCs to stimulate antigen 
presentation. This suggests that future studies should incorporate polyplexes that contain 
greater DNA dosage and an adjuvant (component that enhances  recipient’s  immune  response) 
to trigger such a response (Tang et al, 2010). 
Polyplex nuclear import was studied in Chapter 7 particularly in regards to Imp7 for nuclear 
import. This is interesting as such mechanisms have been observed in regards to viral DNA 
(Zaitseva et al, 2009). Gene expression studies along with qualitative and quantitative 
confocal microscopy analyses indicated possible exploitation of Imp7. However live cell 
imaging experiments showed co-localisation between DNA and nuclei fluorescence in Imp7 
KD cells which suggests other routes of nuclear import may be employed.  
Uptake of PLL/DNA polyplexes stimulated anti-viral innate immune response, particularly in 
Imp7 KD cells. Upregulation of IFIT2 (which is synthesised in response to viral infection) 
was greatest in Imp7 KD cells transfected with SC-pDNA. These results indicate that 
polyplex uptake may occur in a manner similar to viral DNA   
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Therefore the data regarding the mechanism of polyplex uptake and nuclear import has three 
important implications for future studies: 
 PLL/DNA polyplexes (regardless of DNA topology) could incorporate elements 
(such as lipid components that interact with cell membrane) that target various 
endocytic pathways.  
 Incorporating components (such Impβ   that binds with various importin proteins) 
within polyplexes that allow specific recognition by Imp7 to maximise nuclear 
import. 
 The ability to activate and stimulate an immune response in DCs may be achieved 
by increasing DNA dosage and including adjuvants (enhances immune response) 
within polyplexes.    
8.3 Impact on processing 
Although the FDA (U.S Food and Drug Administration) has yet to approve any gene therapy 
products for sale, phase I clinical study of DNA vaccine treatment for diseases such as 
malaria, hepatitis B and HIV has been undertaken (FDA, 2007). This is a long and stringent 
process and in order to enter clinical trials FDA guidelines mentioned how gene therapy 
products must undergo potency tests in order to validate gene therapy products (Guidance for 
Industry: Potency tests for cellular and gene therapy products – FDA, 2011). More 
specifically FDA guidelines require gene therapy products to consist of 80% SC content 
(Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease 
Indications – FDA, 2007). The results presented in this thesis strongly indicate that DNA 
topology does impact on PLL/DNA complex biophysical characteristics and mammalian cell 
uptake. In agreement with FDA guidelines the results of the current investigation 
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recommends the employment of pDNA in the SC confirmation for future gene delivery 
studies. FDA guidelines require removal of other pDNA conformations in bulk product tests, 
which is in agreement of the present study whereby OC- and linear-pDNA polyplexes 
displayed inefficient uptake and gene expression profiles unlike complexes containing SC-
pDNA. Therefore in terms of processing this study recommends the focusing on SC-pDNA 
manufacture for vaccine processing in order to maximise uptake and gene expression 
profiles.         
8.4 Future aspects 
This study focused on the characterisation and uptake of pDNA when bound to PLL. The 
findings presented in this report provide a body of data regarding polyplex biophysical 
attributes, uptake, nuclear import, gene expression, DC phenotype activation and ability to 
induce innate responses. To optimise these key parameters, with the aim of improving gene 
delivery, studies are currently employing multiple polymers. A major advantage of PLL is its 
versatility whereby it can undergo chemical modification for tailor made transfection studies 
(Fu et al, 2011; von Erlach et al, 2011). Modification can take the form of polymers which 
can perform a variety of functions such as shielding complex from nuclease digestion, 
preventing aggregation and enhancing cellular uptake. Such modification has recently been 
applied with DCs. Glycopeptide attachment to enhance interaction with DC surface markers 
was reported to improve complex uptake (Anderson et al, 2010). Therefore the combinational 
use of DNA condensing agents along with co-polymers to prevent nuclease attack and 
enhance cellular uptake is paving the way for future polyplex applications.     
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Appendix I: Plasmid DNA maps 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AI  i:  pSVβ  (6.8kb) (Promega, Southampton, UK) 
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AI ii: pSELECT-NGFP-zeo (3.8kb) (InvivoGen, USA) 
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AI iii: pGEc47 (56.5kb) (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Germany)  
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Appendix II: Charge ratio calculation 
 The theoretical charge ratio between the DNA and PLL was calculated from the equation 
below as deduced from Tsai et al, (1999) and Lollo et al, (2002). The equation is based on 
several assumptions (Tsai et al, 1999):  
1. Average molecular weight of 1 DNA nucleotide = 309 
2. Average molecular weight of 1 lysine chain = 204 
3. Calculation assumes the lysine polymer is protonated to interact and bind with DNA. 
 
  
 
              Mass of PLL    309 
Mass of DNA    204 
x Charge ratio = 
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